UNITED STATES SECURITIES AND EXCHANGE COMMISSION
	FORM 10-K
	(Mark One)
|  |  |  | 
| þ |  | Annual report pursuant to Section 13 or 15(
	d
	) of
	the securities exchange act of 1934 | 
| 
 | 
|  |  | 
	For the fiscal year ended
	December 31, 2008
 | 
| 
 | 
| o |  | Transition report pursuant to section 13 or 15(
	d
	)
	of the securities exchange act of 1934 | 
 
	Commission File Number 001-31225
 
	ENPRO INDUSTRIES, INC.
	(Exact name of registrant, as specified in its charter)
|  |  |  | 
| North Carolina |  | 01-0573945 | 
| (State or other jurisdiction of incorporation) |  | (I.R.S. employer identification no.) | 
|  |  |  | 
| 5605 Carnegie Boulevard, Suite 500, |  | 28209 | 
| Charlotte, North Carolina |  | (Zip code) | 
| (Address of principal executive offices) |  |  | 
 
	(704) 731-1500
	(Registrants telephone number, including area code)
	Securities registered pursuant to Section 12(b) of the Act:
|  |  |  | 
|  |  | Name of each exchange | 
| Title of each class |  | on which registered | 
|  |  |  | 
|  |  |  | 
| Common stock, $0.01 par value Preferred stock purchase rights
 |  | New York Stock Exchange New York Stock Exchange
 | 
 
	Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of
	the Securities Act.
	Yes
	o
	      No
	þ
	Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or
	Section 15(d) of the Act.
	Yes
	o
	      No
	þ
	Indicate by check mark whether the registrant (1) has filed all reports required to be filed by
	Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
	such shorter period that the registrant was required to file such reports), and (2) has been
	subject to such filing requirements for the past 90 days.
	Yes
	þ
	      No
	o
	Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is
	not contained herein, and will not be contained, to the best of the registrants knowledge, in
	definitive proxy or information statements incorporated by reference in Part III of this Form 10-K
	or any amendment to this Form 10-K.
	þ
	Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer,
	a non-accelerated filer, or a smaller reporting company.
	See the definitions of large
	accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
|  |  |  |  |  |  |  | 
| Large accelerated filer
	þ |  | Accelerated filer
	o |  | Non-accelerated filer  
	o (Do not check if a smaller reporting company)
 |  | Smaller Reporting Company
	o | 
 
 
	Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
	Exchange Act).
	Yes
	o
	      No
	þ
	The aggregate market value of voting and nonvoting common stock of the registrant held by
	non-affiliates of the registrant as of June 30, 2008 was $729,959,137. As of February 20, 2009,
	there were 19,816,149 shares of common stock of the registrant outstanding.
	DOCUMENTS INCORPORATED BY REFERENCE
	Portions of the registrants definitive proxy statement for the 2009 annual meeting of shareholders
	are incorporated by reference into Part III.
	 
	 
	 
	 
	ENPRO INDUSTRIES, INC.
	PART I
	ITEM 1. BUSINESS
	     As used in this report, the terms we, us, our, EnPro and Company mean EnPro
	Industries, Inc. and its subsidiaries (unless the context indicates another meaning). The term
	common stock means the common stock of EnPro Industries, Inc., par value $0.01 per share. The
	terms convertible debentures and debentures mean the 3.9375% Convertible Senior Debentures due
	2015 issued by the Company in October 2005.
	Background
	     We were incorporated under the laws of the State of North Carolina on January 11, 2002, as a
	wholly owned subsidiary of Goodrich Corporation (Goodrich) in anticipation of Goodrichs
	announced distribution of its Engineered Industrial Products segment to existing Goodrich
	shareholders, which took place on May 31, 2002 (the Distribution). We are a leader in the
	design, development, manufacturing, and marketing of proprietary engineered industrial products.
	We have 43 primary manufacturing facilities located in the United States and 10 other countries.
	     Our sales by geographic region in 2008, 2007 and 2006 were as follows:
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | 2008 |  |  | 2007 |  |  | 2006 |  | 
|  |  | (in millions) |  | 
| 
	United States
 |  | $ | 610.6 |  |  | $ | 565.7 |  |  | $ | 543.0 |  | 
| 
	Europe
 |  |  | 329.7 |  |  |  | 277.8 |  |  |  | 222.8 |  | 
| 
	Other
 |  |  | 227.5 |  |  |  | 186.5 |  |  |  | 162.6 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Total
 |  | $ | 1,167.8 |  |  | $ | 1,030.0 |  |  | $ | 928.4 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
 
	     We maintain an Internet website at www.enproindustries.com. We will make this annual report,
	in addition to our other annual reports on Form 10-K, quarterly reports on Form 10-Q, current
	reports on Form 8-K and amendments to these reports, available free of charge on our website as
	soon as reasonably practicable after we electronically file such material with, or furnish it to,
	the Securities and Exchange Commission. Our Corporate Governance Guidelines and the charters for
	each of our Board Committees (Audit and Risk Management, Compensation and Human Resources,
	Executive, and Nominating and Corporate Governance committees) are also available on our website,
	and copies of this information are available in print to any shareholder who requests it.
	Information included on or linked to our website is not incorporated by reference into this annual
	report.
	Operations
	     We manage our business as three segments: a sealing products segment, which includes our
	sealing products, heavy-duty wheel end components, polytetrafluoroethylene (PTFE) products, and
	rubber products; an engineered products segment, which includes our bearings, rotary and
	reciprocating air compressors, vacuum pumps, air systems and reciprocating compressor components;
	and an engine products and services segment, which manufactures heavy-duty, medium-speed diesel,
	natural gas and dual fuel reciprocating engines. For financial information with respect to our
	business segments, see Item 7, Managements Discussion and Analysis of Financial Condition and
	Results of Operations  Results of Operations, and Note 16 to our Consolidated Financial
	Statements. Item 7 and Note 16 contain
	1
 
	information about sales and profits for each segment, and Note 16 contains information about
	each segments assets.
	Sealing Products Segment
	     
	Overview
	. Our Sealing Products segment designs, manufactures and sells sealing
	products, including metallic, non-metallic and composite material gaskets, rotary seals,
	compression packing, resilient metal seals, elastomeric seals, hydraulic components and expansion
	joints, as well as wheel-end components and component systems, PTFE products, conveyor belting and
	sheeted rubber products. These products are used in a variety of industries, including chemical
	and petrochemical processing, petroleum extraction and refining, pulp and paper processing,
	heavy-duty trucking, power generation, food and pharmaceutical processing, primary metal
	manufacturing, mining, water and waste treatment, aerospace, medical, filtration and semiconductor
	fabrication. In many of these industries, performance and durability are vital for safety and
	environmental protection. Many of our products are used in applications that are highly demanding,
	e.g., where extreme temperatures, extreme pressures, corrosive environments and/or worn equipment
	make sealing difficult.
	     
	Products
	. Our Sealing Products segment includes the product lines described below,
	which are designed, manufactured and sold by our Garlock Sealing Technologies, Stemco, Plastomer
	Technologies and Garlock Rubber Technologies operations.
	     Gasket products are used for sealing flange joints in chemical, petrochemical and pulp and
	paper processing facilities where high pressures, high temperatures and corrosive chemicals create
	the need for specialized and highly engineered sealing products. We sell these gasket products
	under the Garlock
	®
	,
	Gylon
	®
	,
	Blue-Gard
	®
	,
	Stress-Saver
	®
	,
	Edge
	®
	, Graphonic
	®
	and Flexseal
	®
	brand names.
	These products have a long-standing reputation within the industries we serve for performance and
	reliability.
	     Rotary seals are used in rotating applications to contain the lubricants that protect the
	bearings from excessive friction and heat generation. Because these sealing products are utilized
	in dynamic applications, they are subject to wear. Durability, performance, and reliability are,
	therefore, critical requirements of our customers. These rotary seals are used in demanding
	applications in the steel industry, mining and pulp and paper processing under well-known brand
	names including Klozure
	®
	and Model 64
	®
	.
	     Compression packing is used to provide sealing in pressurized, static and dynamic applications
	such as pumps and valves. Major markets for compression packing products are the pulp and paper,
	mining, petrochemical and hydrocarbon processing industries. Branded products for these markets
	include EVSP, Synthepak
	®
	and Graph-lock
	®
	.
	     Resilient metal seals provide extremely tight sealing performance for highly demanding
	applications such as nuclear power generation, semiconductor fabrication facilities, specific
	chemical processing applications and race car engines. Branded products for these markets include
	Helicoflex
	®
	and Ultraflex
	®
	.
	     Critical service flange gaskets, seals and electrical flange isolation kits are used in
	high-pressure wellhead equipment, flow lines, water injection lines, sour hydrocarbon process
	applications and crude oil and natural gas pipeline/transmission line applications. These products
	are sold under the brand names Pikotek
	®
	, VCS, Flowlok and PGE.
	     Stemco manufactures a variety of high performance wheel-end, steering and suspension
	components used by the heavy-duty trucking industry to improve the performance and longevity of
	commercial tractors and trailers. Products for this market include hub oil seals, axle fasteners,
	hub caps,
	2
 
	wheel bearings, mileage counters, king pin kits and suspension kits. We sell these sealing
	products under the Stemco
	®
	, Stemco Kaiser
	®
	, Grit Guard
	®
	, Guardian
	®
	, Guardian HP
	®
	, Voyager
	®
	,
	Discover
	®
	, Pro-Torq
	®
	, Sentinel
	®
	, DataTrac
	®
	, Qwikkit, Pluskit and Econokit brand names. We also
	sell products under our RFID sensor-based BAT RF
	®
	product line.
	     Plastomer Technologies manufactures PTFE specialty tape, formed PTFE products, and PTFE sheets
	and shapes. These PTFE products provide highly specialized and engineered solutions to our
	customers in the aircraft, fluid handling and semiconductor industries, and are sold under the
	Plastolon
	®
	, Texolon and Amicon brand names.
	     Garlock Rubber Technologies manufactures rubber bearing pads, conveyor belts and other rubber
	products for industrial applications under the DuraKing
	®
	, FlexKing
	®
	, Viblon, Techflex and
	HeatKing brand names.
	     
	Customers
	. Our Sealing Products segment sells products to industrial agents and
	distributors, original equipment manufacturers (OEMs), engineering and construction firms and end
	users worldwide. Sealing products are offered to global customers, with approximately 43% of sales
	delivered to customers outside the United States in 2008. Representative customers include Saudi
	Aramco, Motion Industries, Applied Industrial Technologies, Electricite de France, AREVA, Bayer,
	BASF Corporation, General Electric Company, Georgia-Pacific Corporation, Eastman Chemical Company,
	Exxon Mobil Corporation, Minara Resources, Queensland Alumina, AK Steel Corporation, Volvo
	Corporation, Utility Trailer, Great Dane, Mack Trucks, International Truck, PACCAR and Applied
	Materials. In 2008, no single customer accounted for more than 2% of segment revenues.
	     
	Competition
	. Competition in the sealing markets in which we operate is based on
	proven product performance and reliability, as well as price, customer service, application
	expertise, delivery terms, breadth of product offering, reputation for quality and the availability
	of product. Our leading brand names, including Garlock
	®
	and Stemco
	®
	, have been built upon
	long-standing reputations for reliability and durability. In addition, the breadth, performance
	and quality of our product offerings allow us to achieve premium pricing and have made us a
	preferred supplier among our agents and distributors. We believe that our record of product
	performance in the major markets in which this segment operates is a significant competitive
	advantage for us. Major competitors include A.W. Chesterton Company, Klinger Group, Teadit,
	Lamons, SIEM/Flexitallic, SKF USA Inc., Freudenberg-NOK, Federal-Mogul Corporation and
	Saint-Gobain.
	     
	Raw Materials and Components
	. Our Sealing Products segment uses PTFE resins, aramid
	fibers, specialty elastomers, elastomeric compounds, graphite and carbon, common and exotic metals,
	cold-rolled steel, leather, aluminum die castings, nitrile rubber, powdered metal components, and
	various fibers and resins. We believe that all of these raw materials and components are readily
	available from various suppliers.
	Engineered Products Segment
	     
	Overview
	. Our Engineered Products segment includes operations that design,
	manufacture and sell self-lubricating, non-rolling bearing products, aluminum blocks for hydraulic
	applications, rotary and reciprocating air compressors, vacuum pumps, air systems and compressor
	components.
	     
	Products
	. Our Engineered Products segment includes the product lines described below,
	which are designed, manufactured and sold by GGB, Quincy Compressor and Compressor Products
	International.
	3
 
	     GGB produces self-lubricating, non-rolling, metal polymer, solid polymer and filament wound
	bearing products. The metal-backed or epoxy-backed bearing surfaces are made of PTFE or a mixture
	that includes PTFE to provide maintenance-free performance and reduced friction. These products
	typically perform as sleeve bearings or thrust washers under conditions of no lubrication, minimal
	lubrication or pre-lubrication. These products are used in a wide variety of markets such as the
	automotive, pump and compressor, construction, power generation and machine tool markets. We have
	over 20,000 bearing part numbers of different designs and physical dimensions. GGB is a leading
	and well recognized brand name in this product area.
	     Quincy Compressor
	®
	designs and manufactures rotary screw and reciprocating air compressors and
	vacuum pumps, ranging from one-third to 500 horsepower, used in a wide range of industrial
	applications, including the pharmaceutical, pulp and paper, gas transmission, health, construction,
	petrochemical and automotive industries. Quincy
	®
	also sells a comprehensive line of dryers,
	filters and air treatment products. In addition, Quincy performs comprehensive compressed air
	system audits under the Air Science Engineering brand name and manufactures a complete line of
	pneumatic and hydraulic cylinders under the Ortman brand name.
	     Compressor Products International designs, manufactures and services components for
	reciprocating compressors and engines. These components (packing and wiper assemblies and rings,
	piston and rider rings, compressor valve assemblies and components) are primarily utilized in the
	refining, petrochemical, natural gas gathering, storage and transmission, and general industrial
	markets. Brand names for our products include Hi-Flo, Valvealert, Mentor, Triple Circle, CPI
	Special Polymer Alloys, Twin Ring and Liard. Compressor Products International also designs and
	manufactures the Gar-Seal
	®
	family of PTFE lined butterfly valves.
	     
	Customers
	. Our Engineered Products segment sells its products to a diverse customer
	base using a combination of direct sales and independent distribution networks. GGB has customers
	worldwide in all major industrial sectors, and supplies products both directly to customers through
	their own local distribution system and indirectly to the market through independent agents and
	distributors with their own local network. Quincy Compressor products are sold through a global
	network of independent agents and distributors. Quincy Compressor also sells directly to national
	accounts, OEMs and climate control houses. Compressor Products International sells its products
	globally through a network of company salespersons, independent sales representatives and
	distributors. In 2008, no single customer accounted for more than 3% of segment revenues.
	     
	Competition
	. GGB has a number of competitors, including Kolbenschmidt Pierburg AG,
	Norton Company and Federal-Mogul Corporation. In the markets in which GGB competes, competition is
	based primarily on performance of the product for specific applications, product reliability,
	delivery and price. Quincy Compressors major competitors include Gardner Denver, Inc., Sullair
	Corporation, Ingersoll-Rand Company, Atlas Copco North America Inc. and Kaeser Compressors, Inc.
	In the markets in which Quincy Compressor competes, competition generally is based on reliability,
	quality, delivery times, energy efficiency, service and price. Compressor Products International
	competes against other component manufacturers, such as Cook Compression, Hoerbiger Corporation,
	OEMs and numerous smaller component manufacturers worldwide. Price, availability, product quality,
	engineering support and reliability are the primary competitive drivers in the markets served by
	Compressor Products International.
	     
	Raw Materials and Components
	. GGBs major raw material purchases include steel coil,
	bronze powder and PTFE. GGB sources components from a number of external suppliers. Quincy
	Compressors primary raw materials are iron castings. Components used by Quincy Compressor are
	motors, coolers and accessories such as air dryers, filters and electronic controls. Compressor
	Products Internationals major raw material purchases include PTFE, PEEK (Polyetheretherketone),
	compound additives, cast
	4
 
	iron, bronze, steel and stainless steel bar stock. We believe that all of these raw materials
	and components are readily available from various suppliers.
	Engine Products and Services Segment
	     
	Overview
	. Our Engine Products and Services segment designs, manufactures, sells and
	services heavy-duty, medium-speed diesel, natural gas and dual fuel reciprocating engines. We
	market our products and services under the Fairbanks Morse Engine brand name.
	     
	Products
	. Our Engine Products and Services segment manufactures licensed heavy-duty,
	medium-speed diesel, natural gas and dual fuel reciprocating engines, in addition to its own
	designs. The reciprocating engines range in size from 700 to 31,970 horsepower and from five to 20
	cylinders. The government and the general industrial market for marine propulsion, power
	generation, and pump and compressor applications use these products. We have been building engines
	for over 115 years under the Fairbanks Morse Engine brand name and we have a large installed base
	of engines for which we supply aftermarket parts and service. Additionally, we have been the U.S.
	Navys supplier of choice for medium-speed diesel engines and have supplied engines to the U.S.
	Navy for over 70 years.
	     
	Customers
	. Our Engine Products and Services segment sells its products to customers
	worldwide, including major shipyards, municipal utilities, institutional and industrial
	organizations, sewage treatment plants, nuclear power plants and offshore oil and gas platforms.
	We market our products through a direct sales force of engineers in North America and through
	independent agents worldwide. Our representative customers include Northrop Grumman, General
	Dynamics, Lockheed Martin, the U.S. Navy, the U.S. Coast Guard and Exelon. In 2008, the largest
	customer accounted for approximately 25% of segment revenues.
	     
	Competition
	. Major competitors for our Engine Products and Services segment include
	MTU, Caterpillar Inc. and Wartsila Corporation. Price, delivery time, engineering and service
	support, and engine efficiency relating to fuel consumption and emissions drive competition.
	     
	Raw Materials and Components
	. Our Engine Products and Services segment purchases
	multiple ferrous and non-ferrous castings, forgings, plate stock and bar stock for fabrication and
	machining into engines. In addition, we buy a considerable amount of precision-machined engine
	components. We believe that all of these raw materials and components are readily available from
	various suppliers.
	Research and Development
	     We refer to our research and development efforts as our EnNovation program. The goal of the
	program is to strengthen our product portfolios for traditional markets while simultaneously
	creating distinctive and breakthrough products. EnNovation incorporates a process to move
	product innovations from concept to commercialization, and to identify, analyze, develop and
	implement new product concepts and opportunities aimed at business growth.
	     We employ scientists, engineers and technicians throughout our operations to develop, design
	and test new and improved products. We work closely with our customers to identify issues and
	develop technical solutions. The majority of our research and development expenditures are
	directed toward the development of new sealing products for hostile environments, the development
	of truck and trailer fleet information systems, the development of bearing products and materials
	with increased load carrying capability and superior friction and wear characteristics, and the
	extension of our air compressor product line. Prior to introduction, new products are subject to
	extensive testing at our various facilities and at beta test sites in conjunction with our
	customers.
	5
 
	Backlog
	     At December 31, 2008, we had a backlog of orders valued at $259.4 million compared with $268.6
	million at December 31, 2007. Approximately 62% of the backlog, mainly at Fairbanks Morse Engine,
	is expected to be filled beyond 2009. Backlog represents orders on hand that we believe to be
	firm. However, there is no certainty that the backlog orders will in fact result in actual sales
	at the times or in the amounts ordered. In addition, for most of our business, backlog is not
	particularly predictive of future performance because of our short lead times and some seasonality.
	Quality Assurance
	     We believe that product quality is among the most important factors in developing and
	maintaining strong, long-term relationships with our customers. In order to meet the exacting
	requirements of our customers, we maintain stringent standards of quality control. We routinely
	employ in-process inspection by using testing equipment as a process aid during all stages of
	development, design and production to ensure product quality and reliability. These include
	state-of-the-art CAD/CAM equipment, statistical process control systems, laser tracking devices,
	failure mode and effect analysis and coordinate measuring machines. We are also able to extract
	numerical quality control data as a statistical measurement of the quality of the parts being
	manufactured from our CNC machinery. In addition, we perform quality control tests on parts that
	we outsource. As a result, we are able to significantly reduce the number of defective parts and
	therefore improve efficiency, quality and reliability.
	     As of December 31, 2008, 31 of our manufacturing facilities were ISO 9000, QS 9000 and/or TS
	16949 certified with the remaining facilities working towards obtaining ISO and/or TS
	certification. Twelve of our facilities are ISO 14001 certified. OEMs are increasingly requiring
	these standards in lieu of individual certification procedures and as a condition of awarding
	business.
	Patents, Trademarks and Other Intellectual Property
	     We maintain a number of patents and trademarks issued by the U.S. and other countries relating
	to the name and design of our products and have granted licenses to some of these trademarks and
	patents. We routinely evaluate the need to protect new and existing products through the patent
	and trademark systems in the U.S. and other countries. We also have proprietary information,
	consisting of know-how and trade secrets relating to the design, manufacture and operation of our
	products and their use that is not patented. We do not consider our business as a whole to be
	materially dependent upon any particular patent, patent right, trademark, trade secret or license.
	     In general, we are the owner of the rights to the products that we manufacture and sell.
	However, we also license patented and other proprietary technology and processes from various
	companies and individuals in order to broaden our product offerings. We are dependent on the
	ability of these third parties to diligently protect their intellectual property rights. In
	several cases, the intellectual property licenses are integral to the manufacture of our products.
	For example, Fairbanks Morse Engine licenses technology from MAN Diesel for the four-stroke
	reciprocating engine, and Quincy Compressor licenses from Svenska Rotor Maskiner AB its rotary
	screw compressor design and technology. A loss of these licenses or a failure on the part of the
	third party to protect its own intellectual property could reduce our revenues. Although these
	licenses are all long-term and subject to renewal, it is possible that we may not successfully
	renegotiate these licenses or that they could be terminated for a material breach. If this were to
	occur, our business, financial condition, results of operations and cash flows could be adversely
	affected.
	6
 
	Employees and Labor Relations
	     We currently have approximately 5,100 employees worldwide. Approximately 2,800 employees are
	located within the U.S. and approximately 2,300 employees are located outside the U.S., primarily
	in Europe, Canada and Mexico. Approximately 30% of our U.S. employees are members of trade unions
	covered by collective bargaining agreements. Union agreements relate, among other things, to
	wages, hours and conditions of employment. The wages and benefits furnished are generally
	comparable to industry and area practices.
	     We have collective bargaining agreements in place at four of our U.S. facilities. The hourly
	employees who are unionized are covered by collective bargaining agreements with a number of labor
	unions and with varying contract termination dates ranging from
	November 2010 to June 2012. In
	addition, some of our employees located outside the U.S. are subject to national collective
	bargaining agreements.
	ITEM 1A. RISK FACTORS
	     
	In addition to the risks stated elsewhere in this annual report, set forth below are certain
	risk factors that we believe are material. If any of these risks occur, our business, financial
	condition, results of operations, cash flows and reputation could be harmed. You should also
	consider these risk factors when you read forward-looking statements elsewhere in this report.
	You can identify forward-looking statements by terms such as may, hope, will, should,
	expect, plan, anticipate, intend, believe, estimate, predict, or continue, the
	negative of those terms or other comparable terms. Those forward-looking statements are only
	predictions and can be adversely affected if any of these risks occur.
	Risks Related to Our Business
	Certain of our subsidiaries are defendants in asbestos litigation.
	     The historical business operations of certain subsidiaries of our subsidiary, Coltec
	Industries Inc (Coltec), principally Garlock Sealing Technologies LLC and The Anchor Packing
	Company (Anchor), have resulted in a substantial volume of asbestos litigation in which
	plaintiffs have alleged personal injury or death as a result of exposure to asbestos fibers. Those
	subsidiaries manufactured and/or sold industrial sealing products, predominately gaskets and
	packing products, that contained encapsulated asbestos fibers. Anchor is an inactive and insolvent
	indirect subsidiary of Coltec. There is no remaining insurance coverage available to Anchor and it
	has no assets. Our subsidiaries exposure to asbestos litigation and their relationships with
	insurance carriers are actively managed through another Coltec subsidiary, Garrison Litigation
	Management Group, Ltd. Several risks and uncertainties may result in potential liabilities to us
	in the future that could have a material adverse effect on our business, financial condition,
	results of operations and cash flows. Those risks and uncertainties include the following:
|  |  |  | the potential for a large number of future asbestos claims that are not covered by
	insurance because insurance coverage is, or will be, depleted; | 
|  | 
|  |  |  | the uncertainty of the number and per claim value of pending and potential future
	asbestos claims; | 
|  | 
|  |  |  | the results of litigation and the success of our litigation and settlement
	strategies; | 
 
	7
 
|  |  |  | the potential for large adverse judgments against us not covered by insurance and
	any surety/appeal bonds (and related cash collateral) required in connection with
	appeals; | 
|  | 
|  |  |  | an increase in litigation costs, fees and expenses that are not covered by
	insurance; | 
|  | 
|  |  |  | the financial viability of our subsidiaries insurance carriers and their
	reinsurance carriers, and our subsidiaries ability to collect on claims from them; | 
|  | 
|  |  |  | the timing of claims, payments and insurance recoveries, and limitations imposed on
	the amount that may be recovered from insurance in any year; | 
|  | 
|  |  |  | the unavailability of any insurance for claims alleging first exposure to asbestos
	after July 1, 1984; | 
|  | 
|  |  |  | the potential for asbestos exposure to extend beyond specific Coltec subsidiaries
	arising from corporate veil piercing efforts or other claims by asbestos plaintiffs; | 
|  | 
|  |  |  | bankruptcies of other defendants; and | 
|  | 
|  |  |  | the prospect for and impact of any federal legislation providing national asbestos
	litigation reform. | 
 
	     When settlement payments exceed insurance recoveries from our subsidiaries carriers, our
	subsidiaries will be required to fund these obligations from available cash. This could adversely
	affect our ability to use cash for other purposes, including growth of our business, and adversely
	affect our financial condition.
	     In addition, our estimated liability for claims is highly uncertain and is based on subjective
	assumptions. The actual liability could vary significantly from the estimate recorded in our
	financial statements.
	     Because of the uncertainty as to the number and timing of potential future asbestos claims, as
	well as the amount that will have to be paid to settle or satisfy any such claims in the future
	(including significant bonds required by certain states while we appeal adverse verdicts), and the
	finite amount of insurance available for future payments, future asbestos claims could have a
	material adverse effect on our financial condition, results of operations and cash flows.
	     For a further discussion of our asbestos exposure, see Managements Discussion and Analysis
	of Financial Condition and Results of Operations  Contingencies  Asbestos.
	Our business and some of the markets we serve are cyclical and distressed market conditions could
	have a material adverse effect on our business.
	     The markets in which we sell our products, particularly chemical companies, petroleum
	refineries, heavy-duty trucking, semiconductor manufacturing, capital equipment and the automotive
	industry, are, to varying degrees, cyclical and have historically experienced periodic downturns.
	Prior downturns have been characterized by diminished product demand, excess manufacturing capacity
	and subsequent erosion of average selling prices in these markets resulting in negative effects on
	our net sales, gross margins and net income. The current downward cycle has impacted our results
	of operations for our most recent quarterly periods. The current economic environment may affect
	our opportunities for organic growth and a continued downward cycle could adversely affect our
	operating results. Moreover, a prolonged downward cycle may critically impair the continued
	viability of certain of our customers and
	8
 
	may adversely impact our accounts receivable with these customers. A prolonged and severe
	downward cycle in our markets could have a material adverse effect on our business, financial
	condition, results of operations and cash flows.
	We face intense competition that could have a material adverse effect on our business.
	     We encounter intense competition in almost all areas of our business. Customers for many of
	our products are attempting to reduce the number of vendors from which they purchase in order to
	reduce inventories. To remain competitive, we need to invest continuously in manufacturing,
	marketing, customer service and support and our distribution networks. We also need to develop new
	products to continue to meet the needs and desires of our customers. We may not have sufficient
	resources to continue to make such investments or maintain our competitive position. Additionally,
	some of our competitors are larger than we are and have substantially greater financial resources
	than we do. As a result, they may be better able to withstand the effects of periodic economic
	downturns. Pricing and other competitive pressures could adversely affect our business, financial
	condition, results of operations and cash flows.
	If we fail to retain the independent agents and distributors upon whom we rely to market our
	products, we may be unable to effectively market our products and our revenue and profitability may
	decline.
	     Our marketing success in the U.S. and abroad depends largely upon our independent agents and
	distributors sales and service expertise and relationships with customers in our markets. Many of
	these agents have developed strong ties to existing and potential customers because of their
	detailed knowledge of our products. A loss of a significant number of these agents or
	distributors, or of a particular agent or distributor in a key market or with key customer
	relationships, could significantly inhibit our ability to effectively market our products, which
	could have a material adverse effect on our business, financial condition, results of operations
	and cash flows.
	Increased costs for raw materials or the termination of existing supply agreements could have a
	material adverse effect on our business.
	     The prices for raw materials we purchase increased in 2008. While we have been successful in
	passing along a portion of these higher costs, there can be no assurance that we will be able to
	continue doing so without losing customers. Similarly, the loss of a key supplier or the
	unavailability of a key raw material could adversely affect our business, financial condition,
	results of operations and cash flows.
	     
	We have exposure to some contingent liabilities relating to discontinued operations, which could
	have a material adverse effect on our financial condition, results of operations or cash flows in
	any fiscal period.
	     We have some contingent liabilities related to discontinued operations of our predecessors,
	including environmental liabilities and liabilities for certain products and other matters. In
	some instances we have indemnified others against those liabilities, and in other instances we have
	received indemnities from third parties against those liabilities.
	     Claims could arise relating to products or other matters related to our discontinued
	operations. Some of these claims could seek substantial monetary damages. Specifically, we may
	potentially be subject to the liabilities related to the firearms manufactured prior to 1990 by
	Colt Firearms, a former operation of Coltec, and for electrical transformers manufactured prior to
	1994 by Central Moloney, another former Coltec operation. Coltec also has ongoing obligations with
	regard to workers compensation, retiree medical and other retiree benefit matters associated with
	discontinued operations that relate to Coltecs periods of ownership of those operations.
	9
 
	     We have insurance, reserves and funds held in trust to address these liabilities. However, if
	our insurance coverage is depleted, our reserves are not adequate or the funds held in trust are
	insufficient, environmental and other liabilities relating to discontinued operations could have a
	material adverse effect on our financial condition, results of operations and cash flows.
	We conduct a significant amount of our sales activities outside of the U.S., which subjects us to
	additional business risks that may cause our profitability to decline.
	     Because we sell our products in a number of foreign countries, we are subject to risks
	associated with doing business internationally. In 2008, we derived approximately 48% of our
	revenues from sales of our products outside of the U.S. Our international operations are, and will
	continue to be, subject to a number of risks, including:
|  |  |  | unfavorable fluctuations in foreign currency exchange rates; | 
|  | 
|  |  |  | adverse changes in foreign tax, legal and regulatory requirements; | 
|  | 
|  |  |  | difficulty in protecting intellectual property; | 
|  | 
|  |  |  | trade protection measures and import or export licensing requirements; | 
|  | 
|  |  |  | differing labor regulations; | 
|  | 
|  |  |  | political and economic instability; and | 
|  | 
|  |  |  | acts of hostility, terror or war. | 
 
	Any of these factors, individually or together, could have a material adverse effect on our
	business, financial condition, results of operations and cash flows.
	     We intend to continue to pursue international growth opportunities, which could increase our
	exposure to risks associated with international sales and operations. As we expand our
	international operations, we may also encounter new risks that could adversely affect our revenues
	and profitability. For example, as we focus on building our international sales and distribution
	networks in new geographic regions, we must continue to develop relationships with qualified local
	agents, distributors and trading companies. If we are not successful in developing these
	relationships, we may not be able to increase sales in these regions.
	If we are unable to protect our intellectual property rights and knowledge relating to our
	products, our business and prospects may be negatively impacted.
	     We believe that proprietary products and technology are important to our success. If we are
	unable to adequately protect our intellectual property and know-how, our business and prospects
	could be negatively impacted. Our efforts to protect our intellectual property through patents,
	trademarks, service marks, domain names, trade secrets, copyrights, confidentiality, non-compete
	and nondisclosure agreements and other measures may not be adequate to protect our proprietary
	rights. Patents issued to third parties, whether before or after the issue date of our patents,
	could render our intellectual property less valuable. Questions as to whether our competitors
	products infringe our intellectual property rights or whether our products infringe our
	competitors intellectual property rights may be disputed. In addition, intellectual property
	rights may be unavailable, limited or difficult to enforce in some jurisdictions, which could make
	it easier for competitors to capture market share in those jurisdictions.
	10
 
	     Our competitors may capture market share from us by selling products that claim to mirror the
	capabilities of our products or technology. Without sufficient protection nationally and
	internationally for our intellectual property, our competitiveness worldwide could be impaired,
	which would negatively impact our growth and future revenue. As a result, we may be required to
	spend significant resources to monitor and police our intellectual property rights.
	Risks Related to Ownership of Our Common Stock
	The market price and trading volume of our common stock may be volatile.
	     A relatively small number of shares traded in any one day could have a significant affect on
	the market price of our common stock. The market price of our common stock could fluctuate
	significantly for many reasons, including in response to the risks described in this section and
	elsewhere in this report or for reasons unrelated to our operations, such as reports by industry
	analysts, investor perceptions or negative announcements by our customers, competitors or suppliers
	regarding their own performance, as well as industry conditions and general financial, economic and
	political instability. In particular, reports concerning asbestos litigation or asbestos reform
	could cause a significant increase or decrease in the market price of our common stock.
	Because our quarterly revenues and operating results may vary significantly in future periods, our
	stock price may fluctuate.
	     Our revenue and operating results may vary significantly from quarter to quarter. A high
	proportion of our costs are fixed, due in part to significant selling and manufacturing costs.
	Small declines in revenues could disproportionately affect operating results in a quarter and the
	price of our common stock may fall. We may also incur charges to income to cover increases in the
	estimate of our subsidiaries future asbestos liability. Other factors that could affect quarterly
	operating results include, but are not limited to:
|  |  |  | demand for our products; | 
|  | 
|  |  |  | the timing and execution of customer contracts; | 
|  | 
|  |  |  | the timing of sales of our products; | 
|  | 
|  |  |  | payments related to asbestos litigation or annual costs related to asbestos
	litigation that are not covered by insurance; | 
|  | 
|  |  |  | the timing of receipt of insurance proceeds; | 
|  | 
|  |  |  | increases in manufacturing costs due to equipment or labor issues; | 
|  | 
|  |  |  | changes in foreign currency exchange rates; | 
|  | 
|  |  |  | unanticipated delays or problems in introducing new products; | 
|  | 
|  |  |  | announcements by competitors of new products, services or technological innovations; | 
|  | 
|  |  |  | changes in our pricing policies or the pricing policies of our competitors; | 
 
	11
 
|  |  |  | increased expenses, whether related to sales and marketing, raw materials or
	supplies, product development or administration; | 
|  | 
|  |  |  | major changes in the level of economic activity in North America, Europe, Asia and
	other major regions in which we do business; | 
|  | 
|  |  |  | costs related to possible future acquisitions or divestitures of technologies or
	businesses; | 
|  | 
|  |  |  | an increase in the number or magnitude of product liability claims; | 
|  | 
|  |  |  | our ability to expand our operations and the amount and timing of expenditures
	related to expansion of our operations, particularly outside the United States; and | 
|  | 
|  |  |  | economic assumptions and market factors used to determine post-retirement benefits
	and pension liabilities. | 
 
	Various provisions and laws could delay or prevent a change of control.
	     The anti-takeover provisions of our articles of incorporation and bylaws, our shareholder
	rights plan and provisions of North Carolina law could delay or prevent a change of control or may
	impede the ability of the holders of our common stock to change our management. In particular, our
	articles of incorporation and bylaws, among other things, will:
|  |  |  | require a supermajority shareholder vote to approve any business combination
	transaction with an owner of 5% or more of our shares unless the transaction is
	recommended by disinterested directors; | 
|  | 
|  |  |  | limit the right of shareholders to remove directors and fill vacancies; | 
|  | 
|  |  |  | regulate how shareholders may present proposals or nominate directors for election
	at shareholders meetings; and | 
|  | 
|  |  |  | authorize our board of directors to issue preferred stock in one or more series,
	without shareholder approval. | 
 
	     Our shareholder rights plan will also make an acquisition of a controlling interest in EnPro
	in a transaction not approved by our board of directors more difficult.
	Future sales of our common stock in the public market could lower the market price for our common
	stock and adversely impact the trading price of our convertible debentures.
	     In the future, we may sell additional shares of our common stock to raise capital. In
	addition, a substantial number of shares of our common stock are reserved for issuance under our
	equity compensation plans, including shares to be issued upon the exercise of stock options, and
	upon conversion of our convertible debentures. We cannot predict the size of future issuances or
	the effect, if any, that they may have on the market price for our common stock. The issuance and
	sales of substantial amounts of common stock, or the perception that such issuances and sales may
	occur, could adversely affect the trading price of the debentures and the market price of our
	common stock.
	12
 
	Absence of dividends could reduce our attractiveness to investors.
	     We have never declared or paid cash dividends on our common stock. Moreover, our current
	senior secured credit facility restricts our ability to pay cash dividends on common stock if
	availability under the facility falls below $20 million. As a result, our common stock may be less
	attractive to certain investors than the stock of companies with a history of paying regular
	dividends.
	Risks Related to Our Capital Structure
	Our debt agreement imposes limitations on our operations, which could impede our ability to respond
	to market conditions, address unanticipated capital investments and/or pursue business
	opportunities.
	     We have a $75 million senior secured revolving credit facility that imposes limitations on our
	operations, such as limitations on distributions, limitations on incurrence and repayment of
	indebtedness, and maintenance of a fixed charge coverage financial ratio. These limitations could
	impede our ability to respond to market conditions, address unanticipated capital investment needs
	and/or pursue business opportunities.
	We may not have sufficient cash to repurchase our convertible debentures at the option of the
	holder or upon a change of control or to pay the cash payable upon a conversion.
	     Upon a change of control, subject to certain conditions, we will be required to make an offer
	to repurchase for cash all outstanding convertible debentures at 100% of their principal amount
	plus accrued and unpaid interest, including liquidated damages, if any, up to but not including the
	date of repurchase. Upon a conversion, we will be required to make a cash payment of up to $1,000
	for each $1,000 in principal amount of debentures converted. However, we may not have enough
	available cash or be able to obtain financing at the time we are required to make repurchases of
	tendered debentures or settlement of converted debentures. Any credit facility in place at the
	time of a repurchase or conversion of the debentures may also limit our ability to use borrowings
	to pay any cash payable on a repurchase or conversion of the debentures and may prohibit us from
	making any cash payments on the repurchase or conversion of the debentures if a default or event of
	default has occurred under that facility without the consent of the lenders under that credit
	facility. Our current $75 million senior secured credit facility prohibits distributions from our
	subsidiaries to us to make payments of interest on the debentures if a default or event of default
	exists under the facility. Our senior secured credit facility also prohibits prepayments of the
	debentures or distributions from our subsidiaries to us to make principal payments or payments upon
	conversion of the debentures if a default or event of default exists under the facility or the
	amount of the borrowing base under the facility, less the amount of outstanding borrowings under
	the facility and letters of credit and reserves, is less than $20 million. Our failure to
	repurchase tendered debentures at a time when the repurchase is required by the indenture or to pay
	any cash payable on a conversion of the debentures would constitute a default under the indenture.
	A default under the indenture or the change of control itself could lead to a default under the
	other existing and future agreements governing our indebtedness. If the repayment of the related
	indebtedness were to be accelerated after any applicable notice or grace periods, we may not have
	sufficient funds to repay the indebtedness and repurchase the debentures or make cash payments upon
	conversion thereof.
	Risks Related to the Current Global Financial Crisis
	The volatility and disruption of global credit markets and adverse changes arising from the current
	global financial crisis may negatively impact our ability to access financing and expose us to
	unexpected risks.
	13
 
	The current global financial and credit crisis exposes us to a variety of risks. We have
	historically funded our business with cash from operations and the proceeds from the issuance of
	our convertible debentures. We have a $75 million senior secured revolving credit facility with a
	group of lenders as a backstop to our liquidity needs and there have been no borrowings under this
	facility to date. In light of the unprecedented disruption of global credit markets and the
	instability of financial institutions that until recently were of unquestioned strength, there is a
	risk that a borrowing request properly made under the credit facility would not be honored by one
	or more of our lenders. Under the terms of the credit facility, no lender is obligated to fund a
	portion of a borrowing request that is not funded by another lender. Accordingly, in such an
	instance actual borrowings under our credit facility may be insufficient to support our liquidity
	needs and we would be required to seek alternate sources of liquidity. In light of the current
	capital and credit market disruption and volatility, we cannot assure you that such alternate
	funding will be available to us on terms and conditions acceptable to us, or at all. As of the
	date of this filing we have no reason to believe that a borrowing request, properly submitted by
	us, would not be honored by any of our lenders, all of whom have assured us of their continuing
	ability to fund our facility. In addition, we maintain deposit accounts with numerous financial
	institutions around the world in amounts that exceed applicable governmental deposit insurance
	levels. While we actively monitor our deposit relationships, we are subject to risk of loss in the
	event of the unanticipated failure of a financial institution in which we maintain deposits, which
	loss could be material to our results of operations and financial condition.
	Derivative transactions may expose us to unexpected risk and potential losses.
	     We are party to certain derivative transactions, such as foreign exchange contracts and call
	options (hedge and warrant transactions) with respect to our convertible debentures, with financial
	institutions to hedge against certain financial risks. In light of current economic uncertainty
	and potential for financial institution failures, we may be exposed to the risk that our
	counterparty in a derivative transaction may be unable to perform its obligations as a result of
	being placed in receivership or otherwise. In the event that a counterparty to a material
	derivative transaction is unable to perform its obligations thereunder, we may experience material
	losses that could materially adversely affect our results of operations and financial condition.
	ITEM 1B. UNRESOLVED STAFF COMMENTS
	     Not applicable.
	ITEM 2. PROPERTIES
	     We are headquartered in Charlotte, North Carolina and have 43 primary manufacturing facilities
	in 12 states within the U.S. and 10 countries outside of the U.S. The following table outlines the
	location, business segment and size of our largest facilities, along with whether we own or lease
	each facility:
|  |  |  |  |  |  |  | 
|  |  |  |  | Owned/ |  | Size | 
| Location |  | Segment |  | Leased |  | (Square Feet) | 
| 
	U.S.
 |  |  |  |  |  |  | 
| 
	Palmyra, New York
 |  | Sealing Products |  | Owned |  | 538,000 | 
| 
	Longview, Texas
 |  | Sealing Products |  | Owned |  | 210,000 | 
| 
	Paragould, Arkansas
 |  | Sealing Products |  | Owned |  | 142,000 | 
| 
	Quincy, Illinois
 |  | Engineered Products |  | Owned |  | 323,000 | 
| 
	Bay Minette, Alabama.
 |  | Engineered Products |  | Leased |  | 143,000 | 
| 
	Thorofare, New Jersey
 |  | Engineered Products |  | Owned |  | 120,000 | 
| 
	Beloit, Wisconsin
 |  | Engine Products and Services |  | Owned |  | 433,000 | 
 
	14
 
|  |  |  |  |  |  |  | 
|  |  |  |  | Owned/ |  | Size | 
| Location |  | Segment |  | Leased |  | (Square Feet) | 
| 
	Foreign
 |  |  |  |  |  |  | 
| 
	Mexico City, Mexico
 |  | Sealing Products |  | Owned |  | 131,000 | 
| 
	Saint Etienne, France
 |  | Sealing Products |  | Owned |  | 108,000 | 
| 
	Annecy, France
 |  | Engineered Products |  | Leased |  | 196,000 | 
| 
	Heilbronn, Germany
 |  | Engineered Products |  | Owned |  | 127,000 | 
| 
	Sucany, Slovakia
 |  | Engineered Products |  | Owned |  | 109,000 | 
 
	     Our manufacturing capabilities are flexible and allow us to customize the manufacturing
	process to increase performance and value for our customers and meet particular specifications. We
	also maintain numerous sales offices and warehouse facilities in strategic locations in the U.S.,
	Canada and other countries. We believe our facilities and equipment are generally in good
	condition and are well maintained and able to continue to operate at present levels.
	ITEM 3. LEGAL PROCEEDINGS
	     Descriptions of environmental, asbestos and legal matters are included in Item 7 of this
	annual report under the heading Managements Discussion and Analysis of Financial Condition and
	Results of Operations  Contingencies and in Note 17 to our Consolidated Financial Statements
	which descriptions are incorporated by reference herein.
	     In addition to the matters referenced above, we are from time to time subject to, and are
	presently involved in, other litigation and legal proceedings arising in the ordinary course of
	business. We believe that the outcome of such other litigation and legal proceedings will not have
	a material adverse affect on our financial condition, results of operations or cash flows.
	     We
	were not subject to any penalties associated with any failure to disclose reportable
	transactions under Section 6707A of the Internal Revenue Code.
	ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
	     No matter was submitted to a vote of security holders during the fourth quarter of the fiscal
	year covered by this annual report.
	EXECUTIVE OFFICERS OF THE REGISTRANT
	Information concerning our executive officers is set forth below:
|  |  |  |  |  |  |  | 
| Name |  | Age |  | Position | 
| 
	Stephen E. Macadam
 |  |  | 48 |  |  | President, Chief Executive Officer and Director | 
| 
	 
 |  |  |  |  |  |  | 
| 
	William Dries
 |  |  | 57 |  |  | Senior Vice President and Chief Financial
	Officer | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Richard L. Magee
 |  |  | 51 |  |  | Senior Vice President, General Counsel
	and Secretary | 
 
	15
 
|  |  |  |  |  |  |  | 
| Name |  | Age |  | Position | 
| 
	J. Milton Childress II
 |  |  | 51 |  |  | Vice President, Strategic Planning and
	Business Development | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Dale A. Herold
 |  |  | 41 |  |  | Vice President, Continuous Improvement | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Robert P. McKinney
 |  |  | 45 |  |  | Vice President, Human Resources | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Donald G. Pomeroy II
 |  |  | 41 |  |  | Vice President | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Robert D. Rehley
 |  |  | 48 |  |  | Vice President and Controller | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Orville G. Lunking
 |  |  | 53 |  |  | Vice President and Treasurer | 
 
	     Stephen E. Macadam has served as our Chief Executive Officer and President and as a director
	since April 2008. Prior to accepting these positions with EnPro, Mr. Macadam served as Chief
	Executive Officer of BlueLinx Holdings Inc. since October 2005. Before joining BlueLinx Holdings
	Inc., Mr. Macadam was the President and Chief Executive Officer of Consolidated Container Company
	LLC since August 2001. He served previously with Georgia-Pacific Corp. where he held the position
	of Executive Vice President, Pulp & Paperboard from July 2000 until August 2001, and the position
	of Senior Vice President, Containerboard & Packaging from March 1998 until July 2000. Mr. Macadam
	held positions of increasing responsibility with McKinsey and Company, Inc. from 1988 until 1998,
	culminating in the role of principal in charge of McKinseys Charlotte, North Carolina operation.
	Mr. Macadam is a director of Solo Cup Company.
	     William Dries is currently Senior Vice President and Chief Financial Officer and has held
	these positions since May 2002. He served as a consultant to Goodrich Corporation from September
	2001 through December 2001 and was employed by Coltec Industries Inc from January 2002 through
	April 2002. Prior to that, Mr. Dries was employed by United Dominion Industries, Inc. He was
	Senior Vice President and Chief Financial Officer of United Dominion from December 1999 until May
	2001, having previously served as Senior Vice President  Finance, Vice President and Controller.
	Mr. Dries, a certified public accountant, was with Ernst & Young LLP in New York prior to joining
	United Dominion in 1985. Mr. Dries is a director of Polypore International, Inc.
	     Richard L. Magee is currently Senior Vice President, General Counsel and Secretary and has
	held these positions since May 2002. He served as a consultant to Goodrich Corporation from
	October 2001 through December 2001, and was employed by Coltec Industries Inc from January 2002
	through April 2002. Prior to that, Mr. Magee was Senior Vice President, General Counsel and
	Secretary of United Dominion Industries, Inc. from April 2000 until July 2001, having previously
	served as Vice President, Secretary and General Counsel. Mr. Magee was a partner in the Charlotte,
	North Carolina law firm Robinson, Bradshaw & Hinson, P.A. prior to joining United Dominion in 1989.
	     J. Milton Childress II is currently Vice President, Strategic Planning and Business
	Development and has held this position since February 2006, after having joined the EnPro corporate
	staff in December 2005. He was a co-founder of and served from October 2001 through December 2005
	as Managing Director of Charlotte-based McGuireWoods Capital Group. Prior to that, Mr. Childress
	was Senior Vice President, Planning and Development of United Dominion Industries, Inc. from
	December 1999 until May 2001, having previously served as Vice President. Mr. Childress held a
	number of positions with Ernst & Youngs corporate finance consulting group prior to joining United
	Dominion in 1992.
	16
 
	     Dale A. Herold is currently Vice President, Continuous Improvement and has held this position
	since August 2008. Prior to joining EnPro, Mr. Herold was a regional vice president for BlueLinx
	Holdings Inc. from October 2007 to August 2008. Previously,
	he was that companys Vice President,
	Marketing and Sales Excellence from January 2006 to October 2007. Prior to joining BlueLinx, Mr.
	Herold worked in a variety of marketing and manufacturing roles at Consolidated Container Company
	from March 2004 to January 2006, and at General Electric from July 1989 to March 2004.
	     Robert P. McKinney is currently Vice President, Human Resources and has held this position
	since April 2008, after having previously served as Deputy General Counsel from May 2002 to April
	2008. Prior to joining EnPro, Mr. McKinney was General Counsel at Tredegar Corporation and
	Assistant General Counsel with The Pittston Company, both in Richmond, Virginia. From 1990 to
	1999, Mr. McKinney was employed by United Dominion Industries, Inc. in Charlotte, North Carolina,
	as Corporate Counsel and subsequently Assistant General Counsel. Prior to joining United Dominion,
	he was an associate with the law firm of Smith Helms Mulliss & Moore.
	     Donald G. Pomeroy II is currently Vice President with responsibility for pricing strategies in
	the Companys Continuous Improvement organization. He has held this position since November 2008,
	after having previously served as the Companys Vice President and Controller since September 2007
	and from May 2002 through August 2004, Mr. Pomeroy served as the Vice President, Finance for
	Garlock Sealing Technologies from August 2004 until August 2007. He was Vice President, Finance
	and Information Technology at Stemco for Coltec Industries Inc from August 1998 until October 2001,
	and an employee of Coltec Industries Inc from November 2001 through May 2002. From May 1995 to
	February 1996, Mr. Pomeroy was a financial analyst, and from February 1996 to August 1998, he was
	Controller  International Operations at Garlock Sealing Technologies. Prior to joining Garlock
	Sealing Technologies, Mr. Pomeroy, a certified public accountant, was with Coopers & Lybrand LLP.
	     Robert D. Rehley is currently Vice President and Controller and has held these positions since
	November 2008, after having previously served as the Companys Vice President and Treasurer since
	May 2002. He was employed by Coltec Industries Inc from January 2002 through April 2002. Mr.
	Rehley was Assistant Treasurer of Metaldyne Corporation from October 2001 to January 2002, and was
	Executive Director  Corporate Tax for Metaldyne from December 2000 until October 2001.
	Previously, he was Treasurer of Simpson Industries from April 1998 until December 2000. Mr. Rehley
	was Director  Finance and Business Development for Cummins Engine Company, Inc. from October 1996
	until April 1998.
	     Orville G. Lunking is currently Vice President and Treasurer and has held these positions
	since February 2009. Prior to joining EnPro, Mr. Lunking served as Vice President and Treasurer
	for Novelis Inc. from January 2005 to March 2008. Prior to that, he was Corporate Treasurer for
	Smithfield Foods, Inc. from July 2001 to December 2004. He previously served as Assistant
	Treasurer  International at Sara Lee Corporation from July 1997 to June 2001. Prior to this time,
	he worked in different finance-related roles at Allied Signal Inc., Bankers Trust Company, General
	Motors Corporation and Milliken & Company.
	PART II
	ITEM 5. REGISTRANTS COMMON EQUITY AND RELATED SHAREHOLDER MATTERS
	     Our common stock is publicly traded on the New York Stock Exchange (NYSE) under the symbol
	NPO. As required by Section 3.03A.12(a) of the NYSE listing standards, we filed with the NYSE
	the certification of our Chief Executive Officer that he is not aware of any violation by the
	Company of NYSE corporate governance listing standards.
	17
 
	     As of February 20, 2008, there were 5,343 holders of record of our common stock. The price
	range of our common stock from January 1, 2007 through December 31, 2008 is listed below by
	quarter:
|  |  |  |  |  |  |  |  |  | 
|  |  | Low |  | High | 
|  |  | Sale Price |  | Sale Price | 
| 
	Fiscal 2008:
 |  |  |  |  |  |  |  |  | 
| 
	Fourth Quarter
 |  | $ | 14.40 |  |  | $ | 37.25 |  | 
| 
	Third Quarter
 |  |  | 33.56 |  |  |  | 43.68 |  | 
| 
	Second Quarter
 |  |  | 31.21 |  |  |  | 40.81 |  | 
| 
	First Quarter
 |  |  | 24.40 |  |  |  | 33.46 |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	Fiscal 2007:
 |  |  |  |  |  |  |  |  | 
| 
	Fourth Quarter
 |  | $ | 29.65 |  |  | $ | 43.32 |  | 
| 
	Third Quarter
 |  |  | 31.01 |  |  |  | 46.46 |  | 
| 
	Second Quarter
 |  |  | 35.85 |  |  |  | 44.99 |  | 
| 
	First Quarter
 |  |  | 30.87 |  |  |  | 40.70 |  | 
 
	     We did not declare any cash dividends to our shareholders during 2008. For a discussion of
	the restrictions on payment of dividends on our common stock, see Managements Discussion and
	Analysis of Financial Condition and Results of Operations  Liquidity and Capital Resources 
	Dividends.
	     The following table sets forth all purchases made by us or on our behalf or any affiliated
	purchaser, as defined in Rule 10b-18(a)(3) under the Exchange Act, of shares of our common stock
	during each month in the fourth quarter of 2008.
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | (d) Maximum Number | 
|  |  |  |  |  |  |  |  |  |  | (c) Total Number of |  | (or Approximate Dollar | 
|  |  |  |  |  |  |  |  |  |  | Shares (or Units) |  | Value) of Shares (or | 
|  |  |  |  |  |  |  |  |  |  | Purchased as Part of |  | Units) that May Yet Be | 
|  |  | (a) Total Number |  | (b) Average Price |  | Publicly Announced |  | Purchased Under the | 
|  |  | of Shares (or |  | Paid per Share |  | Plans or Programs |  | Plans or Programs | 
| Period |  | Units) Purchased |  | (or Unit) |  | (1) (2) |  | (1) (2) | 
| 
	October 1 
	October 31, 2008
 |  |  | 252,400 | (2) |  |  | 28.05 | (2) |  |  | 252,400 |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	November 1 
	November 30, 2008
 |  |  | -0- |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	December 1 
	December 31, 2008
 |  |  | 2,230 | (1) |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Total
 |  |  | 254,630 | (1)(2) |  |  | 28.05 | (2) |  |  | 252,400 |  |  |  |  |  | 
 
|  |  |  | 
| (1) |  | A total of 2,230 shares were transferred to a rabbi trust that we established in connection
	with our Deferred Compensation Plan for Non-Employee Directors, pursuant to which non-employee
	directors may elect to defer directors fees into common stock units. Coltec, which is a
	wholly owned subsidiary of EnPro, furnished these shares in exchange for management and other
	services provided by EnPro. These shares were valued at a price of $21.02 per share, the
	average of the high and low prices of our common stock on December 31, 2008. We do not
	consider the | 
	18
 
|  |  |  | 
|  |  | transfer of shares from Coltec in this context to be pursuant to a publicly announced plan
	or program. | 
|  | 
| (2) |  | Pursuant to a share repurchase authorization approved by our board of directors and in
	accordance with the terms of a plan to repurchase shares of our common stock up to $38
	million, which we announced on September 8, 2008, we purchased 252,400 shares of our common
	stock at an aggregate price of approximately $7.09 million from October 1, 2008 to October 29,
	2008, including commissions and other fees. On October 29, 2008, in light of the volatility
	in the financial and credit markets, the board of directors terminated the share repurchase
	plan. | 
	CUMULATIVE TOTAL RETURN PERFORMANCE GRAPH
	     Set forth below is a line graph showing the yearly percentage change in the cumulative total
	shareholder return for our common stock as compared to similar returns for the Russell 2000
	®
	Stock
	Index and a group of our peers consisting of Flowserve Corporation, Robbins & Myers, Inc., Gardner
	Denver, Inc., Circor International, Inc., IDEX Corporation and The Gormann-Rupp Company. These
	manufacturing companies were chosen because they are all similarly situated to EnPro in terms of
	size and markets served. Each of the returns is calculated assuming the investment of $100 in each
	of the securities on December 31, 2003 and reinvestment of dividends into additional shares of the
	respective equity securities when paid. The graph plots the respective values beginning on
	December 31, 2003 and continuing through December 31, 2008. Past performance is not necessarily
	indicative of future performance.
	COMPARISON OF 5-YEAR CUMULATIVE TOTAL RETURN
	AMONG ENPRO INDUSTRIES, INC.,
	RUSSELL 2000 INDEX AND PEER GROUP INDEX
	ITEM 6. SELECTED CONSOLIDATED FINANCIAL DATA
	     The following historical consolidated financial information as of and for each of the years
	ended December 31, 2008, 2007, 2006, 2005 and 2004 has been derived from, and should be read
	together with, our audited Consolidated Financial Statements and the related notes, for each of
	those years. The audited Consolidated Financial Statements and related notes as of December 31,
	2008 and 2007 and for the years ended December 31, 2008, 2007 and 2006 are included elsewhere in
	this annual report. The information
	19
 
	presented below with respect to the last three completed fiscal years should also be read together
	with Item 7, Managements Discussion and Analysis of Financial Condition and Results of
	Operations.
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Year Ended December 31, | 
|  |  | 2008 |  | 2007 |  | 2006 |  | 2005 |  | 2004 | 
|  |  | (in millions, except per share data) | 
| 
	Statement of Operations Data:
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Net sales
 |  | $ | 1,167.8 |  |  | $ | 1,030.0 |  |  | $ | 928.4 |  |  | $ | 838.6 |  |  | $ | 826.3 |  | 
| 
	Income (loss) before extraordinary
	item
 |  | $ | 53.5 |  |  | $ | 37.7 |  |  | $ | (158.9 | ) |  | $ | 58.6 |  |  | $ | 33.8 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Balance Sheet Data:
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Total assets (1)
 |  | $ | 1,352.5 |  |  | $ | 1,470.3 |  |  | $ | 1,406.6 |  |  | $ | 1,276.2 |  |  | $ | 1,181.0 |  | 
| 
	Long-term debt (including current
	portion)
 |  | $ | 182.2 |  |  | $ | 185.7 |  |  | $ | 185.7 |  |  | $ | 185.2 |  |  | $ | 164.8 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Per Common Share Data  Diluted:
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Income (loss) before extraordinary
	item
 |  | $ | 2.54 |  |  | $ | 1.69 |  |  | $ | (7.60 | ) |  | $ | 2.75 |  |  | $ | 1.60 |  | 
 
|  |  |  | 
| (1) |  | For 2004, the total assets reported in the table above contains immaterial errors relating to
	the translation of foreign currency denominated goodwill and other intangible assets. If the
	translation adjustments had been properly recorded, total assets would have been $1,213.2
	million. There would have been no impact upon net income, earnings per share or cash flows
	for the period due to the errors. | 
	ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
	     
	The following is managements discussion and analysis of certain significant factors that have
	affected our consolidated financial condition and operating results during the periods included in
	the accompanying audited Consolidated Financial Statements and the related notes. You should read
	the following discussion in conjunction with our audited Consolidated Financial Statements and the
	related notes, included elsewhere in this annual report.
	Forward-Looking Statements
	     
	This report contains certain statements that are forward-looking statements as that term is
	defined under the Private Securities Litigation Reform Act of 1995 (the Act) and releases issued
	by the Securities and Exchange Commission. The words may, hope, will, should, expect,
	plan, anticipate, intend, believe, estimate, predict, potential, continue, and
	other expressions which are predictions of or indicate future events and trends and which do not
	relate to historical matters identify forward-looking statements. We believe that it is important
	to communicate our future expectations to our shareholders, and we therefore make forward-looking
	statements in reliance upon the safe harbor provisions of the Act. However, there may be events in
	the future that we are not able to accurately predict or control, and our actual results may differ
	materially from the expectations we describe in our forward-looking statements. Forward-looking
	statements involve known and unknown risks, uncertainties and other factors, which may cause our
	actual results, performance or achievements to differ materially from anticipated future results,
	performance or achievements expressed or implied by such forward-looking statements. We advise you
	to read further about certain of these and other risk factors set forth in Item 1A of this annual
	report, entitled Risk Factors We undertake no obligation to publicly update or revise any
	forward-looking statement, either as a result of new
	20
 
	information, future events or otherwise. Whenever you read or hear any subsequent written or oral
	forward-looking statements attributed to us or any person acting on our behalf, you should keep in
	mind the cautionary statements contained or referred to in this section.
	Overview and Outlook
	     
	Overview
	. EnPro was incorporated under the laws of the State of North Carolina on
	January 11, 2002. We design, develop, manufacture and market proprietary engineered industrial
	products. We have 43 primary manufacturing facilities located in the United States and 10
	countries outside the United States.
	     We manage our business as three segments: a Sealing Products segment, an Engineered Products
	segment, and an Engine Products and Services segment.
	     Our Sealing Products segment designs, manufactures and sells sealing products, including
	metallic, non-metallic and composite material gaskets, rotary seals, compression packing, resilient
	metal seals, elastomeric seals, hydraulic components and expansion joints, as well as wheel-end
	component systems, PTFE products, conveyor belting and sheeted rubber products. These products are
	used in a variety of industries, including chemical and petrochemical processing, petroleum
	extraction and refining, pulp and paper processing, heavy-duty trucking, power generation, food and
	pharmaceutical processing, primary metal manufacturing, mining, water and waste treatment,
	aerospace, medical, filtration and semiconductor fabrication.
	     Our Engineered Products segment includes operations that design, manufacture and sell
	self-lubricating, non-rolling, metal-polymer, solid polymer and filament wound bearing products,
	aluminum blocks for hydraulic applications, rotary and reciprocating air compressors, vacuum pumps,
	air systems and compressor components. These products are used in a wide range of applications,
	including the automotive, pharmaceutical, pulp and paper, natural gas, health, pump and compressor
	construction, power generation, machine tools, air treatment, refining, petrochemical and general
	industrial markets.
	     Our Engine Products and Services segment designs, manufactures, sells and services heavy-duty,
	medium-speed diesel, natural gas and dual fuel reciprocating engines. The United States government
	and the general markets for marine propulsion, power generation, and pump and compressor
	applications use these products and services.
	     In January 2008, we acquired certain assets and assumed certain liabilities of Sinflex Sealing
	Technologies, a distributor and manufacturer of industrial sealing products, located in Shanghai,
	China. The operation conducts business as Garlock Sealing Technologies (Shanghai) Co. Ltd. and is
	operated and managed as part of the global Garlock Sealing Technologies business unit in the
	Sealing Products segment. Sinflex was Garlocks principal distributor in China for over a decade.
	     In February 2008, we acquired the stock of V.W. Kaiser Engineering, a manufacturer of pins,
	bushings and suspension kits primarily for the heavy-duty truck and bus aftermarket. V.W. Kaiser
	Engineering is located in Michigan. It is operated and managed as part of the Stemco business
	unit, which is in the Sealing Products segment.
	     In May 2008, we acquired certain assets and assumed certain liabilities of Air Perfection in
	California. Air Perfection is engaged in the audit, sale, distribution, rental and service of
	compressed air systems and the various components that comprise such systems. The business is
	operated and managed as part of the Quincy Compressor business unit, which is in the Engineered
	Products segment.
	21
 
	     In June 2008, we purchased the 20% ownership of the minority shareholder of Garlock Pty
	Limited in Australia. Subsequent to the share purchase, we own 100% of Garlock Pty Limited, which
	is in the Sealing Products segment.
	     In October and November 2008, we acquired certain assets of and assumed certain liabilities of
	three businesses which provide components and aftermarket services for reciprocating compressors to
	customers in the petroleum, natural gas, PET bottle molding and chemical processing industries.
	The acquired businesses are Horizon Compressor Services, Inc., located in Houston, Texas; RAM Air,
	Inc., located in New Smyrna Beach, Florida; and C&P Services (Northern) Limited, located in
	Warrington, UK. The businesses are operated and managed as part of the CPI business unit in the
	Engineered Products segment.
	     In December 2008, we acquired certain assets and assumed certain liabilities of Northern
	Gaskets and Mouldings Limited (NGM), a distributor of sealing products and a manufacturer of
	gaskets, located in Batley, UK. NGM operates as part of Garlock (Great Britain) Limited in the
	Sealing Products segment. NGM increases Garlocks presence in the petrochemical, pharmaceutical
	and oil and gas industries in the UK.
	     On March 3, 2008, pursuant to a $100 million share repurchase authorization approved by our
	board of directors, we entered into an accelerated share repurchase (ASR) agreement with a
	financial institution to provide for the immediate retirement of $50 million of our common stock.
	Under the ASR agreement, we purchased approximately 1.7 million shares of our common stock from a
	financial institution at an initial price of $29.53 per share. Total consideration paid at initial
	settlement to repurchase these shares, including commissions and other fees, was approximately
	$50.2 million and was recorded in shareholders equity as a reduction of common stock and
	additional paid-in capital. The price adjustment period under the ASR terminated on August 29,
	2008. In connection with the finalization of the ASR, we remitted in cash a final settlement
	adjustment of $11.9 million to the financial institution that executed the ASR. The final
	settlement adjustment, recorded as a reduction of additional paid-in capital, was based on the
	average of the reported daily volume-weighted average price of our common stock during the term of
	the ASR. It resulted in a remittance to the financial institution because the volume-weighted
	average price of our common stock during the term of the ASR exceeded the initial price of $29.53
	per share. After the final settlement adjustment, we had completed about $62 million of the share
	repurchase authorization.
	     Pursuant to the share repurchase authorization and in accordance with the terms of a plan to
	repurchase shares announced on September 8, 2008, we acquired 252,400 shares of our common stock in
	open-market transactions at an average price of about $28.00 per share, resulting in total
	repurchases of approximately $7.1 million, including commissions and fees, from October 1, 2008 to
	October 29, 2008. On October 29, 2008, in light of the volatility in the financial and credit
	markets, the board of directors terminated the share repurchase plan.
	     As described elsewhere in this Managements Discussion and Analysis of Financial Condition and
	Results of Operations, we actively manage the asbestos claims against our subsidiaries and the
	remaining insurance assets available for the payment of these claims. We accrue an estimated
	liability for both pending and future asbestos claims for the next ten years. For additional
	information on this subject discussed in this section, see Contingencies  Asbestos.
	     
	Outlook
	     We believe we are making progress in connection with our business priorities to pursue
	operational, commercial, pricing and sourcing excellence; to accelerate growth through new
	products, new markets and acquisitions; and to effectively manage cash. We believe the
	acquisitions we have
	22
 
	completed contribute to the geographic expansion of our key businesses and that they improve
	our product offerings. However, in the current economic environment, activity in our markets has
	slowed significantly. Short lead times for most of our products give us a very limited view of the
	future, which is made even more uncertain by the deterioration of many of our markets in recent
	months. Circumstances that include facility shutdowns by customers in the automotive industry,
	curtailed demand for many of our industrial products, and less favorable foreign exchange rates
	lead us to expect lower sales and operating income in 2009 compared to 2008.
	     As
	a result of recent structural and organizational changes we have made
	in our European operations, we anticipate that our effective tax
	rate for 2009 should be less than 30%. The actual effective tax rate
	will depend on several factors, including our mix of domestic and
	foreign earnings and our actual results versus the projections used
	in estimating the effective tax rate. Due to these factors, the
	actual effective tax rate may vary significantly from the estimate.
	For years beyond 2009, we anticipate that our effective tax rate
	should generally be lower than historical rates, but may not be
	as low as we expect to experience in 2009.
	     We anticipate that cash flows in 2009 should benefit from reduced expenditures for share
	repurchases and lower capital expenditures partially offset by reduced operating income.
	     Due to recent volatility in the equity and fixed income investment markets, we, like many
	companies, have experienced a significant decline in the value of the assets that fund our U.S.
	defined benefit pension plans and an increase in the value of plan liabilities. Based on currently
	available data, which is subject to change, we estimate that we will be required to make cash
	contributions in 2009 totaling $6.4 million. We estimate that the annual U.S. pension expense will
	increase to approximately $14.0  $15.0 million in 2009 compared to $4.8 million in 2008.
	     In connection with our business strategy to accelerate growth, we will continue to evaluate
	acquisitions and divestitures in 2009; however, the impact of such acquisitions and divestitures
	cannot be predicted and therefore is not reflected in this outlook.
	Results of Operations
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Years Ended December 31, |  | 
|  |  | 2008 |  |  | 2007 |  |  | 2006 |  | 
|  |  | (in millions) |  | 
| 
	Sales
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Sealing Products
 |  | $ | 503.5 |  |  | $ | 457.3 |  |  | $ | 432.5 |  | 
| 
	Engineered Products
 |  |  | 524.1 |  |  |  | 445.5 |  |  |  | 391.7 |  | 
| 
	Engine Products and Services
 |  |  | 142.1 |  |  |  | 128.1 |  |  |  | 105.2 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  | 1,169.7 |  |  |  | 1,030.9 |  |  |  | 929.4 |  | 
| 
	Intersegment sales
 |  |  | (1.9 | ) |  |  | (0.9 | ) |  |  | (1.0 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Total sales
 |  | $ | 1,167.8 |  |  | $ | 1,030.0 |  |  | $ | 928.4 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Segment Profit
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Sealing Products
 |  | $ | 90.4 |  |  | $ | 78.0 |  |  | $ | 76.5 |  | 
| 
	Engineered Products
 |  |  | 68.1 |  |  |  | 69.4 |  |  |  | 61.5 |  | 
| 
	Engine Products and Services
 |  |  | 20.8 |  |  |  | 15.3 |  |  |  | 4.9 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Total segment profit
 |  |  | 179.3 |  |  |  | 162.7 |  |  |  | 142.9 |  | 
|  | 
| 
	Corporate expenses
 |  |  | (34.5 | ) |  |  | (34.1 | ) |  |  | (31.6 | ) | 
| 
	Asbestos-related expenses
 |  |  | (52.1 | ) |  |  | (68.4 | ) |  |  | (359.4 | ) | 
| 
	Interest income (expense), net
 |  |  | (5.3 | ) |  |  | 0.2 |  |  |  | (3.2 | ) | 
| 
	Other income (expense), net
 |  |  | (6.7 | ) |  |  | (2.4 | ) |  |  | (2.9 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Income (loss) before income taxes
 |  |  | 80.7 |  |  |  | 58.0 |  |  |  | (254.2 | ) | 
| 
	Income tax benefit (expense)
 |  |  | (27.2 | ) |  |  | (20.3 | ) |  |  | 95.3 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Income (loss) before extraordinary item
 |  |  | 53.5 |  |  |  | 37.7 |  |  |  | (158.9 | ) | 
| 
	Extraordinary item, net of taxes
 |  |  |  |  |  |  | 2.5 |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Net income (loss)
 |  | $ | 53.5 |  |  | $ | 40.2 |  |  | $ | (158.9 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
 
	23
 
	     Segment profit is total segment revenue reduced by operating expenses and restructuring and
	other costs identifiable with the segment. Corporate expenses include general corporate
	administrative costs. Expenses not directly attributable to the segments, corporate expenses, net
	interest expense, asbestos-related expenses, gains/losses or impairments related to the sale of
	assets and income taxes are not included in the computation of segment profit. The accounting
	policies of the reportable segments are the same as those for EnPro.
	     
	2008 Compared to 2007
	     Sales of $1.17 billion in 2008 increased 13% from $1.03 billion in 2007. The results of
	acquisitions added six percentage points of the sales increase. Five percentage points of growth
	were primarily the result of selected price increases and additional volume at several businesses
	partially offset by lower volume at Stemco due to a decline in demand from OEM heavy-duty truck and
	trailer manufacturers and aftermarket customers. The increase in the values of foreign currencies
	relative to the U.S. dollar contributed the remaining two percentage points to the increase.
	     Segment profit, managements primary measure of how our operations perform, increased 10% from
	$162.7 million in 2007 to $179.3 million in 2008. Segment profit increased primarily due to
	selected price increases, increased volume and acquisitions. These improvements were partially
	offset by cost increases in several areas, particularly raw materials and other manufacturing input
	costs. Segment margins, defined as segment profit divided by sales, decreased from 15.8% in 2007
	to 15.4% in 2008.
	     Asbestos expenses in 2008 were $52.1 million and included net cash outlays of $26.2 million
	for legal fees and expenses incurred during the year and $25.9 million in non-cash charges to
	maintain a ten-year liability estimate for future claims and to reflect an adjustment in insurance
	value, asbestos trust interest income and accrued legal fees. In 2007, asbestos expenses were
	$68.4 million. The higher expense in 2007 was primarily the result of adjustments made to
	managements estimation model in the fourth quarter of 2007.
	     Net interest expense in 2008 was $5.3 million compared to net interest income of $0.2 million
	in 2007. The net interest expense was a result of the decrease in invested cash balances and lower
	yields on investments.
	     Our effective tax rate for 2008 was 33.7% compared to 35.0% in 2007. The change in the rate
	is principally a result of the reversal of reserves for uncertain tax positions in connection with
	the settlement of various tax audits and the benefit of reductions in statutory income tax rates in
	several countries.
	     Net income was $53.5 million, or $2.54 per share, in 2008 compared to $40.2 million, or $1.80
	per share, in 2007. Earnings per share are expressed on a diluted basis.
	     Following is a discussion of operating results for each segment during the year:
	     
	Sealing Products
	. Sales of $503.5 million in 2008 were 10% higher than the $457.3
	million reported in 2007, however, the year-to-year improvement decelerated as the year progressed.
	Acquisitions added three percentage points of the growth while organic growth contributed five
	percentage points. The favorable impact of foreign currency exchange rates versus the U.S. dollar
	accounted for two percentage points of the growth. Sales at Garlock Sealing Technologies increased
	12%. Its sales were favorably impacted by increased demand in European markets; strength in the
	oil and gas, energy, mining and primary metals sectors; selected price increases; and increases in
	the value of foreign currencies. Stemcos sales during the year increased 10% as a result of the
	acquisition of the V.W. Kaiser business in late February. Its OEM and aftermarket sales for the
	U.S. heavy-duty truck market continued to be lower compared to 2007 as the number of new trailers
	built and usage of existing
	24
 
	trucks decreased as a result of the U.S. economic slowdown. Garlock Rubber Technologies
	experienced a sales increase of 16% due to strong demand for belt and sheet products. Sales for
	Plastomer Technologies were down 12% in 2008 compared to last year due to slowdowns in its
	semi-conductor markets.
	     Segment profit of $90.4 million in 2008 increased 16% compared to the $78.0 million reported
	in 2007. An increase in profit at Garlock Sealing Technologies resulted from lower restructuring
	charges and reflects the benefits of its higher sales volumes. Stemco reported a 6% increase in
	profit due to the impact of the addition of the V.W. Kaiser business, partially offset by the
	slowdown in the heavy-duty vehicle markets. As a result of its increase in sales, Garlock Rubber
	Technologies contributed to the increase in segment profit. Costs associated with the
	consolidation of its facilities and lower volumes negatively impacted Plastomer Technologies
	results compared to last year. Operating margins for the segment increased to 18.0% in 2008 from
	17.1% in 2007 primarily as a result of the earnings improvement at Garlock Sealing Technologies.
	     
	Engineered Products
	. Sales of $524.1 million in 2008 were 18% higher than 2007 sales
	of $445.5. Acquisitions favorably impacted revenue by nine percentage points and increased
	activity in the segments operations added five percentage points. The increase in the value of
	foreign currencies contributed four percentage points of the sales increase. Sales for Compressor
	Products International in 2008 were higher than 2007 due to acquisitions and increased volumes.
	Despite a significant decline late in the year, GGB sales in 2008 exceeded 2007 sales due to
	favorable foreign exchange rates and an acquisition. Quincy Compressors sales increased as a
	result of the acquisition completed in the second quarter of 2008 and more shipments of
	higher-priced compressors than in 2007.
	     Segment profits were $68.1 million in 2008, which compares to $69.4 million reported in 2007.
	GGBs profits decreased in 2008 due to material cost increases that exceeded price increases.
	Significant market declines in the second half largely negated first half volume gains and resulted
	in lower productivity. Quincy Compressor reported slightly lower profit as a result of material
	and other cost increases and competitive pricing conditions which offset the benefit of more
	favorable sales mix. Profits at Compressor Products International increased as a result of higher
	volumes and acquisitions. Operating margins for the segment decreased from 15.6% in 2007 to 13.0%
	in 2008.
	     
	Engine
	Products and Services
	. Sales increased from $128.1 million in 2007 to $142.1
	million in 2008. The increase in sales was principally due to higher revenue from engines and
	higher parts sales in 2008.
	     The segment reported a profit of $20.8 million in 2008 compared to $15.3 million in 2007. The
	improvement resulted from higher margins on engine sales, increased parts volumes and productivity
	improvements in 2008 compared to 2007. Operating margins for the segment increased to 14.6% in
	2008 from 11.9% in 2007.
	     
	2007 Compared to 2006
	     Sales were $1.03 billion in 2007, an 11% increase compared to the $928.4 million recorded in
	2006. Increases in foreign currency exchange rates relative to the U.S. dollar, with the euro
	being the most significant, and acquisitions added approximately six percentage points to revenue
	growth on a year-over-year basis. The five percentage points of organic growth were the result of
	stronger demand from Garlock Sealing Technologies U.S. and European markets, higher shipments from
	GGBs European operations, continued strong demand in the energy-related markets of Compressor
	Products International, increased engine and parts shipments from Fairbanks Morse Engine, and
	selected price increases at several businesses. These favorable variances were partially offset by
	lower OEM and aftermarket volumes in Stemcos heavy duty truck market, a drop in demand for
	Plastomer Technologies products in
	25
 
	the semiconductor and industrial markets, and a small decrease in shipments from Quincy Compressor,
	coming off of a strong year in 2006, for key markets such as energy, industrial and contractors.
	     Segment profit, one of managements primary measures of how our operations perform, increased
	14% from $142.9 million in 2006 to $162.7 million in 2007. Segment profit was impacted by selected
	price increases and increased sales volume at several businesses, improved margins on Fairbanks
	Morse Engine shipments, a contract loss provision for Fairbanks Morse Engine in 2006 that did not
	recur this year, a reduction in U.S. defined benefit pension expense, contributions from
	acquisitions, and favorable foreign currency exchange rates. The defined benefit pension expense
	declined because amendments to our U.S. salaried defined benefit plan implemented in the first
	quarter of 2007 lowered service costs and because returns on pension assets improved. Despite the
	lower demand experienced by Quincy Compressor and Garlock Rubber Technologies, each contributed to
	the year-over-year increase in segment profit as a result of cost savings and price increases.
	Volume declines at Stemco and Plastomer Technologies and an increase in restructuring expenses in
	2007 partially offset the favorable affects of the previously mentioned items. Restructuring
	expenses in 2007 were $6.0 million compared to $2.3 million in 2006. The restructuring costs in
	each year were primarily for the modernization project at the Garlock Sealing Technologies
	facilities in Palmyra, New York. Segment margins, defined as segment profit divided by sales,
	increased from 15.4% in 2006 to 15.8% in 2007.
	     Asbestos expenses in 2007 were $68.4 million and included net cash outlays of $25.8 million
	for legal fees and expenses incurred during the year and $42.6 million in non-cash charges to
	maintain a ten-year liability estimate for future claims and to reflect an adjustment to our
	internal estimate of the liability. In 2006, asbestos expenses were $359.4 million. The higher
	expense in 2006 was primarily the result of an adjustment we made to record the asbestos liability
	at a point that we believe to be the best estimate within our outside experts range of equally
	likely estimates for the next ten years. For a further discussion of asbestos expenses, see 
	Contingencies  Asbestos.
	     Net interest income in 2007 was $0.2 million compared to net interest expense of $3.2 million
	last year. The net interest income was a result of the increase in invested cash balances while
	the yield on those funds was essentially flat.
	     Our effective tax rate for 2007 was 35.0% compared to 37.5% in 2006. The decrease in the rate
	for 2007 was principally due to the effect on our deferred tax balances of the enactment of reduced
	income and trade tax rates in Germany. This was partially offset by an unfavorable change in the
	mix of foreign and U.S. state and local taxable income.
	     In 2007, we recorded an extraordinary gain of $2.5 million, net of $1.6 million of taxes,
	related to the acquisition of the outstanding shares of a subsidiary held by minority shareholders.
	     Following is a discussion of operating results for each segment during the year:
	     
	Sealing Products
	. Sales of $457.3 million in 2007 were 6% higher than the $432.5
	million reported in 2006. The favorable impact of the euro accounted for three percentage points
	of the growth. Sales at Garlock Sealing Technologies benefited from increased demand in its
	European markets, continued strength in the oil and gas sector, selected price increases and the
	stronger euro. Aftermarket and OEM sales decreased at Stemco due to lower demand in the U.S.
	heavy-duty truck market. Fewer new trucks and trailers were built as usage of existing trucks
	declined. A decline in sales to Plastomer Technologies semiconductor market partially offset the
	increase attributable to including the Amicon business, acquired in July 2006, for a full year in
	2007.
	     Segment profit increased by 2% from $76.5 million in 2006 to $78.0 million in 2007. Profits
	at Garlock Sealing Technologies benefited from higher volumes and selected price increases. These
	26
 
	benefits were partially offset by increased restructuring costs for the modernization project
	at the Garlock Sealing Technologies facilities in Palmyra, NY and additional spending in marketing,
	business development and R&D. Stemco reported a decline in profit in connection with its sales
	decrease and increased costs, but the decline was partially mitigated by price increases. Garlock
	Rubber Technologies increased its profit significantly in 2007 by focusing on cost reductions that
	increased operating margins. Lower volumes negatively impacted Plastomer Technologies results, as
	did increased restructuring expenses for the reorganization of its facilities. Segment margins
	decreased from 17.7% in 2006 to 17.1% in 2007.
	     
	Engineered Products
	. Sales of $445.5 million in 2007 were 14% higher than the $391.7
	million reported in 2006. The increase in the value of the euro and the acquisitions completed in
	2007 favorably impacted revenue by eleven percentage points when compared to 2006. Sales for
	Compressor Products International were higher in 2007 due to the additional volume from the
	acquisitions completed in 2006 and 2007 and increased activity in its North American and European
	markets. In 2007, GGB benefited from the favorable euro exchange rate and increased volume in
	Europe. Quincy Compressors sales were below the record levels of 2006 as demand declined in
	energy and construction markets.
	     Segment profits of $69.4 million in 2007 were 13% higher than the $61.5 million reported in
	2006. GGBs profits increased in 2007, when compared to 2006, due to higher volumes, a stronger
	euro and selected price increases. Profits at Compressor Products International improved
	principally as a result of the acquisitions and selected price increases. However, amortization of
	intangible assets associated with the acquisitions resulted in lower operating margins at both CPI
	and the segment. Despite the decline in revenue, Quincy Compressor was able to increase its
	profitability slightly as a result of price increases and cost reductions. Segment margins were
	essentially flat at 15.6% in 2007 and 15.7% in 2006.
	     
	Engine
	Products and Services
	. Sales increased 22% from the $105.2 million reported in
	2006 to $128.1 million in 2007. About half of the increase was attributable to additional engine
	and related parts shipments for U.S. Navy shipbuilding programs with the other half from sales of
	aftermarket parts and service and selected price increases.
	     The segment reported a profit of $15.3 million in 2007 compared to $4.9 million in 2006. The
	year-over-year improvement was a result of better margins on engine shipments, an increase in parts
	shipments, which have better margins than engine sales, net cost savings in manufacturing and
	administration expenses, and a $3.1 million contract loss on a U.S. Navy engine program recorded in
	2006. Segment margins in 2007 were 11.9% compared to 4.7% in 2006.
	Restructuring and Other Costs
	     Restructuring expense was $4.6 million, $6.0 million and $2.3 million for 2008, 2007 and 2006,
	respectively. The expense in all three years was primarily related to restructuring activities
	associated with the modernization project at our Garlock Sealing Technologies manufacturing
	facilities in Palmyra, New York. The project, which commenced in 2005 and is expected to end in
	2011, will reduce the number of buildings on the site from 26 to 7 and eliminate approximately
	350,000 square feet of space, or approximately half of the space under roof at the beginning of the
	project. See Note 3 to the Consolidated Financial Statements for additional information regarding
	restructuring and other costs in each year.
	Liquidity and Capital Resources
	     Cash requirements for working capital, capital expenditures, acquisitions, debt repayments and
	common stock repurchases have been funded from cash balances on hand and cash generated from
	operations. The Company is proactively pursuing acquisition opportunities, some of which may be of
	a
	27
 
	size which would exceed our cash balances at the time of closing. Should we need additional
	capital, we have other resources available, which are discussed under the heading of Capital
	Resources.
	     
	Cash Flows
	     Operating activities provided $98.2 million, $104.8 million and $75.6 million in 2008, 2007
	and 2006, respectively. The decrease in operating cash flows in 2008 versus 2007 was primarily
	attributable to an increase in working capital and higher net outflows for asbestos. As expected,
	asbestos-related insurance collections were lower in 2008 than in 2007 and amounted to $72.7
	million and $90.2 million, respectively. The decrease in insurance collections was partially
	offset by a decrease in asbestos-related payments, which amounted to $109.7 million in 2008 and
	$115.1 million in 2007. We made a $10 million contribution to the U.S. defined benefit pension
	plans in 2007 but no contribution in 2008. In 2007, operating cash flows increased from 2006
	chiefly as a result of higher net earnings, lower net asbestos payments and a decrease in working
	capital levels. These improvements were partially offset by an increase in payments for
	environmental remediation activities in 2007, which were included in the change in other noncurrent
	assets and liabilities. In 2006, working capital increased primarily due to higher inventories and
	customer receivables at several of our operations. Inventory levels were higher in 2006 primarily
	due to higher material requirements for engine programs at Fairbanks Morse Engine. Although the
	2006 working capital was impacted by an increase in accounts receivable relating to increased sales
	activity, the days sales outstanding for receivables remained constant on a year-over-year basis at
	51 days. Payments for asbestos-related claims and expenses, net of insurance recoveries, were
	$24.9 million in 2007 compared to $38.0 million in 2006.
	     We used $73.2 million, $142.3 million and $27.5 million in investing activities in 2008, 2007
	and 2006, respectively. We made net payments for acquisitions of $43.4 million in 2008 compared to
	$77.0 million in 2007 and $27.3 million in 2006. In addition, we received $10.5 million from the
	distribution of proceeds from an investment and $4.2 million in proceeds from asset sales in 2008.
	Our investing activities in 2008 included capital expenditures of $49.1 million associated with our
	manufacturing facilities, compared to $46.8 million in 2007 and $41.3 million in 2006. The
	increases in capital expenditures in 2008, 2007 and 2006 reflected spending associated with the
	modernization activities at our manufacturing facilities in Palmyra, New York and our continued
	strategy to expand geographically and to increase investments in our operations as part of an
	effort to improve customer satisfaction and reduce costs. The results in 2007 were impacted by the
	reclassification of $19.5 million of unrestricted cash balances to other current and noncurrent
	assets based on changes in expected maturity dates of the underlying investments. The 2006 results
	benefited from the reclassification of $39.8 million from restricted cash to unrestricted cash due
	to the resolution of several verdicts on appeal.
	     In 2008, we paid $69.2 million in connection with the repurchase of approximately 1.9 million
	shares of our common stock under the ASR agreement and share repurchase plan. These transactions
	were reflected as financing activities in the Consolidated Statements of Cash Flows.
	     
	Capital Resources
	     Our primary U.S. operating subsidiaries have a senior secured revolving credit facility with a
	group of banks, which matures on April 21, 2011. We have not borrowed against this facility. The
	facility is collateralized by our receivables, inventories, intellectual property, insurance
	receivables and all other personal property assets (other than fixed assets) of its U.S.
	subsidiaries, and by pledges of 65% of the capital stock of our direct foreign subsidiaries and
	100% of the capital stock of our direct and indirect U.S. subsidiaries. The facility contains
	covenants and restrictions that are customary for an asset-based loan, including limitations on
	dividends, limitations on incurrence of indebtedness and maintenance of a fixed charge coverage
	financial ratio. Certain of the covenants and restrictions apply only if availability under the
	facility falls below certain levels.
	28
 
	     The maximum initial amount available for borrowings under the facility is $75 million. Under
	certain conditions, the borrowers may request that the facility be increased by up to $25 million,
	to $100 million in total. Actual borrowing availability at any date is determined by reference to
	a borrowing base of specified percentages of eligible accounts receivable and inventory and is
	reduced by usage of the facility, which includes outstanding letters of credit, and any reserves.
	     We issued $172.5 million of convertible debentures in 2005. The debentures bear interest at
	an annual rate of 3.9375%, and we pay accrued interest on April 15 and October 15 of each year.
	The debentures will mature on October 15, 2015. The debentures are direct, unsecured and
	unsubordinated obligations and rank equal in priority with our unsecured and unsubordinated
	indebtedness and will be senior in right of payment to all subordinated indebtedness. They
	effectively rank junior to our secured indebtedness to the extent of the value of the assets
	securing such indebtedness. The debentures do not contain any financial covenants. Holders may
	convert the debentures into cash and shares of our common stock, if any, at an initial conversion
	rate of 29.5972 shares of common stock per $1,000 principal amount of debentures (which is equal to
	an initial conversion price of $33.79 per share), subject to adjustment, before the close of
	business on October 15, 2015. Upon conversion, we would deliver (i) cash equal to the lesser of
	the aggregate principal amount of the debentures to be converted or our total conversion
	obligation, and (ii) shares of our common stock in respect of the remainder, if any, of our
	conversion obligation. Conversion is permitted only under certain circumstances that had not
	occurred at December 31, 2008.
	     We used a portion of the net proceeds from the sale of the debentures to enter into call
	options (hedge and warrant transactions), which entitle us to purchase shares of our stock from a
	financial institution at $33.79 per share and entitle the financial institution to purchase shares
	of our stock from us at $46.78 per share. This will reduce potential dilution to our common
	stockholders from conversion of the debentures and have the effect to us of increasing the
	conversion price of the debentures to $46.78 per share.
	     We paid $3.1 million in the second quarter of 2008 to satisfy the outstanding 7
	1
	/
	2
	% Coltec
	Senior Notes. Industrial revenue bonds, in the amount of $9.6 million at December 31, 2008, are
	payable in full in the first quarter of 2009. The industrial revenue bonds bear interest at rates
	ranging from 6.4% to 6.55%.
	     
	Dividends
	     To date, we have not paid dividends. If availability under our senior secured revolving
	credit facility falls below $20 million, we would be limited in our ability to pay dividends. The
	indenture that governs the convertible debentures does not restrict us from paying dividends.
	Critical Accounting Policies and Estimates
	     The preparation of our Consolidated Financial Statements, in accordance with accounting
	principles generally accepted in the United States, requires us to make estimates and judgments
	that affect the reported amounts of assets, liabilities, revenues and expenses, and related
	disclosures pertaining to contingent assets and liabilities. Note 1, Overview and Significant
	Accounting Policies, to the Consolidated Financial Statements describes the significant accounting
	policies used to prepare the Consolidated Financial Statements. On an ongoing basis we evaluate
	our estimates, including, but not limited to, those related to bad debts, inventories, intangible
	assets, income taxes, warranty obligations, restructuring, pensions and other postretirement
	benefits, and contingencies and litigation. We base our estimates on historical experience and on
	various other assumptions that we believe to be reasonable under the circumstances. Actual results
	may differ from these estimates.
	29
 
	     We believe that the following accounting policies and estimates are the most critical. Some
	of them involve significant judgments and uncertainties and could potentially result in materially
	different results under different assumptions and conditions.
	     
	Revenue Recognition
	     Revenue is recognized at the time title and risk of ownership is transferred or when services
	are rendered. Any shipping costs billed to customers are recognized as revenue and expensed in
	cost of goods sold.
	     
	Asbestos
	     In 2005 and the first three quarters of 2006, we recorded a liability related to asbestos
	claims at the low end of a broad ten-year range of equally likely estimates provided by the firm of Bates White, LLC (Bates White), a recognized expert in the field
	of estimating asbestos-related liabilities. Due to the uncertain nature of the estimated
	liability, we and Bates White believed that no single amount in the range was a better estimate
	than any other amount in the range. In accordance with the applicable accounting rules, we
	recorded a liability for these claims at the low end of the range of estimated potential
	liabilities. In the fourth quarter of 2006, based on our experience during the preceding two years
	and other factors, we identified a best estimate within the Bates White range and adjusted the
	liability accordingly.
	     The significant assumptions underlying the material components of the estimated liability
	include: the number and trend of claims to be asserted; the mix of alleged diseases or impairment;
	the trend in the number of claims for non-malignant cases; the probability that some existing and
	potential future claims will eventually be dismissed without payment; the estimated amount to be
	paid per claim; and the timing and impact of large amounts that will become available for the
	payment of claims from the 524(g) trusts of former defendants in bankruptcy. The actual number of
	future actions filed per year and the payments made to resolve those claims could exceed those
	reflected in our estimate.
	     With the assistance of Bates White, we periodically review the period over which we can make a
	reasonable estimate, the assumptions underlying our estimate, the range of reasonably possible
	potential liabilities and managements estimate of the
	liability, and adjust the estimate if necessary. Changing circumstances and new data that may become available could cause a change in
	the estimated liability in the future by an amount that cannot currently be reasonably estimated,
	and that increase could be significant and material. Additional discussion is included in this
	Managements Discussion and Analysis of Financial Condition and Results of Operations in
	Contingencies  Asbestos.
	     
	Derivative Instruments and Hedging Activities
	     We have entered into contracts to hedge forecasted transactions occurring at various dates
	through December 2010 that are denominated in foreign currencies. These contracts are accounted
	for as cash flow hedges. As cash flow hedges, the effective portion of the gain or loss on the
	contracts is reported in other comprehensive income and the ineffective portion is reported in
	income. Amounts in accumulated other comprehensive income are reclassified into income in the
	period when the hedged transactions occur.
	30
 
	     
	Pensions and Postretirement Benefits
	     We and certain of our subsidiaries sponsor domestic and foreign defined benefit pension and
	other postretirement plans. Major assumptions used in the accounting for these employee benefit
	plans include the discount rate, expected return on plan assets, rate of increase in employee
	compensation levels and assumed health care cost trend rates. Assumptions are determined based on
	data available to us and appropriate market indicators, and are evaluated each year as of the
	plans measurement date. A change in any of these assumptions could have a material effect on net
	periodic pension and postretirement benefit costs reported in the Consolidated Statements of
	Operations, as well as amounts recognized in the Consolidated Balance Sheets. See Note 12 to the
	Consolidated Financial Statements for a discussion of pension and postretirement benefits.
	     
	Income Taxes
	     We use the asset and liability method of accounting for income taxes. Temporary differences
	arising from the difference between the tax and book basis of an asset or liability are used to
	compute future tax assets or liabilities. Deferred tax assets and liabilities are measured using
	enacted tax rates expected to apply to the taxable income (losses) in the years in which those
	temporary differences are expected to be recovered or settled. The effect on deferred tax assets
	and liabilities from a change in tax rates is recognized in the period that includes the enactment
	date. See Note 5 to the Consolidated Financial Statements for a discussion of income taxes.
	     
	Goodwill and Other Intangible Assets
	     The goodwill asset impairment test involves comparing the fair value of a reporting unit to
	its carrying amount. If the carrying amount of a reporting unit exceeds its fair value, a second
	step of comparing the implied fair value of the reporting units goodwill to the carrying amount of
	that goodwill is required to measure the potential goodwill impairment loss. There are inherent
	assumptions and estimates used in developing future cash flows which require management to apply
	judgment to the analysis of intangible asset impairment, including projecting revenues, interest
	rates, the cost of capital, royalty rates and tax rates. Many of the factors used in assessing
	fair value are outside the control of management and it is reasonably likely that assumptions and
	estimates will change in future periods. These changes can result in future impairments.
	New
	Accounting Pronouncements
	     See
	Note 1 to the Consolidated Financial Statements for a description of
	new accounting pronouncements, including the expected dates of
	adoption and the expected effects on results of operations, cash
	flows and financial condition, if any.
	Contingencies
	     
	General
	     Various claims, lawsuits and administrative proceedings with respect to commercial, product
	liability, asbestos and environmental matters, all arising in the ordinary course of business, are
	pending or threatened against us or our subsidiaries and seek monetary damages and/or other
	remedies. We believe that any liability that may finally be determined with respect to commercial
	and non-asbestos product liability claims should not have a material effect on our consolidated
	financial condition or results of operations. From time to time, we and our subsidiaries are also
	involved as plaintiffs in legal proceedings involving contract, patent protection, environmental,
	insurance and other matters.
	     
	Environmental
	     Our facilities and operations are subject to federal, state and local environmental and
	occupational health and safety requirements of the U.S. and foreign countries. We take a proactive
	approach in our efforts to comply with environmental, health and safety laws as they relate to our
	manufacturing operations and in proposing and implementing any remedial plans that may be
	necessary. We also
	31
 
	regularly conduct comprehensive environmental, health and safety audits at our facilities to
	maintain compliance and improve operational efficiency.
	     Although we believe past operations were in substantial compliance with the then applicable
	regulations, we or one of our subsidiaries have been named as a potentially responsible party, or
	are otherwise involved, at 20 sites where the costs to us are expected to exceed $100,000.
	Investigations have been completed for 15 sites and are in progress at the other five sites. The
	majority of these sites relate to remediation projects at former operating facilities that were
	sold or closed and primarily deal with soil and groundwater contamination.
	     As of December 31, 2008 and 2007, EnPro had accrued liabilities of $22.1 million and $27.7
	million, respectively, for estimated future expenditures relating to environmental contingencies.
	See Note 17 to the Consolidated Financial Statements for additional information regarding our
	environmental contingencies.
	     
	Colt Firearms and Central Moloney
	     We have contingent liabilities related to divested businesses for which certain of our
	subsidiaries retained liability or are obligated under indemnity agreements. These contingent
	liabilities include, but are not limited to, potential product liability and associated claims
	related to firearms manufactured prior to 1990 by Colt Firearms, a former operation of Coltec, and
	for electrical transformers manufactured prior to 1994 by Central Moloney, another former Coltec
	operation. No product liability claims are currently pending against Coltec related to Colt
	Firearms or Central Moloney. Coltec also has ongoing obligations, which are included in retained
	liabilities of previously owned businesses in our Consolidated Balance Sheets, with regard to
	workers compensation, retiree medical and other retiree benefit matters that relate to Coltecs
	periods of ownership of these operations.
	     
	Crucible Materials Corporation
	     Crucible Materials Corporation (Crucible), which is engaged primarily in the manufacture and
	distribution of specialty metal products, was a wholly owned subsidiary of Coltec until 1985 when a
	majority of the outstanding shares were sold. Coltec divested its remaining minority interest in
	2004. See Note 17 to the Consolidated Financial Statements for information about certain
	liabilities relating to Coltecs ownership of Crucible.
	     
	Debt and Capital Lease Guarantees
	     As of December 31, 2008, we had contingent liabilities for potential payments on guarantees of
	certain debt and lease obligations totaling $6.2 million. These guarantees arose from the
	divestitures of Crucible and Central Moloney, and expire at various dates through 2010. There is
	no liability for these guarantees reflected in our Consolidated Balance Sheets. In the event that
	the other parties do not fulfill their obligations under the debt or lease agreements, we could be
	responsible for these obligations.
	     
	Asbestos
	     
	History
	. Certain of our subsidiaries, primarily Garlock Sealing Technologies LLC
	(Garlock) and The Anchor Packing Company (Anchor), are among a large number of defendants in
	actions filed in various states by plaintiffs alleging injury or death as a result of exposure to
	asbestos fibers. Among the products at issue in these actions are industrial sealing products,
	including gaskets and packing products. Since the first asbestos-related lawsuits were filed
	against Garlock in 1975, Garlock and Anchor have processed more than 900,000 asbestos claims to
	conclusion (including judgments, settlements and dismissals) and, together with their insurers,
	have paid almost $1.4 billion in settlements
	32
 
	and judgments and over $400 million in fees and expenses. See Note 17 to the Consolidated
	Financial Statements for information on the disease mix in the claims, new claims recently filed,
	product defenses asserted by our subsidiaries, recent trial and appellate results, and settlements.
	     
	Status of Anchor
	. Anchor is an inactive and insolvent indirect subsidiary of Coltec.
	There is no remaining insurance coverage available to Anchor. Anchor has no remaining assets and
	has not committed to settle any actions since 1998. As cases reach the trial stage, Anchor is
	typically dismissed without payment.
	     
	Insurance Coverage
	. At December 31, 2008, Garlock had available $307.4 million of
	insurance and trust coverage that we believe will be available to
	cover current and future asbestos claims and
	certain expense payments. We believe that Garlock may also recover some
	additional insurance from insolvent carriers over time. Garlock collected approximately $0.1 million and $1.0
	million, respectively, from insolvent carriers in 2008 and 2007. There can be no assurance that
	Garlock will collect any additional insurance from insolvent carriers. See Note 17 to the Consolidated Financial Statements for
	additional information about the quality of Garlocks insurance, arrangements for payments with
	certain insurers, the resolution of past insurance disputes, and coverage exclusions for exposure
	after July 1, 1984.
	     
	Our Liability Estimate
	. Prior to mid-2004, we maintained that our subsidiaries
	liability for unasserted claims was not reasonably estimable. We estimated and recorded
	liabilities only for pending claims in advanced stages of processing, for which we believed we had
	a basis for making a reasonable estimate. We disclosed the significance of the total potential
	liability for unasserted claims in considerable detail. During 2004 we authorized counsel to
	retain Bates White to assist in estimating our subsidiaries liability for pending and future
	asbestos claims.
	     Bates Whites first report, dated February 17, 2005, provided an estimate of the liability as
	of December 31, 2004 for the following ten years, which represented a time horizon within which
	Bates White believed such liability was both probable and estimable within a range of values.
	Bates White has updated its estimate every quarter since the end of 2004. Each quarter until the
	fourth quarter of 2006, we adopted the Bates White estimate and adjusted the liability to equal the
	low end of the then-current range.
	     The estimated range of potential liabilities provided by Bates White at December 31, 2008 was
	$431 million to $627 million. According to Bates White, increases in the range over time have been
	attributable primarily to (1) the propensity to sue Garlock, (2) an increase in settlement values
	of mesothelioma claims, (3) an increase in claims filings and values in some jurisdictions, most
	notably California, and (4) the delay in, and uncertain impact of, the funding and implementation
	of trusts formed under Section 524(g) of the United States Bankruptcy Code to pay asbestos claims
	against numerous defendants in Chapter 11 reorganization cases. Because the 524(g) trusts are
	estimated by some, including Bates White, to have billions of dollars available for the payment of
	asbestos claims, they could have a significant impact on our future settlement payments and could
	therefore significantly affect our liability.
	     We have independently developed internal estimates for asbestos-related liabilities. We have
	used those estimates for a variety of purposes, including guidance for settlement negotiations and
	trial strategy, in our strategic planning, budgeting and cash flow planning processes, and in
	setting targets for annual and long-term incentive compensation. Our internal estimate has been
	within the Bates White range of equally likely estimates and has proven to be a more precise
	predictor of the actual amounts spent on settlements and verdicts than the low end of the Bates
	White range. As a result, while the low end of the Bates White range still provides a reasonable
	lower boundary of possible outcomes, Bates White and management believe that our internal estimate
	for the next ten years represents the most likely
	33
 
	point within the range. Accordingly, we adjusted the recorded liability from the low end of
	the Bates White estimate to our point estimate in the fourth quarter of 2006 and have adjusted the
	liability in each subsequent quarter consistent with our internal estimate.
	     We currently estimate that the liability of our subsidiaries for the indemnity cost of
	resolving asbestos claims for the next ten years will be $458.7 million. The estimated liability
	of $458.7 million is before any tax benefit and is not discounted to present value, and it does not
	include fees and expenses, which are recorded as incurred. The recorded liability will continue to
	be impacted by actual claims and settlement experience and any change in the legal environment that
	could cause a significant increase or decrease in the long-term expectations of management and
	Bates White. We expect the recorded liability to fluctuate, perhaps significantly. Any
	significant change in the estimated liability could have a material effect on our consolidated
	financial position and results of operations.
	     Our estimate is within the Bates White range, developed independently, and we believe that our
	estimate is the best estimate within the Bates White range of reasonable and probable estimates of
	Garlocks future obligation.
	     Bates White also indicated a broader range of potential estimates from $189 million to $711
	million. We caution that points within that broader range remain possible outcomes. Also, while
	we agree with Bates White that beyond two to four years for Garlocks economically-driven
	non-malignant claims and beyond ten years for Garlocks cancer claims and medically-driven
	non-malignant claims, there are reasonable scenarios in which the [asbestos] expenditure is
	de
	minimus
	, we caution that the process of estimating future liabilities is highly uncertain.
	Adjusting our liability to the best estimate within the range does not change that fact. In the
	words of the Bates White report, the reliability of estimates of future probable expenditures of
	Garlock for asbestos-related personal injury claims declines significantly for each year further
	into the future. Scenarios continue to exist that could result in a total future asbestos
	liability for Garlock in excess of $1 billion.
	     As previously mentioned, the liability estimate does not include legal fees and expenses,
	which add considerably to the costs each year. Over the last two years, these expenses have
	averaged approximately $7 million per quarter. In addition to these legal fees and expenses, we
	expect to continue to record charges to income in future quarters for:
|  |  |  | Increases or decreases, if any, in our estimate of Garlocks potential liability,
	plus | 
|  | 
|  |  |  | Increases, if any, that result from additional quarters added to maintain the
	ten-year estimation period (increases of this type have averaged approximately $6  7
	million per quarter for the last two years), plus | 
|  | 
|  |  |  | Amounts, if any, of solvent insurance lost or commuted, offset by insolvent
	recoveries and earnings from insurance settlement trusts. | 
 
	     In 2008, we recorded a pre-tax charge of $52.1 million to reflect net cash outlays of $26.2
	million for legal fees and expenses paid during the year and a $25.9 million non-cash charge. The
	non-cash charge included $23.8 million, primarily to add an estimate of the liability for 2018 to
	maintain a ten-year estimate and $2.1 million to reduce the remaining insurance estimated to be
	available from remaining policies with various London market carriers.
	     In 2007, we recorded a pre-tax charge to income of $68.4 million to reflect net cash outlays
	of $25.8 million for legal fees and expenses incurred during the year, and a $42.6 million non-cash
	charge. The non-cash charge included $23.2 million related to the addition of periods to maintain
	a ten-year liability estimate and $19.4 million to adjust the liability based on revisions to
	managements estimate in the fourth quarter of 2007. We made this adjustment based on our review
	of negotiations and payment
	34
 
	trends and our belief that it is more likely that, in the future, a higher percentage of
	settlement commitments made in any year will also be paid in that same year.
	     See Note 17 to the Consolidated Financial Statements for additional information about our
	liability estimate.
	     
	Quantitative Claims and Insurance Information
	. Our liability as of December 31, 2008
	was $465.5 million (our estimate of the liability described above of $458.7 million plus $6.8
	million of accrued legal and other fees already incurred but not yet paid). The liability included
	$85.3 million classified as a current liability and $380.2 million classified as a noncurrent
	liability. The recorded amounts do not include legal fees and expenses to be incurred in the
	future. See Note 17 to the Consolidated Financial Statements for additional information about
	pending cases, insurance, cash flows and our liability.
	     
	Strategy
	. Garlocks strategy is to focus on trial-listed cases and other cases in
	advanced stages, to reduce new settlement commitments each year, to carefully manage and maximize
	insurance collections, and to proactively support legislative and other efforts aimed at meaningful
	asbestos reform. We believe that this strategy should result in the reduction of the negative
	annual cash flow impact from asbestos claims over time. However, the risk of large verdicts
	sometimes impacts the implementation of the strategy, and therefore it is likely that, from time to
	time, Garlock will enter into settlements that involve large numbers of cases, including
	early-stage cases. We believe that, as predicted in various epidemiological studies that are
	publicly available, the incidence of asbestos-related disease is in decline and should continue to
	decline steadily over the next decade and thereafter, so that claims activity against Garlock will
	eventually decline to a level that can be paid from the cash flow expected from Garlocks
	operations, even after Garlock exhausts its insurance coverage. However, there can be no assurance
	that epidemiological predictions about incidence of asbestos-related disease will prove to be
	accurate, or that, even if they are, there will be a commensurate decline in the number of
	asbestos-related claims filings.
	     Considering the foregoing, as well as the experience of our subsidiaries and other defendants
	in asbestos litigation, the likely sharing of judgments among multiple responsible defendants,
	bankruptcies of other defendants, and legislative efforts, and given the amount of insurance
	coverage available to our subsidiaries from solvent insurance carriers, we believe that pending
	asbestos actions against our subsidiaries are not likely to have a material adverse effect on our
	financial condition, but could be material to our results of operations or cash flows in given
	future periods. We anticipate that asbestos claims will continue to be filed against our
	subsidiaries. Because of (1) the uncertainty as to the number and timing of potential future
	claims and the amount that will have to be paid to litigate, settle or satisfy claims, and (2) the
	finite amount of insurance available for future payments, future claims could have a material
	adverse effect on our financial condition, results of operations and cash flows.
	Off Balance Sheet Arrangements
	     
	Lease Agreements
	     We have several operating leases primarily for real estate, equipment and vehicles. Operating
	lease arrangements are generally utilized to secure the use of assets from time to time if the
	terms and conditions of the lease or the nature of the asset makes the lease arrangement more
	favorable than a purchase. As of December 31, 2008, approximately $57.3 million of future minimum
	lease payments were outstanding under these agreements. See Note 17, Commitments and
	Contingencies  Other Commitments, to the Consolidated Financial Statements for additional
	disclosure.
	35
 
	     
	Debt and Capital Lease Guarantees
	     At December 31, 2008, we have outstanding contingent liabilities for guaranteed debt and lease
	payments of $6.2 million related to previously divested businesses.
	Contractual Obligations
	     A summary of our contractual obligations and commitments at December 31, 2008 is as follows:
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Payments Due by Period (in millions) |  | 
|  |  |  |  |  |  | Less than |  |  |  |  |  |  |  |  |  |  | More than |  | 
| Contractual Obligations |  | Total |  |  | 1 Year |  |  | 1-3 Years |  |  | 3-5 Years |  |  | 5 Years |  | 
| 
	Long-term debt
 |  | $ | 182.2 |  |  | $ | 9.6 |  |  | $ | 0.1 |  |  | $ |  |  |  | $ | 172.5 |  | 
| 
	Interest on long-term debt
 |  |  | 46.8 |  |  |  | 6.9 |  |  |  | 13.6 |  |  |  | 13.6 |  |  |  | 12.7 |  | 
| 
	Operating leases
 |  |  | 57.3 |  |  |  | 13.0 |  |  |  | 20.2 |  |  |  | 14.5 |  |  |  | 9.6 |  | 
| 
	Other long-term
	liabilities
 |  |  | 54.9 |  |  |  | 5.2 |  |  |  | 5.7 |  |  |  | 5.1 |  |  |  | 38.9 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Total
 |  | $ | 341.2 |  |  | $ | 34.7 |  |  | $ | 39.6 |  |  | $ | 33.2 |  |  | $ | 233.7 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
 
	     Payment for long-term debt may be accelerated under certain circumstances because the
	convertible debentures due in 2015 may be converted earlier, requiring payment of the principal
	amount thereof in cash. Additional discussion regarding the convertible debentures is included in
	this Managements Discussion and Analysis of Financial Condition and Results of Operations in
	Liquidity and Capital Resources  Capital Resources, and in Note 10 to the Consolidated
	Financial Statements.
	     Payments for other long-term liabilities are estimates of amounts that will be paid for
	environmental and retained liabilities of previously owned businesses included in the Consolidated
	Balance Sheets at December 31, 2008. These estimated payments are based on information currently
	known to us. However, it is possible that these estimates will vary from actual results if new
	information becomes available in the future or if there are changes in the facts and circumstances
	related to these liabilities. Additional discussion regarding these liabilities is included
	earlier in this Managements Discussion and Analysis of Financial Condition and Results of
	Operations in Contingencies  Environmental, Contingencies  Colt Firearms and Central Moloney,
	Contingencies  Crucible Materials Corporation, and in Note 17 to the Consolidated Financial
	Statements.
	     At December 31, 2008, we had a $5.1 million reserve for unrecognized tax benefits which is not
	reflected in the table above. Substantially all of this tax reserve is classified in other
	long-term liabilities and deferred income taxes in our Consolidated Balance Sheet. The table also
	does not include obligations under our pension and postretirement benefit plans, which are included
	in Note 12 to the Consolidated Financial Statements.
	ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
	     We are exposed to certain market risks as part of our ongoing business operations, including
	risks from changes in foreign currency exchange rates and interest rates that could impact our
	financial condition, results of operations and cash flows. We manage our exposure to these and
	other market risks through regular operating and financing activities and through the use of
	derivative financial instruments. We intend to use derivative financial instruments as risk
	management tools and not for speculative investment purposes.
	36
 
	Interest Rate Risk
	     We are exposed to interest rate risk as a result of our outstanding debt obligations. The
	table below provides information about our debt obligations as of December 31, 2008. The table
	represents principal cash flows (in millions) and related weighted average interest rates by
	expected (contractual) maturity dates.
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Fair | 
|  |  | 2009 |  | 2010 |  | 2011 |  | 2012 |  | 2013 |  | Thereafter |  | Total |  | Value | 
| 
	Fixed rate debt
 |  | $ | 9.6 |  |  | $ | 0.1 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 172.5 |  |  | $ | 182.2 |  |  | $ | 145.1 |  | 
| 
	Average
	interest rate
 |  |  | 6.5 | % |  |  | 9.1 | % |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3.9 | % |  |  | 4.1 | % |  |  |  |  | 
 
	Foreign Currency Risk
	     We are exposed to foreign currency risks that arise from normal business operations. These
	risks include the translation of local currency balances on our foreign subsidiaries balance
	sheets, intercompany loans with foreign subsidiaries and transactions denominated in foreign
	currencies. Our objective is to control our exposure to these risks through our normal operating
	activities and, where appropriate, through foreign currency forward or option contracts. The
	following table provides information about our outstanding foreign currency forward and option
	contracts as of December 31, 2008.
|  |  |  |  |  |  |  |  |  | 
|  |  | Notional Amount |  |  |  |  |  | 
|  |  | Outstanding in |  |  |  |  |  | 
|  |  | Millions of U.S. |  |  |  |  |  | 
| Transaction Type |  | Dollars (USD) |  |  | Maturity Dates |  | Exchange Rate Ranges | 
| 
	Forward Contracts
 |  |  |  |  |  |  |  |  | 
| 
	Sell Slovakian koruna/buy euro
 |  | $ | 27.5 |  |  | Jan 2009 |  | 30.138 to 30.156 koruna/euro | 
| 
	Sell British pound/buy euro
 |  |  | 20.3 |  |  | Jan 2009 |  | 0.977 to 0.978 pound/euro | 
| 
	Sell euro/buy Australian dollar
 |  |  | 18.4 |  |  | Jan 2009 |  | 2.049 to 2.053 Australian dollar/euro | 
| 
	Buy US dollar/sell euro
 |  |  | 17.0 |  |  | Jan 2009  Dec 2009 |  | 1.455 to 1.468 USD/euro | 
| 
	Buy euro/sell US dollar
 |  |  | 12.9 |  |  | Jan 2009  Mar 2010 |  | 1.299 to 1.516 USD/euro | 
| 
	Buy US dollar/sell Australian dollar
 |  |  | 4.2 |  |  | Jan 2009  Dec 2009 |  | 0.825 to 0.851 USD/Australian dollar | 
| 
	Buy British
	pound/sell euro
 |  |  | 4.2 |  |  | Jan 2009  Dec 2009 |  | 0.795 to 0.799 pound/euro | 
| 
	Sell US dollar/buy Canadian dollar
 |  |  | 4.0 |  |  | Jan 2009  Dec 2009 |  | 1.061 to 1.064 Canadian dollar/USD | 
| 
	Buy euro/sell peso
 |  |  | 2.4 |  |  | Jan 2009 |  | 18.443 to 18.612 peso/euro | 
| 
	 
 |  |  |  |  |  |  |  | 
| 
	 
 |  |  | 110.9 |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	Option Contracts
 |  |  |  |  |  |  |  |  | 
| 
	Buy euro/sell US dollar
 |  |  | 19.4 |  |  | Jan 2009  Dec 2010 |  | 1.336 USD/euro | 
| 
	 
 |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  | $ | 130.3 |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  | 
 
	37
 
	ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAL DATA
	ENPRO INDUSTRIES, INC.
	Index to Consolidated Financial Statements
|  |  |  |  |  | 
|  |  | Page | 
| 
	Report of Independent Registered Public Accounting Firm
 |  |  | 47 |  | 
| 
	Consolidated Statements of Operations for the years ended December 31, 2008, 2007 and 2006
 |  |  | 49 |  | 
| 
	Consolidated Statements of Cash Flows for the years ended December 31, 2008, 2007 and 2006
 |  |  | 50 |  | 
| 
	Consolidated Balance Sheets as of December 31, 2008 and 2007
 |  |  | 51 |  | 
| 
	Consolidated Statements of Changes in Shareholders Equity for the years ended December 31,
	2008, 2007 and 2006
 |  |  | 52 |  | 
| 
	Notes to Consolidated Financial Statements
 |  |  | 53 |  | 
 
	ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
	     Not applicable.
	ITEM 9A. CONTROLS AND PROCEDURES
	     
	Disclosure Controls and Procedures
	     As of the end of the period covered by this report, we carried out an evaluation, under the
	supervision and with the participation of our chief executive officer and chief financial officer,
	of the effectiveness of the design and operation of our disclosure controls and procedures. The
	purpose of our disclosure controls and procedures is to provide reasonable assurance that
	information required to be disclosed in our reports filed under the Exchange Act, including this
	report, is recorded, processed, summarized and reported within the time periods specified, and that
	such information is accumulated and communicated to our management to allow timely decisions
	regarding disclosure.
	     Management does not expect that our disclosure controls and procedures or internal controls
	will prevent all errors and all fraud. A control system, no matter how well conceived or operated,
	can provide only reasonable, not absolute, assurance that the objectives of the control system are
	met. Further, the design of a control system must reflect the fact that there are resource
	constraints, and the benefits of controls must be considered relative to their costs. Because of
	the inherent limitations in all control systems, no evaluation of controls can provide absolute
	assurance that all control issues and instances of fraud, if any, within the company have been
	detected. These inherent limitations include the realities that judgments in decision-making can
	be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be
	circumvented by the individual acts of some persons, by collusion of two or more people, or by
	management override of the controls. The design of any system of controls is based in part on
	certain assumptions about the likelihood of future events, and there can be no assurance that any
	design will succeed in achieving its stated goals under all potential future conditions. Over
	time, controls may become inadequate because of changes in conditions or deterioration in the
	degree of compliance with polices or procedures. Because of the inherent limitations in a
	cost-effective control system, misstatements due to error or fraud may occur and not be detected.
	     Based on the controls evaluation, our chief executive officer and chief financial officer have
	concluded that our disclosure controls and procedures are effective to reasonably ensure that
	information
	38
 
	required to be disclosed in our reports filed under the Exchange Act is recorded, processed,
	summarized and reported within the time periods specified, and that management will be timely
	alerted to material information required to be included in our periodic reports filed with the
	Securities and Exchange Commission.
	     In addition, no change in our internal control over financial reporting has occurred during
	the quarter ended December 31, 2008 that has materially affected, or is reasonably likely to
	materially affect, our internal control over financial reporting.
	Managements Report on Internal Control over Financial Reporting
	     Our management is responsible for establishing and maintaining adequate internal control over
	financial reporting, as such term is defined in Rule 13a-15(f) under the Exchange Act. Our
	internal control over financial reporting is a process designed to provide reasonable assurance
	regarding the reliability of financial reporting and the preparation of financial statements for
	external purposes in accordance with generally accepted accounting principles. Because of its
	inherent limitations, internal control over financial reporting may not prevent or detect
	misstatements. Also, projections of any evaluation of effectiveness to future periods are subject
	to the risk that controls may become inadequate because of changes in conditions, or that the
	degree of compliance with policies and procedures may deteriorate. Therefore, even those systems
	determined to be effective can provide only reasonable assurance with respect to financial
	statement preparation and presentation.
	     We carried out an evaluation, under the supervision and with the participation of our chief
	executive officer and our chief financial officer, of the effectiveness of our internal control
	over financial reporting as of the end of the period covered by this report. However, the
	assessment did not include the following operations that we acquired within the past year, none of
	which, individually or in the aggregate, would be considered significant under Rule 1-02(w) of
	Regulation SX of the SEC: Air Perfection, Inc., C&P Services (Northern) Ltd., Horizon Compressor
	Services, Inc., Northern Gaskets & Mouldings Ltd., Reciprocating Aircompressor Maintenance, Inc.
	(d/b/a RAM Air, Inc.), Shanghai Sinflex Sealing Technologies Co. and V.W. Kaiser Engineering, Inc.
	In making this assessment, we used the criteria set forth by the Committee of Sponsoring
	Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework. Based on
	our assessment, we have concluded that, as of December 31, 2008, our internal control over
	financial reporting was effective based on those criteria.
	     The effectiveness of our internal control over financial reporting as of December 31, 2008,
	has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm,
	as stated in their report which appears in this Annual Report on Form 10-K.
	ITEM 9B. OTHER INFORMATION
	     Not applicable.
	39
 
	PART III
	ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
	     Information concerning our directors and officers appearing under the captions Election of
	Directors, Legal Proceedings, Corporate Governance Policies and Practices, and information
	under the caption Security Ownership of Certain Beneficial Owners and Management  Section 16(a)
	Beneficial Ownership Reporting Compliance in our definitive proxy statement for the 2009 annual
	meeting of shareholders is incorporated herein by reference.
	     We have adopted a written Code of Business Conduct that applies to all of our directors,
	officers and employees, including our principal executive officer, principal financial officer and
	principal accounting officer. The Code is available on our Internet site at
	www.enproindustries.com. We intend to disclose on our Internet site any substantive changes to the
	Code and any waivers granted under the Code to the specified officers.
	ITEM 11. EXECUTIVE COMPENSATION
	     A description of the compensation of our executive officers is set forth under the caption
	Executive Compensation in our definitive proxy statement for the 2009 annual meeting of
	shareholders and is incorporated herein by reference.
	ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS
	     Security ownership data appearing under the caption Security Ownership of Certain Beneficial
	Owners and Management in our definitive proxy statement for the 2009 annual meeting of
	shareholders is incorporated herein by reference.
	     The table below contains information as of December 31, 2008, with respect to our Amended and
	Restated 2002 Equity Compensation Plan, the only compensation plan or arrangement (other than our
	tax-qualified plans) under which we have options, warrants or rights to receive equity securities
	authorized for issuance.
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  | Number of Securities | 
|  |  |  |  |  |  |  |  |  |  | Remaining Available for | 
|  |  | Number of Securities |  |  |  |  |  | Future Issuance Under | 
|  |  | to be Issued Upon |  | Weighted-Average |  | Equity Compensation | 
|  |  | Exercise of Outstanding |  | Exercise Price of |  | Plans (Excluding | 
|  |  | Options, Warrants |  | Outstanding Options, |  | Securities Reflected in | 
| Plan Category |  | and Rights |  | Warrants and Rights |  | Column (a)) | 
|  |  | (a) |  | (b) |  | (c) | 
| 
	Equity compensation plans
	approved by security holders
 |  |  | 1,398,955 | (1) |  | $ | 9.35 | (2) |  |  | 695,596 |  | 
| 
	Equity
	compensation plans not approved by security holders
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Total
 |  |  | 1,398,955 | (1) |  | $ | 9.35 | (2) |  |  | 695,596 |  | 
 
|  |  |  | 
| (1) |  | Includes performance shares awarded under our Amended and Restated 2002 Equity Compensation
	Plan at the level paid for the 2006  2008 performance cycle and the maximum levels payable
	for the 2007  2009 and 2008  2010 performance cycles. | 
	40
 
|  |  |  | 
| (2) |  | The weighted average exercise price does not take into account awards of performance shares
	or phantom shares made under our Amended and Restated 2002 Equity Compensation Plan.
	Information with respect to these awards is incorporated by reference to the information
	appearing under the captions Corporate Governance Policies and Practices  Director
	Compensation and Executive Compensation  Grants of Plan Based Awards  LTIP Awards in
	our definitive proxy statement for the 2009 annual meeting of shareholders. | 
	     Information
	concerning the inducement awards granted in 2008 to our Chief Executive Officer outside of our
	Amended and Restated 2002 Equity Compensation Plan is incorporated by reference to the
	information appearing under the caption Executive Compensation  Employment Agreement in
	our definitive proxy statement for the 2009 annual meeting of shareholders.
	ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
	     Information concerning the independence of our directors is set forth under the caption
	Corporate Governance Policies and Practices  Director Independence in our definitive proxy
	statement for the 2009 annual meeting of shareholders and is incorporated herein by reference.
	ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
	     Information appearing under the caption Independent Registered Public Accounting Firm in our
	definitive proxy statement for the 2009 annual meeting of shareholders is incorporated herein by
	reference.
	PART IV
	ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
	     (a) The following documents are filed as part of this report:
	     1. Financial Statements
	     The financial statements filed as part of this report are listed in Part II, Item 8 of this
	report on the Index to Consolidated Financial Statements.
	     2. Financial Statement Schedule
	     Schedule II  Valuation and Qualifying Accounts for the years ended December 31, 2008, 2007
	and 2006 appears on page 93.
	     Other schedules are omitted because of the absence of conditions under which they are required
	or because the required information is provided in the Consolidated Financial Statements or notes
	thereto.
	     3. Exhibits
	     The exhibits to this report on Form 10-K are listed in the Exhibit Index appearing on pages 43
	to 46.
	41
 
	SIGNATURES
	     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
	caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the
	City of Charlotte, North Carolina on this 2
	nd
	day of March, 2009.
|  |  |  |  |  | 
|  | ENPRO INDUSTRIES, INC. 
 |  | 
| Date: March 2, 2009 | By: | /s/ Richard L. Magee |  | 
|  |  | Richard L. Magee |  | 
|  |  | Senior Vice President, General Counsel and
	Secretary |  | 
|  | 
|  |  |  | 
|  | By: | /s/ William Dries |  | 
|  |  | William Dries |  | 
|  |  | Senior Vice President and Chief Financial Officer (Principal Accounting Officer)
 |  | 
|  | 
	     Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been
	signed below by the following persons, or in their behalf by their duly appointed attorney-in-fact,
	on behalf of the registrant in the capacities and on the date indicated.
|  |  |  |  |  | 
| Signatures |  | Title |  | Date | 
| 
	 
 |  |  |  |  | 
| 
	/s/ Stephen E. Macadam
 
	 
 
	     Stephen E. Macadam
 |  | President and Chief Executive Officer
 (Principal Executive Officer) and Director
 |  | March 2, 2009 | 
| 
	 
 |  |  |  |  | 
| 
	/s/ William R. Holland
 
	 
 
	     William R. Holland*
 |  | Chairman of the Board and Director |  | March 2, 2009 | 
| 
	 
 |  |  |  |  | 
| 
	/s/ J. P. Bolduc
 
	 
 
	     J. P. Bolduc*
 |  | Director |  | March 2, 2009 | 
| 
	 
 |  |  |  |  | 
| 
	/s/ Peter C. Browning
 
	 
 
	     Peter C. Browning*
 |  | Director |  | March 2, 2009 | 
| 
	 
 |  |  |  |  | 
| 
	/s/ Don DeFossett
 
	 
 
	     Don DeFossett
 |  | Director |  | March 2, 2009 | 
| 
	 
 |  |  |  |  | 
| 
	/s/ Joe T. Ford
 
	 
 
	     Joe T. Ford*
 |  | Director |  | March 2, 2009 | 
| 
	 
 |  |  |  |  | 
| 
	/s/ Gordon D. Harnett
 
	 
 
	     Gordon D. Harnett*
 |  | Director |  | March 2, 2009 | 
| 
	 
 |  |  |  |  | 
| 
	/s/ David L. Hauser
 
	 
 
	     David L. Hauser*
 |  | Director |  | March 2, 2009 | 
| 
	 
 |  |  |  |  | 
| 
	/s/ Wilbur J. Prezzano, Jr.
 
	 
 
	     Wilbur J.
	Prezzano, Jr.*
 |  | Director |  | March 2, 2009 | 
 
|  |  |  |  |  | 
| 
	* By:
 |  | /s/ Richard L. Magee 
	 
Richard L. Magee, Attorney-in-Fact |  |  | 
 
	42
 
	EXHIBIT INDEX
| 3.1 |  | Restated Articles of Incorporation of EnPro Industries, Inc., (incorporated by reference to
	Exhibit 3.1 to the Form 10-Q for the period ended June 30, 2008 filed by EnPro Industries,
	Inc. (File No. 001-31225)) | 
|  | 
| 3.2 |  | Amended Bylaws of EnPro Industries, Inc. (incorporated by reference to Exhibit 99.1 to the
	Form 8-K dated December 12, 2007 filed by EnPro Industries, Inc. (File No. 001-31225)) | 
|  | 
| 4.1 |  | Form of certificate representing shares of common stock, par value $0.01 per share, of EnPro
	Industries, Inc. (incorporated by reference to Amendment No. 4 of the Registration Statement
	on Form 10 of EnPro Industries, Inc. (File No. 001-31225)) | 
|  | 
| 4.2 |  | Rights Agreement between EnPro Industries, Inc. and The Bank of New York, as rights agent
	(incorporated by reference to Exhibit 4.7 to the Registration Statement on Form S-8 filed by
	EnPro Industries, Inc., the EnPro Industries, Inc. Retirement Savings Plan for Hourly Workers
	and the EnPro Industries, Inc. Retirement Savings Plan for Salaried Workers (File No.
	333-89576)) | 
|  | 
| 4.5 |  | Indenture dated as of October 26, 2005 between EnPro Industries, Inc. and Wachovia Bank,
	National Association, as trustee (incorporated by reference to Exhibit 10.1 to the Form 8-K
	dated October 26, 2005 filed by EnPro Industries, Inc. (File No. 001-31225)) | 
|  | 
| 10.1 |  | Form of Indemnification Agreement for directors and officers (incorporated by reference to
	Exhibit 10.5 to Amendment No. 3 of the Registration Statement on Form 10 of EnPro Industries,
	Inc. (File No. 001-31225)) | 
|  | 
| 10.2+ |  | EnPro Industries, Inc. 2002 Equity Compensation Plan (2005 Amendment and Restatement)
	(incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A dated March
	29, 2005 filed by EnPro Industries, Inc. (File No. 001-31225)) | 
|  | 
| 10.3+ |  | EnPro Industries, Inc. Senior Executive Annual Performance Plan (incorporated by reference
	to Appendix A to the Proxy Statement on Schedule 14A dated March 22, 2007 filed by EnPro
	Industries, Inc. (File No. 001-31225)) | 
|  | 
| 10.4+ |  | EnPro Industries, Inc. Long-Term Incentive Plan (incorporated by reference to Appendix B to
	the Proxy Statement on Schedule 14A dated March 22, 2007 filed by EnPro Industries, Inc. (File
	No. 001-31225)) | 
|  | 
| 10.5+ |  | Form of EnPro Industries, Inc. Long-Term Incentive Plan Award Grant (incorporated by
	reference to Exhibit 10.5 to the Form 10-K for the year ended December 31, 2007 filed by EnPro
	Industries, Inc. (File No. 001-31225)) | 
|  | 
| 10.6+ |  | Form of EnPro Industries, Inc. Phantom Share Award Grant for Outside Directors (2005
	Amendment and Restatement) (incorporated by reference to Exhibit 10.6 to the Form 10-K for the
	year ended December 31, 2007 filed by EnPro Industries, Inc. (File No. 001-31225)) | 
|  | 
| 10.7+ |  | Form of EnPro Industries, Inc. Restricted Share Award Agreement (incorporated by reference
	to Exhibit 10.1 to the Form 8-K dated February 14, 2008 filed by EnPro Industries, Inc. (File
	No. 001-31225)) | 
 
	43
 
| 10.8+ |  | EnPro Industries, Inc. Defined Benefit Restoration Plan (amended and restated effective as
	of January 1, 2007) (incorporated by reference to Exhibit 10.25 to the Form 10-K for the year
	ended December 31, 2006 filed by EnPro Industries, Inc. (File No. 001-31225)) | 
|  | 
| 10.9+ |  | EnPro Industries, Inc. Deferred Compensation Plan (as amended and restated effective January
	1, 2007) (incorporated by reference to Exhibit 10.9 to the Form 10-K for the year ended
	December 31, 2007 filed by EnPro Industries, Inc. (File No. 001-31225)) | 
|  | 
| 10.10+ |  | EnPro Industries, Inc. Deferred Compensation Plan for Non-Employee Directors (as amended and
	restated effective February 12, 2008) (incorporated by reference to Exhibit 10.1 to the Form
	10-Q for the period ended March 31, 2008 filed by EnPro Industries, Inc. (File No. 001-31225)) | 
|  | 
| 10.11+ |  | EnPro Industries, Inc. Outside Directors Phantom Share Plan (incorporated by reference to
	Exhibit 10.14 to the Form 10-K for the year ended December 31, 2002 filed by EnPro Industries,
	Inc. (File No. 001-31225)) | 
|  | 
| 10.12 |  | Amended and Restated Loan and Security Agreement, dated April 26, 2006 by and among Coltec
	Industries Inc, Coltec Industrial Products LLC, Garlock Sealing Technologies LLC, GGB LLC,
	Corrosion Control Corporation and Stemco LP, as Borrowers; EnPro Industries, Inc., as Parent;
	QFM Sales and Services, Inc., Coltec International Services Co, Garrison Litigation Management
	Group, Ltd., GGB, Inc., Garlock International Inc, Stemco Delaware LP, Stemco Holdings, Inc.,
	Stemco Holdings Delaware, Inc. and Garlock Overseas Corporation, as Subsidiary Guarantors; the
	various financial institutions listed on the signature pages thereof, as Lenders; Bank of
	America, N.A., as Agent and Issuing Bank; and Banc of America Securities LLC, as Sole Lead
	Arranger and Sole Book Manager (incorporated by reference to Exhibit 10.1 to the Form 8-K
	dated April 26, 2006 filed by EnPro Industries, Inc. (File No. 001-31225)) | 
|  | 
| 10.13+* |  | Management Continuity Agreement dated as of April 14, 2008 between EnPro Industries, Inc.
	and Stephen E. Macadam | 
|  | 
| 10.14+ |  | Management Continuity Agreement dated as of August 1, 2002 between EnPro Industries, Inc.
	and William Dries (incorporated by reference to Exhibit 10.23 to the Form 10-K for the year
	ended December 31, 2002 filed by EnPro Industries, Inc. (File No. 001-31225)) | 
|  | 
| 10.15+ |  | Management Continuity Agreement dated as of August 1, 2002 between EnPro Industries, Inc.
	and Richard L. Magee (incorporated by reference to Exhibit 10.25 to the Form 10-K for the year
	ended December 31, 2002 filed by EnPro Industries, Inc. (File No. 001-31225)) | 
|  | 
| 10.16+ |  | Management Continuity Agreement dated as of August 1, 2002 between EnPro Industries, Inc.
	and Robert D. Rehley (incorporated by reference to Exhibit 10.28 to the Form 10-K for the year
	ended December 31, 2002 filed by EnPro Industries, Inc. (File No. 001-31225)) | 
|  | 
| 10.17+ |  | Management Continuity Agreement dated as of January 30, 2006 between EnPro Industries, Inc.
	and J. Milton Childress II (incorporated by reference to Exhibit 10.28 to the Form 10-K for
	the year ended December 31, 2005 filed by EnPro Industries, Inc. (File No. 001-31225)) | 
|  | 
| 10.18+ |  | Management Continuity Agreement dated as of September 1, 2007 between EnPro Industries, Inc.
	and Donald G. Pomeroy II (incorporated by reference to Exhibit 10.1 to the Form 8-K dated
	August 17, 2007 filed by EnPro Industries, Inc. (File No. 001-31225)) | 
 
	44
 
| 10.19+* |  | Management Continuity Agreement dated as of February 11, 2009 between EnPro Industries, Inc.
	and Orville G. Lunking | 
|  | 
| 10.20+ |  | Death Benefits Agreement dated as of December 12, 2002 between EnPro Industries, Inc. and
	William Dries (incorporated by reference to Exhibit 10.31 to the Form 10-K for the year ended
	December 31, 2002 filed by EnPro Industries, Inc. (File No. 001-31225)) | 
|  | 
| 10.21+ |  | Death Benefits Agreement dated as of December 12, 2002 between EnPro Industries, Inc. and
	Richard L. Magee (incorporated by reference to Exhibit 10.33 to the Form 10-K for the year
	ended December 31, 2002 filed by EnPro Industries, Inc. (File No. 001-31225)) | 
|  | 
| 10.22+ |  | Supplemental Retirement and Death Benefits Agreement dated as of November 8, 2005 between
	EnPro Industries, Inc. and William Dries (incorporated by reference to Exhibit 10.2 to the
	Form 10-Q for the quarter ended September 30, 2005 filed by EnPro Industries, Inc. (File No.
	001-31225)) | 
|  | 
| 10.23+ |  | Supplemental Retirement and Death Benefits Agreement dated as of November 8, 2005 between
	EnPro Industries, Inc. and Richard L. Magee (incorporated by reference to Exhibit 10.3 to the
	Form 10-Q for the quarter ended September 30, 2005 filed by EnPro Industries, Inc. (File No.
	001-31225)) | 
|  | 
| 10.24+ |  | EnPro Industries, Inc. Senior Officer Severance Plan (effective as of January 1, 2008)
	(incorporated by reference to Exhibit 10.25 to the Form 10-K for the year ended December 31,
	2007 filed by EnPro Industries, Inc. (File No. 001-31225)) | 
|  | 
| 10.25 |  | Variable Term Accelerated Share Repurchase Transaction dated March 3, 2008 between EnPro
	Industries, Inc. and Credit Suisse International (incorporated by reference to Exhibit 10.1 to
	the Form 8-K dated March 3, 2008 filed by EnPro Industries, Inc. (File No. 001-31225)) | 
|  | 
| 10.26 |  | Settlement Agreement dated as of April 11, 2008 among EnPro Industries, Inc. and Steel
	Partners II, L.P., Steel Partners II GP LLC, Steel Partners II Master Fund L.P., Steel
	Partners LLC, Warren G. Lichtenstein, James R. Henderson, John J. Quicke, Kevin C. King, Don
	DeFosset and Delyle Bloomquist (incorporated by reference to Exhibit 10.1 to the Form 8-K
	dated April 11, 2008 filed by EnPro Industries, Inc. (File No. 001-31225)) | 
|  | 
| 10.27+* |  | Summary of Executive and Director Compensation Arrangements | 
|  | 
| 10.28* |  | Letter Agreement dated December 16, 2008 by and among
	Coltec Industries Inc, Coltec Industrial Products LLC, Garlock
	Sealing Technologies LLC, GGB LLC, Corrosion Control Corporation,
	Stemco LP and V.W. Kaiser Engineering, Incorporated, as
	Borrowers; EnPro Industries, Inc., QFM Sales and Services, Inc.,
	Coltec International Services Co., Garrison Litigation Management
	Group, Ltd., GGB, Inc., Garlock International Inc., Garlock Overseas
	Corporation, Stemco Holdings, Inc., Compressor Products Holdings,
	Inc. and Compressor Services Holdings, Inc., as Guarantors; the
	various financial institutions listed on the signature pages thereof,
	as Lenders; and Bank of America, N.A., in its capacity as a Lender
	and as collateral and administrative agent for Lenders, which letter
	agreement includes amendments to the Amended and Restated Loan and
	Security Agreement dated April 26, 2006 | 
|  | 
| 14 |  | EnPro Industries, Inc. Code of Business Conduct (incorporated by reference to Exhibit 14 to
	the Form 10-K for the year ended December 31, 2002 filed by EnPro Industries, Inc. (File No.
	001-31225)) | 
|  | 
| 21* |  | List of Subsidiaries | 
|  | 
| 23.1* |  | Consent of PricewaterhouseCoopers LLP | 
|  | 
| 23.2* |  | Consent of Bates White, LLC | 
|  | 
| 24.1* |  | Power of Attorney from J. P. Bolduc | 
|  | 
| 24.2* |  | Power of Attorney from Peter C. Browning | 
|  | 
| 24.3* |  | Power of Attorney from Joe T. Ford | 
 
	45
 
| 24.4* |  | Power of Attorney from Gordon D. Harnett | 
|  | 
| 24.5* |  | Power of Attorney from David L. Hauser | 
|  | 
| 24.6* |  | Power of Attorney from William R. Holland | 
|  | 
| 24.7* |  | Power of Attorney from Wilbur J. Prezzano, Jr. | 
|  | 
| 24.8* |  | Power of Attorney from Don DeFosset | 
|  | 
| 31.1* |  | Certification of Chief Executive Officer pursuant to
	Rule 13a - 14(a)/15d - 14(a) | 
|  | 
| 31.2* |  | Certification of Chief Financial Officer pursuant to
	Rule 13a - 14(a)/15d - 14(a) | 
|  | 
| 32* |  | Certification pursuant to Section 1350 | 
 
|  |  |  | 
| * |  | Items marked with an asterisk are filed herewith. | 
|  | 
| + |  | Management contract or compensatory plan required to be filed under Item 15(c) of this report
	and Item 601 of Regulation S-K of the Securities and Exchange Commission. | 
	46
 
	REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
	To the Board of Directors and Shareholders of EnPro Industries, Inc.:
	In our opinion, the consolidated financial statements listed in the accompanying index present
	fairly, in all material respects, the financial position of EnPro Industries, Inc. and its
	subsidiaries at December 31, 2008 and 2007, and the results of their operations and their cash
	flows for each of the three years in the period ended December 31, 2008 in conformity with
	accounting principles generally accepted in the United States of America. In addition, in our
	opinion, the financial statement schedule listed in the accompanying index
	presents
	fairly, in all material respects, the information set forth therein when read in conjunction with
	the related consolidated financial statements. Also in our opinion, the Company maintained, in all
	material respects, effective internal control over financial reporting as of December 31, 2008,
	based on criteria established in
	Internal Control  Integrated Framework
	issued by the Committee of
	Sponsoring Organizations of the Treadway Commission (COSO). The Companys management is responsible
	for these financial statements and financial statement schedule, for maintaining effective internal
	control over financial reporting and for its assessment of the effectiveness of internal control
	over financial reporting, included in Managements Report on Internal Control over Financial
	Reporting appearing under Item 9A. Our responsibility is to express opinions on these financial
	statements, on the financial statement schedule, and on the Companys internal control over
	financial reporting based on our integrated audits. We conducted our audits in accordance with the
	standards of the Public Company Accounting Oversight Board (United States). Those standards
	require that we plan and perform the audits to obtain reasonable assurance about whether the
	financial statements are free of material misstatement and whether effective internal control over
	financial reporting was maintained in all material respects. Our audits of the financial
	statements included examining, on a test basis, evidence supporting the amounts and disclosures in
	the financial statements, assessing the accounting principles used and significant estimates made
	by management, and evaluating the overall financial statement presentation. Our audit of internal
	control over financial reporting included obtaining an understanding of internal control over
	financial reporting, assessing the risk that a material weakness exists, and testing and evaluating
	the design and operating effectiveness of internal control based on the assessed risk. Our audits
	also included performing such other procedures as we considered necessary in the circumstances. We
	believe that our audits provide a reasonable basis for our opinions.
	A companys internal control over financial reporting is a process designed to provide reasonable
	assurance regarding the reliability of financial reporting and the preparation of financial
	statements for external purposes in accordance with generally accepted accounting principles. A
	companys internal control over financial reporting includes those policies and procedures that (i)
	pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the
	transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that
	transactions are recorded as necessary to permit preparation of financial statements in accordance
	with generally accepted accounting principles, and that receipts and expenditures of the company
	are being made only in accordance with authorizations of management and directors of the company;
	and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized
	acquisition, use, or disposition of the companys assets that could have a material effect on the
	financial statements.
	47
 
	Because of its inherent limitations, internal control over financial reporting may not prevent or
	detect misstatements. Also, projections of any evaluation of effectiveness to future periods are
	subject to the risk that controls may become inadequate because of changes in conditions, or that
	the degree of compliance with the policies or procedures may deteriorate.
	/s/ PricewaterhouseCoopers LLP
	Charlotte, North Carolina
	March 2, 2009
	48
 
	PART I. FINANCIAL INFORMATION
	ENPRO INDUSTRIES, INC.
	CONSOLIDATED STATEMENTS OF OPERATIONS
	Years Ended December 31, 2008, 2007 and 2006
	(in millions, except per share data)
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | 2008 |  |  | 2007 |  |  | 2006 |  | 
| 
	Net sales
 |  | $ | 1,167.8 |  |  | $ | 1,030.0 |  |  | $ | 928.4 |  | 
| 
	Cost of sales
 |  |  | 760.5 |  |  |  | 670.0 |  |  |  | 621.1 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Gross profit
 |  |  | 407.3 |  |  |  | 360.0 |  |  |  | 307.3 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Operating expenses:
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Selling, general and administrative expenses
 |  |  | 264.1 |  |  |  | 228.4 |  |  |  | 196.3 |  | 
| 
	Asbestos-related expenses
 |  |  | 52.1 |  |  |  | 68.4 |  |  |  | 359.4 |  | 
| 
	Other operating expense (income)
 |  |  | (0.3 | ) |  |  | 6.0 |  |  |  | 2.9 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  | 315.9 |  |  |  | 302.8 |  |  |  | 558.6 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Operating income (loss)
 |  |  | 91.4 |  |  |  | 57.2 |  |  |  | (251.3 | ) | 
| 
	Interest expense
 |  |  | (8.0 | ) |  |  | (8.1 | ) |  |  | (8.1 | ) | 
| 
	Interest income
 |  |  | 2.7 |  |  |  | 8.3 |  |  |  | 4.9 |  | 
| 
	Other income (expense)
 |  |  | (5.4 | ) |  |  | 0.6 |  |  |  | 0.3 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Income (loss) before income taxes
 |  |  | 80.7 |  |  |  | 58.0 |  |  |  | (254.2 | ) | 
| 
	Income tax benefit (expense)
 |  |  | (27.2 | ) |  |  | (20.3 | ) |  |  | 95.3 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Income (loss) before extraordinary item
 |  |  | 53.5 |  |  |  | 37.7 |  |  |  | (158.9 | ) | 
| 
	Extraordinary item, net of taxes
 |  |  |  |  |  |  | 2.5 |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Net income (loss)
 |  | $ | 53.5 |  |  | $ | 40.2 |  |  | $ | (158.9 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Basic earnings (loss) per share:
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Income (loss) before extraordinary item
 |  | $ | 2.64 |  |  | $ | 1.77 |  |  | $ | (7.60 | ) | 
| 
	Extraordinary item
 |  |  |  |  |  |  | 0.12 |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Net income (loss)
 |  | $ | 2.64 |  |  | $ | 1.89 |  |  | $ | (7.60 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Diluted earnings (loss) per share:
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Income (loss) before extraordinary item
 |  | $ | 2.54 |  |  | $ | 1.69 |  |  | $ | (7.60 | ) | 
| 
	Extraordinary item
 |  |  |  |  |  |  | 0.11 |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Net income (loss)
 |  | $ | 2.54 |  |  | $ | 1.80 |  |  | $ | (7.60 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
 
	     See notes to Consolidated Financial Statements.
	49
 
	ENPRO INDUSTRIES, INC.
	CONSOLIDATED STATEMENTS OF CASH FLOWS
	Years Ended December 31, 2008, 2007 and 2006
	(in millions)
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | 2008 |  |  | 2007 |  |  | 2006 |  | 
| 
	OPERATING ACTIVITIES
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Net income (loss)
 |  | $ | 53.5 |  |  | $ | 40.2 |  |  | $ | (158.9 | ) | 
| 
	Adjustments to reconcile net income (loss) to net cash
	provided by operating activities:
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Depreciation
 |  |  | 30.9 |  |  |  | 29.1 |  |  |  | 26.4 |  | 
| 
	Amortization
 |  |  | 13.9 |  |  |  | 11.1 |  |  |  | 8.8 |  | 
| 
	Deferred income taxes
 |  |  | 1.2 |  |  |  | (8.4 | ) |  |  | (104.5 | ) | 
| 
	Stock-based compensation
 |  |  | 3.9 |  |  |  | 3.6 |  |  |  | 5.5 |  | 
| 
	Excess tax benefits from stock-based compensation
 |  |  | (0.8 | ) |  |  | (3.8 | ) |  |  | (1.3 | ) | 
| 
	Loss (gain) on sale of assets, net
 |  |  | (2.4 | ) |  |  |  |  |  |  | 0.6 |  | 
| 
	Extraordinary gain, net of taxes
 |  |  |  |  |  |  | (2.5 | ) |  |  |  |  | 
| 
	Change in assets and liabilities, net of effects of
	acquisitions of businesses:
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Asbestos liabilities, net of insurance receivables
 |  |  | 15.2 |  |  |  | 43.0 |  |  |  | 321.4 |  | 
| 
	Accounts and notes receivable
 |  |  | 8.3 |  |  |  | (11.0 | ) |  |  | (7.9 | ) | 
| 
	Inventories
 |  |  | (14.0 | ) |  |  | 18.2 |  |  |  | (9.7 | ) | 
| 
	Accounts payable
 |  |  | (12.7 | ) |  |  | 11.9 |  |  |  | 3.7 |  | 
| 
	Other current assets and liabilities
 |  |  | (3.6 | ) |  |  | (6.4 | ) |  |  | (2.9 | ) | 
| 
	Other noncurrent assets and liabilities
 |  |  | 4.8 |  |  |  | (20.2 | ) |  |  | (5.6 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Net cash provided by operating activities
 |  |  | 98.2 |  |  |  | 104.8 |  |  |  | 75.6 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	INVESTING ACTIVITIES
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Purchases of property, plant and equipment
 |  |  | (49.1 | ) |  |  | (46.8 | ) |  |  | (41.3 | ) | 
| 
	Proceeds from sales of assets
 |  |  | 4.2 |  |  |  | 0.3 |  |  |  | 0.2 |  | 
| 
	Proceeds from liquidation of investments
 |  |  | 10.5 |  |  |  |  |  |  |  |  |  | 
| 
	Reclassification of investments from cash equivalents
 |  |  |  |  |  |  | (19.5 | ) |  |  |  |  | 
| 
	Receipts from restricted cash accounts
 |  |  | 1.1 |  |  |  | 0.2 |  |  |  | 39.8 |  | 
| 
	Acquisitions, net of cash acquired
 |  |  | (43.4 | ) |  |  | (77.0 | ) |  |  | (27.3 | ) | 
| 
	Other
 |  |  | 3.5 |  |  |  | 0.5 |  |  |  | 1.1 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Net cash used in investing activities
 |  |  | (73.2 | ) |  |  | (142.3 | ) |  |  | (27.5 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	FINANCING ACTIVITIES
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Repayments of debt
 |  |  | (4.1 | ) |  |  | (2.1 | ) |  |  | (0.5 | ) | 
| 
	Common stock repurchases
 |  |  | (69.2 | ) |  |  |  |  |  |  |  |  | 
| 
	Proceeds from issuance of common stock
 |  |  | 0.4 |  |  |  | 1.0 |  |  |  | 0.7 |  | 
| 
	Excess tax benefits from stock-based compensation
 |  |  | 0.8 |  |  |  | 3.8 |  |  |  | 1.3 |  | 
| 
	Other
 |  |  |  |  |  |  |  |  |  |  | (0.6 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Net cash provided by (used in) financing activities
 |  |  | (72.1 | ) |  |  | 2.7 |  |  |  | 0.9 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Effect of exchange rate changes on cash and cash
	equivalents
 |  |  | (5.8 | ) |  |  | 3.0 |  |  |  | 2.5 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Net increase (decrease) in cash and cash equivalents
 |  |  | (52.9 | ) |  |  | (31.8 | ) |  |  | 51.5 |  | 
| 
	Cash and cash equivalents at beginning of year
 |  |  | 129.2 |  |  |  | 161.0 |  |  |  | 109.5 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Cash and cash equivalents at end of year
 |  | $ | 76.3 |  |  | $ | 129.2 |  |  | $ | 161.0 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Supplemental disclosures of cash flow information:
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Cash paid during the year for:
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Interest
 |  | $ | 8.0 |  |  | $ | 8.1 |  |  | $ | 7.9 |  | 
| 
	Income taxes
 |  | $ | 37.0 |  |  | $ | 21.7 |  |  | $ | 13.0 |  | 
| 
	Asbestos-related claims and expenses, net of
	insurance recoveries
 |  | $ | 37.0 |  |  | $ | 24.9 |  |  | $ | 38.0 |  | 
 
	See notes to Consolidated Financial Statements.
	50
 
	ENPRO INDUSTRIES, INC.
	CONSOLIDATED BALANCE SHEETS
	As of December 31, 2008 and 2007
	(in millions, except share amounts)
|  |  |  |  |  |  |  |  |  | 
|  |  | 2008 |  |  | 2007 |  | 
| 
	ASSETS
 |  |  |  |  |  |  |  |  | 
| 
	Current assets
 |  |  |  |  |  |  |  |  | 
| 
	Cash and cash equivalents
 |  | $ | 76.3 |  |  | $ | 129.2 |  | 
| 
	Accounts and notes receivable, less allowance for doubtful accounts
	of $4.9 in 2008 and $3.6 in 2007
 |  |  | 157.7 |  |  |  | 167.6 |  | 
| 
	Asbestos insurance receivable
 |  |  | 67.9 |  |  |  | 70.0 |  | 
| 
	Inventories
 |  |  | 84.8 |  |  |  | 70.3 |  | 
| 
	Other current assets
 |  |  | 40.9 |  |  |  | 55.3 |  | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Total current assets
 |  |  | 427.6 |  |  |  | 492.4 |  | 
| 
	Property, plant and equipment
 |  |  | 206.1 |  |  |  | 193.5 |  | 
| 
	Goodwill
 |  |  | 218.1 |  |  |  | 213.8 |  | 
| 
	Other intangible assets
 |  |  | 103.4 |  |  |  | 103.5 |  | 
| 
	Asbestos insurance receivable
 |  |  | 239.5 |  |  |  | 311.5 |  | 
| 
	Deferred income taxes
 |  |  | 96.5 |  |  |  | 90.3 |  | 
| 
	Other assets
 |  |  | 61.3 |  |  |  | 65.3 |  | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Total assets
 |  | $ | 1,352.5 |  |  | $ | 1,470.3 |  | 
| 
	 
 |  |  |  |  |  |  | 
| 
	LIABILITIES AND SHAREHOLDERS EQUITY
 |  |  |  |  |  |  |  |  | 
| 
	Current liabilities
 |  |  |  |  |  |  |  |  | 
| 
	Current maturities of long-term debt
 |  | $ | 9.6 |  |  | $ | 3.6 |  | 
| 
	Accounts payable
 |  |  | 66.4 |  |  |  | 80.1 |  | 
| 
	Asbestos liability
 |  |  | 85.3 |  |  |  | 86.9 |  | 
| 
	Other accrued expenses
 |  |  | 86.4 |  |  |  | 89.8 |  | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Total current liabilities
 |  |  | 247.7 |  |  |  | 260.4 |  | 
| 
	Long-term debt
 |  |  | 172.6 |  |  |  | 182.1 |  | 
| 
	Asbestos liability
 |  |  | 380.2 |  |  |  | 437.5 |  | 
| 
	Pension liability
 |  |  | 80.3 |  |  |  | 18.9 |  | 
| 
	Other liabilities
 |  |  | 74.6 |  |  |  | 96.3 |  | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Total liabilities
 |  |  | 955.4 |  |  |  | 995.2 |  | 
| 
	 
 |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	Commitments and contingencies
 |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	Shareholders equity
 |  |  |  |  |  |  |  |  | 
| 
	Common stock  $.01 par value; 100,000,000 shares authorized;
	issued 20,031,709 shares at December 31, 2008 and 21,631,176
	shares at December 31, 2007
 |  |  | 0.2 |  |  |  | 0.2 |  | 
| 
	Additional paid-in capital
 |  |  | 363.0 |  |  |  | 427.2 |  | 
| 
	Retained earnings (accumulated deficit)
 |  |  | 52.8 |  |  |  | (0.7 | ) | 
| 
	Accumulated other comprehensive income (loss)
 |  |  | (17.4 | ) |  |  | 49.9 |  | 
| 
	Common stock held in treasury, at cost  217,790 shares at
	December 31, 2008 and 223,081 shares at December 31, 2007
 |  |  | (1.5 | ) |  |  | (1.5 | ) | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Total shareholders equity
 |  |  | 397.1 |  |  |  | 475.1 |  | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Total liabilities and shareholders equity
 |  | $ | 1,352.5 |  |  | $ | 1,470.3 |  | 
| 
	 
 |  |  |  |  |  |  | 
 
	     See notes to Consolidated Financial Statements.
	51
 
	ENPRO INDUSTRIES, INC.
	CONSOLIDATED
	STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY
	Years Ended December 31, 2008, 2007 and 2006
	(dollars and shares in millions)
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | Retained |  |  | Accumulated |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  | Additional |  |  | Earnings |  |  | Other |  |  |  |  |  |  | Total |  | 
|  |  | Common Stock |  |  | Paid-in |  |  | (Accumulated |  |  | Comprehensive |  |  | Treasury |  |  | Shareholders |  | 
|  |  | Shares |  |  | Amount |  |  | Capital |  |  | Deficit) |  |  | Income (Loss) |  |  | Stock |  |  | Equity |  | 
| 
	Balance, December 31, 2005
 |  |  | 20.8 |  |  | $ | 0.2 |  |  | $ | 411.4 |  |  | $ | 117.9 |  |  | $ | 12.0 |  |  | $ | (1.6 | ) |  | $ | 539.9 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Net loss
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (158.9 | ) |  |  |  |  |  |  |  |  |  |  | (158.9 | ) | 
| 
	Other comprehensive loss:
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Cumulative translation
	adjustment
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 17.3 |  |  |  |  |  |  |  | 17.3 |  | 
| 
	Minimum pension liability
	adjustment
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 11.9 |  |  |  |  |  |  |  | 11.9 |  | 
| 
	Gain on cash flow hedges
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.7 |  |  |  |  |  |  |  | 0.7 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Total comprehensive loss
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (129.0 | ) | 
| 
	Adjustment to initially apply
	SFAS No. 158, net of tax
	benefit of $8.7 million
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (14.6 | ) |  |  |  |  |  |  | (14.6 | ) | 
| 
	Exercise of stock options and
	other incentive plan activity
 |  |  | 0.2 |  |  |  |  |  |  |  | 7.5 |  |  |  |  |  |  |  |  |  |  |  | 0.1 |  |  |  | 7.6 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Balance, December 31, 2006
 |  |  | 21.0 |  |  |  | 0.2 |  |  |  | 418.9 |  |  |  | (41.0 | ) |  |  | 27.3 |  |  |  | (1.5 | ) |  |  | 403.9 |  | 
| 
	Net income
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 40.2 |  |  |  |  |  |  |  |  |  |  |  | 40.2 |  | 
| 
	Other comprehensive income:
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Cumulative translation
	adjustment
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 25.3 |  |  |  |  |  |  |  | 25.3 |  | 
| 
	Pension and other postretirement
	benefit plans
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (2.7 | ) |  |  |  |  |  |  | (2.7 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Total comprehensive income
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 62.8 |  | 
| 
	Adjustment to initially apply
	FIN 48
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.1 |  |  |  |  |  |  |  |  |  |  |  | 0.1 |  | 
| 
	Exercise of stock options and
	other incentive plan activity
 |  |  | 0.4 |  |  |  |  |  |  |  | 8.3 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 8.3 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Balance, December 31, 2007
 |  |  | 21.4 |  |  |  | 0.2 |  |  |  | 427.2 |  |  |  | (0.7 | ) |  |  | 49.9 |  |  |  | (1.5 | ) |  |  | 475.1 |  | 
| 
	Net income
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 53.5 |  |  |  |  |  |  |  |  |  |  |  | 53.5 |  | 
| 
	Other comprehensive income:
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Cumulative translation
	adjustment
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (31.6 | ) |  |  |  |  |  |  | (31.6 | ) | 
| 
	Pension and other postretirement
	benefit plans
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (35.6 | ) |  |  |  |  |  |  | (35.6 | ) | 
| 
	Loss on cash flow hedges
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (0.1 | ) |  |  |  |  |  |  | (0.1 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Total comprehensive loss
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (13.8 | ) | 
| 
	Common stock repurchases
 |  |  | (1.9 | ) |  |  |  |  |  |  | (69.2 | ) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (69.2 | ) | 
| 
	Exercise of stock options and
	other incentive plan activity
 |  |  | 0.3 |  |  |  |  |  |  |  | 5.0 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5.0 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Balance, December 31, 2008
 |  |  | 19.8 |  |  | $ | 0.2 |  |  | $ | 363.0 |  |  | $ | 52.8 |  |  | $ | (17.4 | ) |  | $ | (1.5 | ) |  | $ | 397.1 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
 
	See notes to Consolidated Financial Statements.
	52
 
	ENPRO INDUSTRIES, INC.
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
	1. Overview and Significant Accounting Policies
	     
	Overview
	     EnPro Industries, Inc. (EnPro or the Company) is a leader in the design, development,
	manufacturing and marketing of well recognized, proprietary engineered industrial products that
	include sealing products, metal and metal polymer bearings and filament wound products, air
	compressors, and heavy-duty, medium-speed diesel, natural gas and dual fuel reciprocating engines.
	     
	Summary of Significant Accounting Policies
	     
	Principles of Consolidation
	 The Consolidated Financial Statements reflect the accounts of
	the Company and its majority-owned and controlled subsidiaries. All significant intercompany
	accounts and transactions have been eliminated.
	     
	Use of Estimates
	- The preparation of financial statements in conformity with generally
	accepted accounting principles requires management to make estimates and assumptions that affect
	the amounts reported in the financial statements and accompanying notes. Actual results could
	differ from those estimates.
	     
	Reclassifications
	 Certain prior year amounts in the accompanying prior year annual
	financial statements have been reclassified to conform with the current year presentation.
	     
	Revenue Recognition
	 Revenue is recognized at the time title and risk of product ownership
	is transferred or when services are rendered. Any shipping costs billed to customers are
	recognized as revenue and expensed in cost of goods sold.
	     
	Foreign Currency Translation
	 The financial statements of those operations whose functional
	currency is a foreign currency are translated into U.S. dollars using the current rate method.
	Under this method, all assets and liabilities are translated into U.S. dollars using current
	exchange rates, and income statement activities are translated using weighted average exchange
	rates. The foreign currency translation adjustment is reflected in the Consolidated Statements of
	Changes in Shareholders Equity and is included in accumulated other comprehensive income (loss) in
	the Consolidated Balance Sheets. Gains and losses on foreign currency transactions are included in
	operating income. Foreign currency transaction gains (losses) totaled $(3.8) million, $0.1 million
	and $(0.5) million for 2008, 2007 and 2006, respectively.
	     
	Research and Development Expense
	 Costs related to research and development activities are
	expensed as incurred. The Company performs research and development under Company-funded programs
	for commercial products. Total research and development expenditures in 2008, 2007 and 2006 were
	$15.3 million, $14.1 million and $12.8 million, respectively.
	     
	Income Taxes
	 The Company uses the asset and liability method of accounting for income
	taxes. Temporary differences arising from the difference between the tax basis of an asset or
	liability and its carrying amount on the Consolidated Balance Sheet are used to calculate future
	income tax assets or liabilities. This method also requires the recognition of deferred tax
	benefits, such as net operating loss carryforwards, to the extent that realization of such benefits
	is more likely than not. Deferred tax assets and liabilities are measured using enacted tax rates
	expected to apply to taxable income (losses) in the
	53
 
	years in which those temporary differences are expected to be recovered or settled. The
	effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in
	the period that includes the enactment date.
	     
	Cash and Cash Equivalents
	 Cash and cash equivalents include cash on hand, demand deposits
	and highly liquid investments with a maturity of three months or less at the time of purchase. The
	Consolidated Statement of Cash Flows for the year ended December 31, 2007, reflects the
	reclassification of $19.5 million of unrestricted cash balances to other current and noncurrent
	assets based on changes in expected maturity dates of the underlying investments. Much of this has
	subsequently been collected and only $7.1 million remains classified in other current and
	noncurrent assets at December 31, 2008.
	     
	Receivables
	 Accounts receivable are stated at the historical carrying amount net of
	write-offs and allowance for doubtful accounts. The Company establishes an allowance for doubtful
	accounts receivable based on historical experience and any specific customer collection issues that
	the Company has identified. Doubtful accounts receivable are written off when a settlement is
	reached for an amount that is less than the outstanding historical balance or when the Company has
	determined the balance will not be collected.
	     The balances billed but not paid by customers pursuant to retainage provisions in long-term
	contracts and programs will be due upon completion of the contracts and acceptance by the owner.
	At December 31, 2008, the Company had $3.1 million of retentions expected to be collected in 2009
	recorded in accounts and notes receivable and $3.2 million of retentions expected to be collected
	beyond 2009 recorded in other noncurrent assets in the Consolidated Balance Sheets. At December
	31, 2007, the Company had $3.9 million of current retentions and $2.4 million of non-current
	retentions recorded in the Consolidated Balance Sheets.
	     
	Inventories
	 Certain domestic inventories are valued by the last-in, first-out (LIFO) cost
	method. Inventories not valued by the LIFO method, other than inventoried costs relating to
	long-term contracts and programs, are valued using the first-in, first-out (FIFO) cost method,
	and are recorded at the lower of cost or market. Approximately 39% and 45% of inventories were
	valued by the LIFO method in 2008 and 2007, respectively.
	     Inventoried costs relating to long-term contracts and programs are stated at the actual
	production cost, including factory overhead, incurred to date. Progress payments related to
	long-term contracts and programs are shown as a reduction of inventories. Initial program start-up
	costs and other nonrecurring costs are expensed as incurred. Inventoried costs relating to
	long-term contracts and programs are reduced by any amounts in excess of estimated realizable value
	and charged to cost of sales.
	     
	Property, Plant and Equipment
	 Property, plant and equipment are recorded at cost. Major
	renewals and betterments are capitalized; whereas, maintenance and repairs are expensed as
	incurred. Depreciation of plant and equipment is determined on the straight-line method over the
	following estimated useful lives of the assets: buildings and improvements, 3 to 40 years;
	machinery and equipment, 3 to 20 years.
	     
	Goodwill and Other Intangible Assets
	 Goodwill represents the excess of the purchase price
	over the fair value of the net assets of acquired businesses. Goodwill is not amortized, but
	instead is subject to annual impairment testing conducted each year as of October 1. The goodwill
	asset impairment test involves comparing the fair value of a reporting unit to its carrying amount.
	If the carrying amount of a reporting unit exceeds its fair value, a second step of comparing the
	implied fair value of the reporting units goodwill to the carrying amount of that goodwill is
	required to measure the potential goodwill impairment loss. Interim tests may be required if an
	event occurs or circumstances change that would more likely than not reduce the fair value of a
	reporting unit below its carrying amount. The Company
	54
 
	completed its required annual impairment tests of goodwill as of October 1, 2008, 2007 and
	2006. The results of these assessments did not indicate any impairment of the goodwill.
	     As of November 30, 2008, due to the recent deterioration in the global economic environment
	and the decline in the Companys market capitalization, the Company concluded there was an
	indication of possible impairment and conducted an interim goodwill impairment test. Certain key
	assumptions used to determine the fair value of each reporting unit as of November 30, 2008 were
	revised to reflect: (a) significant reductions in future expected cash flows for the period from
	2009 to 2013 due to the continuing soft economy, and (b) a discount rate of 12.3%, which was based
	on the Companys best estimate of the after-tax weighted average cost of capital, adjusted for its
	increased level of financial risk and the increased risk associated with its future operations.
	     As a result of the first step of the interim goodwill impairment analysis, the fair value of
	each reporting unit exceeded its carrying value. Therefore, the second step was not necessary.
	However, a 7% decline in fair value of the Companys GGB reporting unit or a 16% decline in fair
	value of the Companys Plastomer Technologies reporting unit would have caused the carrying values
	for these reporting units to be in excess of fair values which would require the second step to be
	performed. The second step could have resulted in an impairment loss for goodwill.
	     While the Company believes it has made reasonable estimates and assumptions to calculate the
	fair value of the reporting units and other intangible assets, it is possible a material change
	could occur. If the Companys actual results are not consistent with its estimates and assumptions
	used to calculate fair value, it may be required to perform the second step which could result in a
	material impairment of its goodwill at some point in the future.
	     Other intangible assets are recorded at cost, or when acquired as a part of a business
	combination, at estimated fair value. These assets include customer relationships, patents and
	other technology agreements, trademarks, licenses and non-compete agreements. Intangible assets
	that have definite lives are amortized using a method that reflects the pattern in which the
	economic benefits of the assets are consumed or the straight-line method over estimated useful
	lives of 2 to 25 years. Intangible assets with indefinite lives are subject to at least annual
	impairment testing, which compares the fair value of the intangible asset with its carrying amount.
	The results of these assessments did not indicate any impairment to these intangible assets for
	the years presented.
	     
	Asbestos
	 In 2005 and the first three quarters of 2006, the Company recorded a liability
	related to asbestos claims at the low end of a broad ten-year range
	of equally likely estimates
	provided by the firm of Bates White, LLC (Bates White), a recognized expert in the field of
	estimating asbestos-related liabilities. Due to the uncertain nature of the estimated liability,
	the Company and Bates White believed that no single amount in the range was a better estimate than
	any other amount within the range. In accordance with the applicable accounting rules, the Company
	recorded a liability for these claims at the lower end of the range of estimated potential
	liabilities. In the fourth quarter of 2006, based on the Companys experience over the prior two
	years and other factors, management identified a best estimate within the Bates White range and
	adjusted the liability accordingly.
	     The significant assumptions underlying the material components of the estimated liability
	include: the number and trend of claims to be asserted; the mix of alleged diseases or impairment;
	the trend in the number of claims for non-malignant cases; the probability that some existing and
	potential future claims will eventually be dismissed without payment; the estimated amount to be
	paid per claim, and the timing and impact of large amounts that will become available for the
	payment of claims from the 524(g) trusts of former defendants in bankruptcy. The actual number of
	future actions filed per year and the payments made to resolve those claims could exceed those
	reflected in managements estimate of the liability.
	55
 
	     With the assistance of Bates White, the Company periodically reviews the period over which it
	can make a reasonable estimate, the assumptions underlying the Companys estimate, the range of
	reasonably possible potential liabilities and managements estimate of the liability, and adjusts
	the estimate if necessary. Changing circumstances and new data that may become available could
	cause a change in the estimated liability in the future by an amount that cannot currently be
	reasonably estimated, and that increase could be significant and material. Additional discussion
	is included in Note 17 to the Consolidated Financial Statements, Commitments and Contingencies 
	Asbestos.
	     
	Derivative Instruments
	 The Company uses derivative financial instruments to manage its
	exposure to various risks. The use of these financial instruments modifies the exposure with the
	intent of reducing the risk to the Company. The Company does not use financial instruments for
	trading purposes, nor does it use leveraged financial instruments. The counterparties to these
	contractual arrangements are major financial institutions. The Company uses several different
	financial institutions for derivative contracts to minimize the concentration of credit risk.
	Statement of Financial Accounting Standards No. 133, Accounting for Derivative Instruments and
	Hedging Activities (SFAS 133), as amended, requires that all derivative instruments be reported
	in the Consolidated Balance Sheets at fair value and that changes in a derivatives fair value be
	recognized currently in earnings unless specific hedge criteria are met.
	     The Company is exposed to foreign currency risks that arise from normal business operations.
	These risks include the translation of local currency balances on its foreign subsidiaries balance
	sheets, intercompany loans with foreign subsidiaries and transactions denominated in foreign
	currencies. The Company strives to control its exposure to these risks through its normal
	operating activities and, where appropriate, through derivative instruments. The Company has
	entered into contracts to hedge forecasted transactions occurring at various dates through December
	2010 that are denominated in foreign currencies. The notional amount of foreign exchange contracts
	hedging foreign currency transactions was $130.3 million and $141.5 million at December 31, 2008
	and 2007, respectively. These contracts are accounted for as cash flow hedges. As cash flow
	hedges, the effective portion of the gain or loss on the contracts is reported in accumulated other
	comprehensive income and the ineffective portion is reported in income. Amounts in accumulated
	other comprehensive income are reclassified into income in the period that the hedged transactions
	affect earnings. It is anticipated that $0.2 million of the amounts within accumulated other
	comprehensive income at December 31, 2008, will be reclassified into income within the next twelve
	months.
	     
	Fair Value Measurements
	 On January 1, 2008, the Company adopted Statement of Financial
	Accounting Standards No. 157,
	Fair Value Measurements,
	(SFAS 157) for financial assets and
	liabilities. As permitted by FASB Staff Position No. FAS 157-2, 
	Effective Date of FASB Statement
	No 157
	, the Company elected to defer the adoption of SFAS 157 for all nonfinancial assets and
	nonfinancial liabilities. SFAS 157 provides a framework for measuring fair value and requires
	expanded disclosures regarding fair value measurements. SFAS 157 defines fair value as the
	exchange price that would be received for an asset or paid to transfer a liability (an exit price)
	in the principal or most advantageous market for the asset or liability in an orderly transaction
	between market participants on the measurement date.
	     SFAS 157 utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques
	used to measure fair value into three broad levels. The following is a brief description of those
	three levels:
|  |  |  | Level 1: Observable inputs such as quoted prices in active markets for identical
	assets or liabilities. | 
|  | 
|  |  |  | Level 2: Inputs other than quoted prices that are observable for the asset or
	liability, either directly or indirectly. These include quoted prices for similar
	assets or liabilities in active | 
 
	56
 
|  |  |  | markets and quoted prices for identical or similar assets or liabilities in markets that
	are not active. | 
|  | 
|  |  |  | Level 3: Unobservable inputs that reflect the reporting entitys own assumptions. | 
 
	     
	New Accounting Pronouncements
	 In December 2008, the Financial Accounting Standards Board
	(FASB) issued FASB Staff Position No. 132(R)-1,
	Employers Disclosures about Postretirement
	Benefit Plan Assets
	(FSP 132(R)-1). FSP 132(R)-1 amends FASB Statement No. 132(R),
	Employers
	Disclosures about Pensions and Other Postretirement Benefits
	to require additional disclosures
	about assets held in an employers defined benefit pension or other postretirement plan. FSP
	132(R)-1 is effective for fiscal years ending after December 15, 2009. Since FSP 132(R)-1 requires
	only additional disclosures, adoption of the standard will not affect the Companys financial
	condition, results of operations or cash flows.
	     In May 2008, the FASB issued FASB Staff Position No. APB 14-1, 
	Accounting for Convertible
	Debt Instruments That May Be Settled in Cash Upon Conversion (Including Partial Cash Settlement)
	
	(APB 14-1). APB 14-1 requires the issuer of certain convertible debt instruments that may be
	settled in cash on conversion to separately account for the liability and equity components of the
	instrument in a manner that reflects the issuers nonconvertible debt borrowing rate. APB 14-1 is
	effective for financial statements issued for fiscal years beginning after December 15, 2008, and
	interim periods within those fiscal years. Early application is not permitted; however, the
	transition guidance requires retrospective application to all periods presented.
	     The impact of adopting APB 14-1 as of January 1, 2009 is expected to result in decreases in
	noncurrent assets (deferred tax assets and capitalized debt issuance costs) totaling $18.7 million,
	a decrease in long-term debt of $47.7 million and an increase in equity of $29.0 million.
	     If the Company had accounted for its convertible debt using APB 14-1 for the years ended
	December 31, 2008, 2007 and 2006, pro forma net income (loss) and earnings (loss) per share would
	have been as follows:
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | 2008 |  |  | 2007 |  |  | 2006 |  | 
| 
	Net income (loss):
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	As reported
 |  | $ | 53.5 |  |  | $ | 40.2 |  |  | $ | (158.9 | ) | 
| 
	APB 14-1 impact
 |  |  | (2.9 | ) |  |  | (2.6 | ) |  |  | (2.3 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Pro forma
 |  | $ | 50.6 |  |  | $ | 37.6 |  |  | $ | (161.2 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Basic earnings (loss) per share:
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	As reported
 |  | $ | 2.64 |  |  | $ | 1.89 |  |  | $ | (7.60 | ) | 
| 
	Pro forma
 |  | $ | 2.50 |  |  | $ | 1.77 |  |  | $ | (7.72 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Diluted earnings (loss) per share:
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	As reported
 |  | $ | 2.54 |  |  | $ | 1.80 |  |  | $ | (7.60 | ) | 
| 
	Pro forma
 |  | $ | 2.40 |  |  | $ | 1.68 |  |  | $ | (7.72 | ) | 
 
	     It is estimated that annual earnings after taxes will be reduced between $3.1 million and $5.1
	million over the remaining life of the convertible debt as a result of the increase in non-cash
	interest expense that will need to be recorded using the effective interest rate method for the
	debt discount amortization computation.
	     In March 2008, the FASB issued Statement of Financial Accounting Standards No. 161,
	"
	Disclosures About Derivative Instruments and Hedging Activities, an amendment of FASB Statement
	No. 133
	(SFAS 161). SFAS 161 amends and expands the disclosure requirements of SFAS 133 with
	the intent to provide users of financial statements with an enhanced understanding of: (a) how and
	why an
	57
 
	entity uses derivative instruments; (b) how derivative instruments and related hedged items are
	accounted for under SFAS 133 and its related interpretations; and (c) how derivative instruments
	and related hedged items affect an entitys financial position, financial performance and cash
	flows. This statement is effective for financial statements issued for fiscal years and interim
	periods beginning after November 15, 2008, with early application encouraged. Since SFAS 161
	requires only additional disclosures concerning derivatives and hedging activities, adoption of the
	statement will not affect the Companys financial condition, results of operations or cash flows.
	     In December 2007, the FASB issued Statement of Financial Accounting Standards No. 141(R),
	
	Business Combinations
	 (SFAS 141(R)) and Statement of Financial Accounting Standards No. 160,
	
	Noncontrolling Interests in Consolidated Financial Statements  an Amendment of ARB No. 51
	 (SFAS
	160). These new standards will significantly change the financial accounting and reporting for
	future business combination transactions and noncontrolling (or minority) interests in consolidated
	financial statements on a prospective basis. The Company will be required to adopt SFAS 141(R) and
	SFAS 160 for periods beginning on or after December 15, 2008. Adoption of SFAS 141(R) and SFAS 160
	will not affect the Companys financial condition, results of operations or cash flows, but may
	have an effect on accounting for future business combinations.
	2. Acquisitions
	     In June 2008, the Company purchased the 20% ownership of the minority shareholder of Garlock
	Pty Limited in Australia. Subsequent to the share purchase, the Company owns 100% of Garlock Pty
	Limited, which is in the Sealing Products segment. In May 2008, the Company acquired certain
	assets and assumed certain liabilities of Air Perfection, Inc., a privately-held business which
	audits, sells and services compressed air systems. This acquisition is included in the Companys
	Engineered Products segment. In February 2008, the Company acquired V.W. Kaiser Engineering, a
	privately-held manufacturer of pins, bushings and suspension kits for the commercial vehicle
	aftermarket. In January 2008, the Company acquired certain assets and assumed certain liabilities
	of Sinflex Sealing Technologies, a distributor and manufacturer of industrial sealing products,
	located in Shanghai, China. These acquisitions are included in the Companys Sealing Products
	segment. The Company also purchased several small product lines during 2008.
	     The acquisitions completed during 2008 were paid for with $43.4 million in cash. They
	resulted in increases in working capital of $6.7 million, property, plant and equipment of $1.9
	million, goodwill of $18.3 million, other intangible assets of $20.8 million, other noncurrent
	assets of $0.3 million and debt of $0.4 million, as well as decreases in long-term deferred tax
	assets of $6.6 million and other noncurrent liabilities of $2.4 million. The purchase price
	allocations of recently acquired businesses are subject to the completion of the valuation of
	certain assets and liabilities.
	     In June 2007, the Company acquired Texflo Machining Ltd., a privately-held company that
	services and repairs reciprocating compressors, primarily for the natural gas market in western
	Canada. In July 2007, the Company acquired Compressor Products International Limited, a
	privately-held manufacturer of critical sealing components for reciprocating compressors, gas
	engines and related equipment. These acquisitions are included in the Companys Engineered
	Products segment. The Company also purchased the remaining ownership interest in one of its
	subsidiaries and two small product lines during 2007.
	     The acquisitions completed during 2007 were paid for with $77.0 million in cash. They
	resulted in increases in property, plant and equipment of $4.5 million, goodwill of $42.3 million,
	other intangible assets of $40.3 million and debt of $2.2 million, decreases in long-term deferred
	tax assets of $7.6 million, other noncurrent liabilities of $4.1 million and working capital of
	$0.3 million, as well as an
	58
 
	extraordinary gain of $4.1 million related to the purchase of the remaining ownership interest
	in one of the Companys subsidiaries. The gain was recorded net of $1.6 million of income taxes.
	     In May 2006, the Company acquired Allwest Compressor Services (Allwest), a privately-held
	manufacturer of compressor components primarily for the natural gas and oil production industries
	in Western Canada. Allwest, along with Southwest Compressor Services and H.A.R. Compressor
	Products, which were also acquired during the year, are included in the Companys Engineered
	Products segment. In July 2006, the Company acquired Amicon Plastics, a privately-held company
	that manufactures and sells customized fluoropolymer and engineered plastic components to
	semiconductor, pump and valve, oilfield and other industries. This acquisition is included in the
	Companys Sealing Products segment.
	     The acquisitions completed during 2006 were paid for with $27.3 million in cash, and a $1.0
	million note payable to one of the sellers.
	3. Other Operating Expense (Income)
	     The Company incurred $4.6 million, $6.0 million and $2.3 million of restructuring costs during
	the years ended December 31, 2008, 2007 and 2006, respectively.
	     In 2005, the Company approved a plan to modernize the Palmyra, New York facilities of Garlock
	Sealing Technologies, included within the Sealing Products segment. Garlock Sealing Technologies
	has been on its current site since the early 1900s, with the buildings dating from 1907 to 1956.
	The project will reduce the number of buildings on the site from 26 to 7 and eliminate 350,000
	square feet of space, or approximately half of the space currently under roof. Work on the project
	began in the second half of 2005. The modernization will be completed over six years at an
	expected cost, including expenses and capital expenditures, of approximately $45 million, excluding
	the impact of grants, tax abatements and tax credits. Through 2008, the Company has recorded
	expenses, primarily demolition of existing structures, site remediation and equipment relocation of
	$8.0 million and capital expenditures of $22.5 million, offset by $8.6 million of grants, tax
	abatements and tax credits. It is currently anticipated that an additional $8.5 million of
	expenses and $6.4 million of capital expenditures will be incurred to complete the project, offset
	by an additional $13.4 million of tax abatements and tax credits.
	     During 2007, the Company announced the planned consolidation of facilities for a unit within
	the Sealing Products segment. Approximately $0.6 million of costs were incurred during 2007 of the
	total $2.3 million for the entire initiative. Workforce reductions announced totaled 34, primarily
	hourly manufacturing positions, all of which took place during 2008. The project was completed in
	2008. In connection with this facilities consolidation, the Company sold a building for $3.0
	million, resulting in a pre-tax gain of $2.2 million. This gain is included in other operating
	expense (income) for the year ended December 31, 2008.
	     Several smaller restructuring initiatives were begun and completed during 2008, primarily the
	consolidation of two small facilities. Approximately $0.9 million of costs were incurred.
	59
 
	     Restructuring reserves at December 31, 2008, as well as activity during the year, consisted
	of:
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Balance |  |  |  |  |  |  |  |  |  |  | Balance |  | 
|  |  | December 31, |  |  |  |  |  |  |  |  |  |  | December 31, |  | 
|  |  | 2007 |  |  | Provision |  |  | Payments |  |  | 2008 |  | 
|  |  |  |  |  |  | (in millions) |  |  |  |  |  | 
| 
	Personnel-related costs
 |  | $ | 0.4 |  |  | $ | 1.6 |  |  | $ | (0.8 | ) |  | $ | 1.2 |  | 
| 
	Facility demolition and
	relocation costs
 |  |  |  |  |  |  | 3.0 |  |  |  | (3.0 | ) |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  | $ | 0.4 |  |  | $ | 4.6 |  |  | $ | (3.8 | ) |  | $ | 1.2 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
 
	     Restructuring reserves at December 31, 2007, as well as activity during the year, consisted
	of:
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | Direct |  |  |  |  | 
|  |  | Balance |  |  |  |  |  |  |  |  |  |  | Credits to |  |  | Balance |  | 
|  |  | December 31, |  |  |  |  |  |  |  |  |  |  | Environmental |  |  | December 31, |  | 
|  |  | 2006 |  |  | Provision |  |  | Payments |  |  | Liabilities |  |  | 2007 |  | 
|  |  |  |  |  |  |  |  |  |  | (in millions) |  |  |  |  |  |  |  |  |  | 
| 
	Personnel-related costs
 |  | $ | 0.1 |  |  | $ | 0.7 |  |  | $ | (0.4 | ) |  | $ |  |  |  | $ | 0.4 |  | 
| 
	Facility demolition and
	relocation costs
 |  |  |  |  |  |  | 5.3 |  |  |  | (3.0 | ) |  |  | (2.3 | ) |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  | $ | 0.1 |  |  | $ | 6.0 |  |  | $ | (3.4 | ) |  | $ | (2.3 | ) |  | $ | 0.4 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
 
	     Restructuring reserves at December 31, 2006, as well as activity during the year, consisted
	of:
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | Direct |  |  |  |  | 
|  |  | Balance |  |  |  |  |  |  |  |  |  |  | Credits to |  |  | Balance |  | 
|  |  | December 31, |  |  |  |  |  |  |  |  |  |  | Environmental |  |  | December 31, |  | 
|  |  | 2005 |  |  | Provision |  |  | Payments |  |  | Liabilities |  |  | 2006 |  | 
|  |  |  |  |  |  |  |  |  |  | (in millions) |  |  |  |  |  |  |  |  |  | 
| 
	Personnel-related costs
 |  | $ | 0.1 |  |  | $ |  |  |  | $ |  |  |  | $ |  |  |  | $ | 0.1 |  | 
| 
	Facility demolition and
	relocation costs
 |  |  |  |  |  |  | 2.3 |  |  |  | (0.9 | ) |  |  | (1.4 | ) |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  | $ | 0.1 |  |  | $ | 2.3 |  |  | $ | (0.9 | ) |  | $ | (1.4 | ) |  | $ | 0.1 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
 
	     Restructuring costs by reportable segment are as follows:
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Years Ended December 31, |  | 
|  |  | 2008 |  |  | 2007 |  |  | 2006 |  | 
|  |  | (in millions) |  | 
| 
	Sealing Products
 |  | $ | 3.7 |  |  | $ | 6.0 |  |  | $ | 2.3 |  | 
| 
	Engineered Products
 |  |  | 0.9 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  | $ | 4.6 |  |  | $ | 6.0 |  |  | $ | 2.3 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
 
	     Also included in other operating expense (income) for the year ended December 31, 2008 was
	$2.5 million received related to the favorable settlement of a warranty claim against a supplier.
	60
 
	4. Other Income (Expense)
	     Included in other non-operating expense for the year ended December 31, 2008, were $3.4
	million of incremental costs for legal, financial and strategic advice and proxy solicitation in
	connection with the contested election of directors initiated by one of the Companys shareholders.
	On April 11, 2008, an agreement with the shareholder was entered into that resolved the contested
	election.
	5. Income Taxes
	     Income (loss) before income taxes and extraordinary items as shown in the Consolidated
	Statements of Operations consists of the following:
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Years Ended December 31, |  | 
|  |  | 2008 |  |  | 2007 |  |  | 2006 |  | 
|  |  | (in millions) |  | 
| 
	Domestic
 |  | $ | 32.5 |  |  | $ | 12.4 |  |  | $ | (285.7 | ) | 
| 
	Foreign
 |  |  | 48.2 |  |  |  | 45.6 |  |  |  | 31.5 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Total
 |  | $ | 80.7 |  |  | $ | 58.0 |  |  | $ | (254.2 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
 
	     A summary of income tax benefit (expense) in the Consolidated Statements of Operations before
	extraordinary items is as follows:
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Years Ended December 31, |  | 
|  |  | 2008 |  |  | 2007 |  |  | 2006 |  | 
|  |  | (in millions) |  | 
| 
	Current:
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Federal
 |  | $ | (10.2 | ) |  | $ | (10.6 | ) |  | $ | 2.0 |  | 
| 
	Foreign
 |  |  | (14.9 | ) |  |  | (17.3 | ) |  |  | (10.6 | ) | 
| 
	State
 |  |  | (0.9 | ) |  |  | (0.8 | ) |  |  | (0.6 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  | (26.0 | ) |  |  | (28.7 | ) |  |  | (9.2 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Deferred:
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Federal
 |  |  | (0.1 | ) |  |  | 6.5 |  |  |  | 99.2 |  | 
| 
	Foreign
 |  |  | (1.1 | ) |  |  | 1.5 |  |  |  | (2.4 | ) | 
| 
	State
 |  |  |  |  |  |  | 0.4 |  |  |  | 7.7 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  | (1.2 | ) |  |  | 8.4 |  |  |  | 104.5 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Total
 |  | $ | (27.2 | ) |  | $ | (20.3 | ) |  | $ | 95.3 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
 
	     Significant components of deferred income tax assets and liabilities at December 31, 2008 and
	2007 are as follows:
|  |  |  |  |  |  |  |  |  | 
|  |  | 2008 |  |  | 2007 |  | 
|  |  | (in millions) |  | 
| 
	Deferred income tax assets:
 |  |  |  |  |  |  |  |  | 
| 
	Accrual for post-retirement benefits other than pensions
 |  | $ | 3.1 |  |  | $ | 3.0 |  | 
| 
	Environmental reserves
 |  |  | 8.3 |  |  |  | 10.4 |  | 
| 
	Retained liabilities of previously owned businesses
 |  |  | 12.3 |  |  |  | 12.1 |  | 
| 
	Call options
 |  |  | 16.8 |  |  |  | 18.7 |  | 
| 
	Inventories
 |  |  |  |  |  |  | 1.9 |  | 
| 
	Accruals and reserves
 |  |  | 18.3 |  |  |  | 18.0 |  | 
| 
	Minimum pension liability
 |  |  | 33.1 |  |  |  | 10.1 |  | 
| 
	Asbestos accrual
 |  |  | 153.1 |  |  |  | 143.4 |  | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Total deferred income tax assets
 |  |  | 245.0 |  |  |  | 217.6 |  | 
| 
	 
 |  |  |  |  |  |  | 
 
	61
 
|  |  |  |  |  |  |  |  |  | 
|  |  | 2008 |  |  | 2007 |  | 
|  |  | (in millions) |  | 
| 
	Deferred income tax liabilities:
 |  |  |  |  |  |  |  |  | 
| 
	Pensions
 |  |  | (3.2 | ) |  |  | (4.8 | ) | 
| 
	Tax depreciation and amortization in excess of book
 |  |  | (44.5 | ) |  |  | (37.1 | ) | 
| 
	Payments in excess of insurance recoveries
 |  |  | (78.1 | ) |  |  | (62.5 | ) | 
| 
	Inventories
 |  |  | (0.8 | ) |  |  |  |  | 
| 
	Other
 |  |  |  |  |  |  | (0.8 | ) | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Total deferred income tax liabilities
 |  |  | (126.6 | ) |  |  | (105.2 | ) | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Net deferred income taxes
 |  | $ | 118.4 |  |  | $ | 112.4 |  | 
| 
	 
 |  |  |  |  |  |  | 
 
	     The Company concluded that a valuation allowance on its deferred tax assets at December 31,
	2008 and 2007, was not required. The Companys methodology for determining the realizability of
	deferred tax assets involves estimates of future taxable income from its operations. These
	estimates are projected through the life of the related deferred tax assets based on assumptions
	that the Company believes to be reasonable and consistent with current operating results. Changes
	in future operating results not currently forecasted may have a significant impact on the
	realization of deferred tax assets.
	     The effective income tax rate from operations varied from the statutory federal income tax
	rate as follows:
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Percent of Pretax Income | 
|  |  | Years Ended December 31, | 
|  |  | 2008 |  | 2007 |  | 2006 | 
| 
	Statutory federal income tax rate
 |  |  | 35.0 | % |  |  | 35.0 | % |  |  | (35.0 | )% | 
| 
	Credits
 |  |  | (0.3 | ) |  |  | (1.6 | ) |  |  |  |  | 
| 
	State and local taxes
 |  |  | 1.2 |  |  |  | 0.7 |  |  |  | (2.8 | ) | 
| 
	Domestic manufacturers deduction
 |  |  | (1.0 | ) |  |  | (0.5 | ) |  |  | (0.1 | ) | 
| 
	Foreign tax rate differences
 |  |  | (2.0 | ) |  |  | (2.6 | ) |  |  | 0.2 |  | 
| 
	Uncertain tax positions
 |  |  | 1.3 |  |  |  | 2.7 |  |  |  |  |  | 
| 
	Audit settlements
 |  |  | (2.1 | ) |  |  | (0.7 | ) |  |  |  |  | 
| 
	Other items
 |  |  | 1.6 |  |  |  | 2.0 |  |  |  | 0.2 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Effective income tax rate
 |  |  | 33.7 | % |  |  | 35.0 | % |  |  | (37.5 | )% | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
 
	     At December 31, 2008, the Company had undistributed earnings of approximately $73.6 million
	from subsidiaries in Australia, Canada, Mexico and Brazil that are not considered to be permanently
	reinvested. Based on current income tax rates, the Company believes the tax effect on any
	distribution will be immaterial due to the Companys foreign tax credit position. Accordingly, no
	deferred taxes have been provided for these undistributed foreign earnings.
	     The Company has not provided for the federal and foreign withholding taxes on $140.9 million
	of the remaining foreign subsidiaries undistributed earnings as of December 31, 2008, because such
	earnings are intended to be reinvested indefinitely. On repatriation, certain foreign countries
	impose withholding taxes. The amount of withholding tax that would be payable on remittance of the
	entire amount would approximate $12.0 million. Based on current income tax rates, the Company
	believes the tax effect of any distribution will be immaterial due to the Companys foreign tax
	credit position.
	     The Company adopted FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes
	(FIN 48) on January 1, 2007. As of December 31, 2008 and 2007, the Company had $5.6 million and
	$19.1 million, respectively, of liabilities recorded for unrecognized tax benefits. These amounts
	included interest of $0.5 million and $1.9 million, respectively. The unrecognized tax benefit
	62
 
	balances as of December 31, 2008 and 2007, also included $1.6 million and $13.2 million,
	respectively, for tax positions for which the ultimate deductibility was highly certain but for
	which there was uncertainty about the timing of such deductibility. Included in the unrecognized
	tax benefits as of December 31, 2008 and 2007, were cumulative amounts of $4.0 million and $5.9
	million, respectively, for uncertain tax positions that would affect the Companys effective tax
	rate if recognized. The Company records interest and penalties related to unrecognized tax
	benefits in income tax expense. A reconciliation of the beginning and ending amount of the
	unrecognized tax benefits (excluding interest) is as follows:
|  |  |  |  |  |  |  |  |  | 
| (in millions) |  | 2008 |  |  | 2007 |  | 
| 
	Balance at beginning of year
 |  | $ | 17.2 |  |  | $ | 21.8 |  | 
| 
	Additions based on tax positions related to the current year
 |  |  | 2.5 |  |  |  | 0.7 |  | 
| 
	Additions for tax positions of prior years
 |  |  | 0.7 |  |  |  | 0.1 |  | 
| 
	Reductions for tax positions of prior years
 |  |  |  |  |  |  | (4.5 | ) | 
| 
	Reductions as a result of audit settlements
 |  |  | (15.3 | ) |  |  | (0.9 | ) | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Balance at end of year
 |  | $ | 5.1 |  |  | $ | 17.2 |  | 
| 
	 
 |  |  |  |  |  |  | 
 
	     During the year ending December 31, 2008, the Company recorded a net non-cash benefit of $1.8
	million to income tax expense related to the reversal of reserves for uncertain tax benefits
	resulting from the completion of the U.S. federal income tax return examination for 2003 to 2006.
	     The Company and its subsidiaries are subject to U.S. federal income tax as well as income tax
	in multiple state and foreign jurisdictions. Substantially all state, local and foreign income tax
	returns for the years 2003 through 2007 are open to examination. The U.S. federal income tax
	return for 2007 is also open to examination. Various foreign and state tax returns are currently
	under examination and may conclude within the next twelve months. The final outcomes of these
	audits are not yet determinable; however, management believes that any assessments that may arise
	will not be material to the Companys financial condition or results of operations.
	6. Earnings (Loss) Per Share
	     Basic earnings (loss) per share is computed by dividing the applicable net income (loss) by
	the weighted-average number of common shares outstanding for the period. Diluted earnings (loss)
	per share is calculated using the weighted-average number of shares of common stock as adjusted for
	any potentially dilutive shares as of the balance sheet date. The computation of basic and diluted
	earnings (loss) per share is as follows:
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
| (in millions, except per share amounts) |  | 2008 |  |  | 2007 |  |  | 2006 |  | 
| 
	Numerator (basic and diluted):
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Net income (loss)
 |  | $ | 53.5 |  |  | $ | 40.2 |  |  | $ | (158.9 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Denominator:
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Weighted-average shares  basic
 |  |  | 20.2 |  |  |  | 21.3 |  |  |  | 20.9 |  | 
| 
	Share-based awards
 |  |  | 0.5 |  |  |  | 0.5 |  |  |  |  |  | 
| 
	Convertible debentures
 |  |  | 0.3 |  |  |  | 0.5 |  |  |  |  |  | 
| 
	Other
 |  |  | 0.1 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Weighted-average shares  diluted
 |  |  | 21.1 |  |  |  | 22.3 |  |  |  | 20.9 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Earnings (loss) per share:
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Basic
 |  | $ | 2.64 |  |  | $ | 1.89 |  |  | $ | (7.60 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Diluted
 |  | $ | 2.54 |  |  | $ | 1.80 |  |  | $ | (7.60 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
 
	63
 
	     As discussed further in Note 10, the Company has issued convertible debentures. Under the
	terms of the debentures, the Company would settle the par amount of its obligations in cash and the
	remaining obligations, if any, in common shares. In accordance with the current applicable
	accounting guidelines, the Company includes the conversion option effect in diluted earnings per
	share during such periods when the Companys stock price exceeds the initial conversion price of
	$33.79 per share.
	     In 2006, there was a loss attributable to common shares. Potentially dilutive share-based
	awards of 0.6 million shares and convertible debentures of 0.1 million shares were excluded from
	the calculation of diluted earnings per share as they were antidilutive.
	7. Inventories
	     Inventories consists of the following:
|  |  |  |  |  |  |  |  |  | 
|  |  | As of December 31, |  | 
|  |  | 2008 |  |  | 2007 |  | 
|  |  | (in millions) |  | 
| 
	Finished products
 |  | $ | 53.5 |  |  | $ | 45.7 |  | 
| 
	Costs relating to long-term contracts and programs
 |  |  | 41.5 |  |  |  | 19.4 |  | 
| 
	Work in process
 |  |  | 16.1 |  |  |  | 23.0 |  | 
| 
	Raw materials and supplies
 |  |  | 36.9 |  |  |  | 30.8 |  | 
| 
	 
 |  |  |  |  |  |  | 
| 
	 
 |  |  | 148.0 |  |  |  | 118.9 |  | 
| 
	Reserve to reduce certain inventories to LIFO basis
 |  |  | (16.9 | ) |  |  | (16.2 | ) | 
| 
	Progress payments
 |  |  | (46.3 | ) |  |  | (32.4 | ) | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Total
 |  | $ | 84.8 |  |  | $ | 70.3 |  | 
| 
	 
 |  |  |  |  |  |  | 
 
	8. Property, Plant and Equipment
	     Property, plant and equipment consists of the following:
|  |  |  |  |  |  |  |  |  | 
|  |  | As of December 31, |  | 
|  |  | 2008 |  |  | 2007 |  | 
|  |  | (in millions) |  | 
| 
	Land
 |  | $ | 3.5 |  |  | $ | 4.0 |  | 
| 
	Buildings and improvements
 |  |  | 115.0 |  |  |  | 107.7 |  | 
| 
	Machinery and equipment
 |  |  | 369.7 |  |  |  | 344.1 |  | 
| 
	Construction in progress
 |  |  | 23.8 |  |  |  | 33.1 |  | 
| 
	 
 |  |  |  |  |  |  | 
| 
	 
 |  |  | 512.0 |  |  |  | 488.9 |  | 
| 
	Less accumulated depreciation
 |  |  | (305.9 | ) |  |  | (295.4 | ) | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Total
 |  | $ | 206.1 |  |  | $ | 193.5 |  | 
| 
	 
 |  |  |  |  |  |  | 
 
	     Construction in progress was reduced by $1.5 million as of December 31, 2008, for grants and
	credits receivable from governmental agencies to reimburse the Company for expenditures made on the
	Palmyra, New York modernization project.
	9. Goodwill and Other Intangible Assets
	     The changes in the net carrying value of goodwill by reportable segment for the years ended
	December 31, 2008 and 2007 are as follows:
	64
 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  | Engine |  |  |  |  | 
|  |  | Sealing |  |  | Engineered |  |  | Products and |  |  |  |  | 
|  |  | Products |  |  | Products |  |  | Services |  |  | Total |  | 
|  |  | (in millions) |  | 
| 
	Goodwill, net as of December 31, 2006
 |  | $ | 48.6 |  |  | $ | 105.9 |  |  | $ | 7.1 |  |  | $ | 161.6 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Foreign currency translation
 |  |  | 1.2 |  |  |  | 8.7 |  |  |  |  |  |  |  | 9.9 |  | 
| 
	Acquisitions
 |  |  |  |  |  |  | 42.3 |  |  |  |  |  |  |  | 42.3 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Goodwill, net as of December 31, 2007
 |  |  | 49.8 |  |  |  | 156.9 |  |  |  | 7.1 |  |  |  | 213.8 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Foreign currency translation
 |  |  | (1.3 | ) |  |  | (12.7 | ) |  |  |  |  |  |  | (14.0 | ) | 
| 
	Acquisitions
 |  |  | 17.9 |  |  |  | 0.4 |  |  |  |  |  |  |  | 18.3 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Goodwill, net as of December 31, 2008
 |  | $ | 66.4 |  |  | $ | 144.6 |  |  | $ | 7.1 |  |  | $ | 218.1 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
 
	     The gross carrying amount and accumulated amortization of identifiable intangible assets is as
	follows:
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | As of December 31, 2008 |  |  | As of December 31, 2007 |  | 
|  |  | Gross |  |  |  |  |  | Gross |  |  |  |  | 
|  |  | Carrying |  |  | Accumulated |  |  | Carrying |  |  | Accumulated |  | 
|  |  | Amount |  |  | Amortization |  |  | Amount |  |  | Amortization |  | 
|  |  |  |  |  |  | (in millions) |  |  |  |  |  | 
| 
	Customer relationships
 |  | $ | 77.3 |  |  | $ | 27.1 |  |  | $ | 68.4 |  |  | $ | 20.9 |  | 
| 
	Existing technology
 |  |  | 22.4 |  |  |  | 5.0 |  |  |  | 21.0 |  |  |  | 3.8 |  | 
| 
	Trademarks
 |  |  | 36.5 |  |  |  | 6.4 |  |  |  | 38.4 |  |  |  | 5.8 |  | 
| 
	Other
 |  |  | 14.1 |  |  |  | 8.4 |  |  |  | 13.3 |  |  |  | 7.1 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  | $ | 150.3 |  |  | $ | 46.9 |  |  | $ | 141.1 |  |  | $ | 37.6 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
 
	     Amortization expense for the years ended December 31, 2008, 2007 and 2006 was $10.8 million,
	$7.8 million and $6.1 million, respectively. Amortization expense for these intangible assets for
	the years 2009 through 2013 is estimated to be $10.3 million, $10.1 million, $9.7 million, $9.1
	million and $8.4 million, respectively. The Company has trademarks with indefinite lives that were
	included in the table above with a carrying amount of approximately $23 million as of December 31,
	2008 that were not amortized.
	10. Long-Term Debt
	     The Companys long-term debt at December 31, 2008 and 2007 is summarized as follows:
|  |  |  |  |  |  |  |  |  | 
|  |  | 2008 |  |  | 2007 |  | 
|  |  | (in millions) |  | 
| 
	Convertible Debentures
 |  | $ | 172.5 |  |  | $ | 172.5 |  | 
| 
	Coltec Senior Notes
 |  |  |  |  |  |  | 3.1 |  | 
| 
	Industrial revenue bonds
 |  |  | 9.6 |  |  |  | 9.6 |  | 
| 
	Other notes payable
 |  |  | 0.1 |  |  |  | 0.5 |  | 
| 
	 
 |  |  |  |  |  |  | 
| 
	 
 |  |  | 182.2 |  |  |  | 185.7 |  | 
| 
	Less current maturities of long-term debt
 |  |  | 9.6 |  |  |  | 3.6 |  | 
| 
	 
 |  |  |  |  |  |  | 
| 
	 
 |  | $ | 172.6 |  |  | $ | 182.1 |  | 
| 
	 
 |  |  |  |  |  |  | 
 
	     The Companys primary U.S. operating subsidiaries have a senior secured revolving credit
	facility with a group of banks. The credit agreement for this facility was originally executed on
	May 16,
	65
 
	2002. On April 26, 2006, the Company and its primary U.S. operating subsidiaries amended and
	extended the facility. As amended, the maximum initial amount available for borrowings under the
	facility is $75 million. Under certain conditions, the borrowers may request that the facility be
	increased by up to $25 million, to $100 million total. The facility matures on April 21, 2011.
	Borrowings are available at LIBOR plus a margin of 1.00% to 1.75%. The Company pays an annual
	unused line fee of 0.25%.
	     There have been no borrowings under this credit facility since its inception. Borrowings
	under the credit facility would be collateralized by receivables, inventories, intellectual
	property, insurance receivables and all other personal property assets (other than fixed assets) of
	the Company and its U.S. subsidiaries, and by pledges of 65% of the capital stock of its foreign
	subsidiaries and 100% of the capital stock of its domestic subsidiaries. The credit facility
	contains customary restrictions, covenants and events of default for financings of this type,
	including but not limited to limitations on the ability to pay dividends, limitations on the
	incurrence and repayment of additional debt and maintenance of a fixed charge coverage financial
	ratio. Certain of the covenants and restrictions apply only if availability under the facility
	falls below certain levels.
	     In 2005, the Company issued $172.5 million in aggregate principal amount of Convertible Senior
	Debentures (the Debentures). The Debentures bear interest at the annual rate of 3.9375%, with
	interest due on April 15 and October 15 of each year. The Debentures will mature on October 15,
	2015 unless they are converted prior to that date. The Debentures are the Companys direct,
	unsecured and unsubordinated obligations and would rank equal in priority with all unsecured and
	unsubordinated indebtedness and senior in right of payment to all subordinated indebtedness. They
	would effectively rank junior to all secured indebtedness to the extent of the value of the assets
	securing such indebtedness. The Debentures do not contain any financial covenants.
	     Holders may convert the Debentures into cash and shares of the Companys common stock, under
	certain circumstances. The initial conversion rate, which is subject to adjustment, is 29.5972
	shares of common stock per $1,000 principal amount of Debentures. This is equal to an initial
	conversion price of $33.79 per share. The debentures may be converted under the following
	circumstances:
|  |  |  | during any fiscal quarter (and only during such fiscal quarter), if the closing
	price of the Companys common stock for at least 20 trading days in the 30 consecutive
	trading-day period ending on the last trading day of the preceding fiscal quarter was
	130% or more of the then current conversion price per share of common stock on that
	30
	th
	trading day; | 
|  | 
|  |  |  | during the five business day period after any five consecutive trading-day period
	(which is referred to as the measurement period) in which the trading price per
	debenture for each day of the measurement period was less than 98% of the product of
	the closing price of the Companys common stock and the applicable conversion rate for
	the debentures; | 
|  | 
|  |  |  | on or after September 15, 2015; | 
|  | 
|  |  |  | upon the occurrence of specified corporate transactions; or | 
|  | 
|  |  |  | in connection with a transaction or event constituting a change of control. | 
 
	     The conditions that permit conversion were not satisfied at December 31, 2008.
	     Upon conversion of any Debentures, the principal amount would be settled in cash.
	Specifically, in connection with any conversion, the Company will satisfy its obligations under the
	Debentures by
	66
 
	delivering to holders, in respect of each $1,000 aggregate principal amount of Debentures
	being converted:
|  |  |  | cash equal to the lesser of $1,000 or the Conversion Value, and | 
|  | 
|  |  |  | to the extent the Conversion Value exceeds $1,000, a number of shares equal to the
	sum of, for each day of the Cash Settlement Period (defined below), (1) 5% of the
	difference between (A) the product of the conversion rate (plus any additional shares
	as an adjustment upon a change of control) and the closing price of the Companys
	common stock for such date and (B) $1,000, divided by (2) the closing price of the
	Companys common stock for such day. | 
 
	     Conversion Value means the product of (1) the conversion rate in effect (plus any additional
	shares as an adjustment upon a change of control) and (2) the average of the closing prices of the
	Companys common stock for the 20 consecutive trading days beginning on the second trading day
	after the conversion date for those Debentures.
	     The industrial revenue bonds are payable in full in 2009 and bear interest at rates ranging
	from 6.4% to 6.55%.
	     Future principal payments on long-term debt are as follows:
|  |  |  |  |  | 
|  |  | (in millions) |  | 
| 
	2009
 |  | $ | 9.6 |  | 
| 
	2010
 |  |  | 0.1 |  | 
| 
	2011
 |  |  |  |  | 
| 
	2012
 |  |  |  |  | 
| 
	2013
 |  |  |  |  | 
| 
	Thereafter
 |  |  | 172.5 |  | 
| 
	 
 |  |  |  | 
| 
	 
 |  | $ | 182.2 |  | 
| 
	 
 |  |  |  | 
 
	11. Fair Value Measurements
	     Assets and liabilities measured at fair value on a recurring basis are summarized as
	follows:
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Fair Value Measurements as of |  | 
|  |  | December 31, 2008 |  | 
|  |  | Total |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |  | 
|  |  |  |  |  |  | (in millions) |  |  |  |  |  | 
| 
	Assets
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Cash equivalents
 |  | $ | 65.8 |  |  | $ | 65.8 |  |  | $ |  |  |  | $ |  |  | 
| 
	Crucible back-up trust assets
 |  |  | 22.4 |  |  |  | 22.4 |  |  |  |  |  |  |  |  |  | 
| 
	Cash management fund
 |  |  | 7.1 |  |  |  |  |  |  |  | 7.1 |  |  |  |  |  | 
| 
	Foreign currency derivatives
 |  |  | 1.8 |  |  |  |  |  |  |  | 1.8 |  |  |  |  |  | 
| 
	Deferred compensation assets
 |  |  | 2.6 |  |  |  | 2.6 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  | $ | 99.7 |  |  | $ | 90.8 |  |  | $ | 8.9 |  |  | $ |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Liabilities
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Deferred compensation liabilities
 |  | $ | 4.1 |  |  | $ | 4.1 |  |  | $ |  |  |  | $ |  |  | 
| 
	Foreign currency derivatives
 |  |  | 0.7 |  |  |  |  |  |  |  | 0.7 |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  | $ | 4.8 |  |  | $ | 4.1 |  |  | $ | 0.7 |  |  | $ |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
 
	67
 
	     The Companys cash equivalents, Crucible back-up trust assets and deferred compensation assets
	and liabilities are classified within Level 1 of the fair value hierarchy because they are valued
	using quoted market prices. For further discussion of the Crucible back-up trust, see Note 17,
	Commitments and Contingencies  Crucible Materials Corporation. The fair values for foreign
	currency derivatives are based on quoted market prices from various banks for similar instruments.
	     In December 2007, the Company was notified that the cash management fund held at a financial
	institution would be closed and liquidated. In addition, (1) cash redemptions were temporarily
	suspended, although redemptions could be filled through a pro-rata distribution of the underlying
	securities, consisting principally of high-quality corporate debt, mortgage-backed securities and
	asset-backed securities; (2) the funds valuation would be based on the market value of the
	underlying securities, whereas historically the funds valuation was based on amortized cost; and
	(3) interest would continue to accrue. Due to this event, the Company re-evaluated the nature of
	the investment and determined that it should be reclassified as an investment rather than as a cash
	equivalent in its Consolidated Financial Statements. The Company has been advised by the fund
	manager that the intention is to make an orderly liquidation of the cash management fund with the
	goal of preserving and distributing as much of the original investment values as possible to the
	fund investors. The fair value of the cash management fund assets is determined through a
	combination of broker quotations, alternative pricing sources with reasonable levels of price
	transparency and review of management, and is reflected in the net asset value of the fund. In the
	years ended December 31, 2008 and 2007, the Company recorded expense of $2.0 million and $0.4
	million, respectively, related to decreases in the value of the cash management fund which is
	included in other income (expense) in the accompanying Consolidated Statements of Operations.
	     The carrying values of the Companys significant financial instruments reflected in the
	Consolidated Balance Sheets approximate their respective fair values at December 31, 2008 and 2007,
	except for the following instruments:
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | 2008 |  | 2007 | 
|  |  | Carrying |  | Fair |  | Carrying |  | Fair | 
|  |  | Value |  | Value |  | Value |  | Value | 
|  |  | (in millions) | 
| 
	Long-term debt
 |  | $ | 182.2 |  |  | $ | 145.1 |  |  | $ | 185.7 |  |  | $ | 215.9 |  | 
 
	     The fair values for long-term debt are based on quoted market prices or on rates available to
	the Company for debt with similar terms and maturities.
	12. Pensions and Postretirement Benefits
	     The Company and its subsidiaries have several non-contributory defined benefit pension plans
	covering eligible employees in the United States, Canada, Mexico and several European countries.
	Salaried employees benefit payments are generally determined using a formula that is based on an
	employees compensation and length of service. The Company closed its defined benefit pension plan
	for new salaried employees in the United States who joined the Company after January 1, 2006, and
	effective January 1, 2007, benefits were frozen for all salaried employees who were not age 40 or
	older as of December 31, 2006, and other employees who chose to freeze their benefits. Hourly
	employees benefit payments are generally determined using stated amounts for each year of service.
	The Companys employees also participate in voluntary contributory retirement savings plans for
	salaried and hourly employees maintained by the Company and its subsidiaries. Under these plans,
	eligible employees can receive matching contributions up to the first 6% of their eligible
	earnings. Effective January 1, 2007, those employees whose defined benefit pension plan benefits
	were frozen receive an additional 2%
	68
 
	Company contribution each year. The Company recorded $6.9 million, $6.2 million and $5.2
	million in expenses in 2008, 2007 and 2006, respectively, for matching contributions under these
	plans.
	     The Companys general funding policy for qualified defined benefit pension plans is to
	contribute amounts that are at least sufficient to satisfy regulatory funding standards. In both
	2007 and 2006, the Company contributed discretionary amounts of $10.0 million to the U.S. pension
	plans. The Company anticipates that there will be a required funding of $6.4 million in 2009. The
	Company expects to make total contributions of approximately $0.9 million in 2009 to the foreign
	pension plans. The projected benefit obligation, accumulated benefit obligation and fair value of
	plan assets for the defined benefit pension plans with accumulated benefit obligations in excess of
	plan assets were $190.0 million, $177.6 million and $109.7 million at December 31, 2008, and $186.7
	million, $172.5 million and $167.5 million at December 31, 2007, respectively.
	     The Company amortizes prior service cost and unrecognized gains and losses using the
	straight-line basis over the average future service life of active participants.
	     The Company provides, through non-qualified plans, supplemental pension benefits to a limited
	number of employees. Certain of the Companys subsidiaries also sponsor unfunded defined benefit
	postretirement plans that provide certain health-care and life insurance benefits to eligible
	employees. The health-care plans are contributory, with retiree contributions adjusted
	periodically, and contain other cost-sharing features, such as deductibles and coinsurance. The
	life insurance plans are generally noncontributory. The amounts included in Other Benefits in
	the following tables include the non-qualified plans and the other defined benefit postretirement
	plans discussed above.
	Domestic Plans
	     The following table sets forth the changes in projected benefit obligations and plan assets of
	the Companys U.S. defined benefit pension and other non-qualified and postretirement plans as of
	and for the years ended December 31, 2008 and 2007.
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Pension Benefits |  |  | Other Benefits |  | 
|  |  | 2008 |  |  | 2007 |  |  | 2008 |  |  | 2007 |  | 
|  |  | (in millions) |  | 
| 
	Change in Projected Benefit Obligations
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Projected benefit obligations at
	beginning of year
 |  | $ | 168.6 |  |  | $ | 155.8 |  |  | $ | 12.9 |  |  | $ | 11.9 |  | 
| 
	Service cost
 |  |  | 5.8 |  |  |  | 5.8 |  |  |  | 1.0 |  |  |  | 1.5 |  | 
| 
	Interest cost
 |  |  | 10.4 |  |  |  | 9.7 |  |  |  | 0.7 |  |  |  | 0.7 |  | 
| 
	Actuarial loss
 |  |  | 1.7 |  |  |  | 3.0 |  |  |  | 0.7 |  |  |  |  |  | 
| 
	Amendments
 |  |  | 0.5 |  |  |  | 0.4 |  |  |  |  |  |  |  | 0.5 |  | 
| 
	Administrative expenses
 |  |  | (1.2 | ) |  |  | (1.3 | ) |  |  |  |  |  |  |  |  | 
| 
	Benefits paid
 |  |  | (5.5 | ) |  |  | (4.8 | ) |  |  | (1.2 | ) |  |  | (1.7 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Projected benefit obligations at end of year
 |  |  | 180.3 |  |  |  | 168.6 |  |  |  | 14.1 |  |  |  | 12.9 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Change in Plan Assets
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Fair value of plan assets
	at beginning of year
 |  |  | 157.1 |  |  |  | 143.2 |  |  |  |  |  |  |  |  |  | 
| 
	Actual return on plan assets
 |  |  | (44.2 | ) |  |  | 10.0 |  |  |  |  |  |  |  |  |  | 
| 
	Administrative expenses
 |  |  | (1.2 | ) |  |  | (1.3 | ) |  |  |  |  |  |  |  |  | 
| 
	Company contributions
 |  |  |  |  |  |  | 10.0 |  |  |  |  |  |  |  |  |  | 
| 
	Benefits paid
 |  |  | (5.5 | ) |  |  | (4.8 | ) |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Fair value of plan assets at end of year
 |  |  | 106.2 |  |  |  | 157.1 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Funded Status at End of Year
 |  | $ | (74.1 | ) |  | $ | (11.5 | ) |  | $ | (14.1 | ) |  | $ | (12.9 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
 
	69
 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Pension Benefits |  |  | Other Benefits |  | 
|  |  | 2008 |  |  | 2007 |  |  | 2008 |  |  | 2007 |  | 
|  |  | (in millions) |  | 
| 
	Amounts Recognized in the
	Consolidated Balance Sheets
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Current liabilities
 |  | $ |  |  |  | $ |  |  |  | $ | (4.2 | ) |  | $ | (0.8 | ) | 
| 
	Noncurrent liabilities
 |  |  | (74.1 | ) |  |  | (11.5 | ) |  |  | (9.9 | ) |  |  | (12.1 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  | $ | (74.1 | ) |  | $ | (11.5 | ) |  | $ | (14.1 | ) |  | $ | (12.9 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
 
	     Recent volatility in the equity and fixed income markets has caused a significant decline in
	the value of the U.S. pension plan assets and an increase in plan liabilities. The resulting
	decline in the plans funded status has created the requirement of significant charges to
	accumulated other comprehensive income during the year ended December 31, 2008. Pre-tax charges
	recognized in accumulated other comprehensive income as of December 31, 2008 and 2007 consist of:
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Pension Benefits |  |  | Other Benefits |  | 
|  |  | 2008 |  |  | 2007 |  |  | 2008 |  |  | 2007 |  | 
|  |  | (in millions) |  | 
| 
	Net actuarial loss
 |  | $ | 78.9 |  |  | $ | 20.3 |  |  | $ | 3.0 |  |  | $ | 2.5 |  | 
| 
	Prior service cost
 |  |  | 3.7 |  |  |  | 4.5 |  |  |  | 1.4 |  |  |  | 1.6 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  | $ | 82.6 |  |  | $ | 24.8 |  |  | $ | 4.4 |  |  | $ | 4.1 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
 
	     The accumulated benefit obligation for all domestic defined benefit pension plans was $169.0
	million and $156.7 million at December 31, 2008 and 2007, respectively.
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Pension Benefits |  |  | Other Benefits |  | 
|  |  | 2008 |  |  | 2007 |  |  | 2006 |  |  | 2008 |  |  | 2007 |  |  | 2006 |  | 
|  |  | (in millions) |  | 
| 
	Net Periodic Benefit Cost
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Service cost
 |  | $ | 5.8 |  |  | $ | 5.8 |  |  | $ | 7.4 |  |  | $ | 1.0 |  |  | $ | 1.5 |  |  | $ | 0.9 |  | 
| 
	Interest cost
 |  |  | 10.4 |  |  |  | 9.7 |  |  |  | 8.9 |  |  |  | 0.7 |  |  |  | 0.7 |  |  |  | 0.7 |  | 
| 
	Expected return on plan assets
 |  |  | (13.1 | ) |  |  | (12.5 | ) |  |  | (10.5 | ) |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Amortization of prior service cost
 |  |  | 1.2 |  |  |  | 1.2 |  |  |  | 2.5 |  |  |  | 0.2 |  |  |  | 0.2 |  |  |  | (0.1 | ) | 
| 
	Recognized net actuarial loss
 |  |  | 0.5 |  |  |  | 0.1 |  |  |  | 1.8 |  |  |  | 0.2 |  |  |  | 0.2 |  |  |  | 0.2 |  | 
| 
	Curtailment loss
 |  |  |  |  |  |  |  |  |  |  | 0.2 |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Net periodic benefit cost
 |  |  | 4.8 |  |  |  | 4.3 |  |  | $ | 10.3 |  |  |  | 2.1 |  |  |  | 2.6 |  |  | $ | 1.7 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Other Changes in Plan Assets and
	Benefit Obligations Recognized in
	Other Comprehensive Income
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Net loss
 |  |  | 59.1 |  |  |  | 5.6 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Prior service cost
 |  |  | 0.4 |  |  |  | 0.3 |  |  |  |  |  |  |  | 0.7 |  |  |  | 0.7 |  |  |  |  |  | 
| 
	Amortization of net loss
 |  |  | (0.5 | ) |  |  | (0.1 | ) |  |  |  |  |  |  | (0.2 | ) |  |  | (0.2 | ) |  |  |  |  | 
| 
	Amortization of prior service cost
 |  |  | (1.2 | ) |  |  | (1.2 | ) |  |  |  |  |  |  | (0.2 | ) |  |  | (0.2 | ) |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Total
	recognized in other comprehensive income
 |  |  | 57.8 |  |  |  | 4.6 |  |  |  |  |  |  |  | 0.3 |  |  |  | 0.3 |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Total Recognized in Net Periodic Benefit
	Cost and Other Comprehensive
	Income
 |  | $ | 62.6 |  |  | $ | 8.9 |  |  |  |  |  |  | $ | 2.4 |  |  | $ | 2.9 |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
 
	70
 
	     The estimated net loss and prior service cost for the defined benefit pension plans that will
	be amortized from accumulated other comprehensive income into net periodic benefit cost over the
	next fiscal year are $6.4 million and $0.9 million, respectively. The estimated net loss and prior
	service cost for the other defined benefit postretirement plans that will be amortized from
	accumulated other comprehensive income into net periodic benefit cost over the next fiscal year is
	$0.2 million and $0.2 million, respectively.
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Pension Benefits |  | Other Benefits | 
|  |  | 2008 |  | 2007 |  | 2006 |  | 2008 |  | 2007 |  | 2006 | 
| 
	Weighted-Average Assumptions Used to
	Determine Benefit Obligations at
	December 31
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Discount rate
 |  |  | 6.25 | % |  |  | 6.25 | % |  |  | 6.25 | % |  |  | 6.25 | % |  |  | 6.25 | % |  |  | 6.25 | % | 
| 
	Rate of compensation increase
 |  |  | 4.0 | % |  |  | 4.0 | % |  |  | 4.0 | % |  |  | 4.0 | % |  |  | 4.0 | % |  |  | 4.0 | % | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Weighted-Average Assumptions Used to
	Determine Net Periodic Benefit Cost for
	Years Ended December 31
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Discount rate
 |  |  | 6.25 | % |  |  | 6.25 | % |  |  | 5.75 | % |  |  | 6.25 | % |  |  | 6.25 | % |  |  | 5.75 | % | 
| 
	Expected long-term return
	on plan assets
 |  |  | 8.5 | % |  |  | 8.5 | % |  |  | 8.5 | % |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Rate of compensation increase
 |  |  | 4.0 | % |  |  | 4.0 | % |  |  | 4.0 | % |  |  | 4.0 | % |  |  | 4.0 | % |  |  | 4.0 | % | 
 
	     The discount rate reflects the current rate at which the pension liabilities could be
	effectively settled at the end of the year. The discount rate was determined by matching the
	Companys expected benefit payments, taking into account the plans demographics, to the Citigroup
	Pension Discount Curve. This produced a discount rate of 6.25% at December 31, 2008. As of the
	date of these financial statements, there are no known or anticipated changes in our discount rate
	assumption that will impact our pension expense in 2009. A 25 basis point decrease (increase) in
	our discount rate, holding constant our expected long-term return on plan assets and other
	assumptions, would increase (decrease) pension expense by approximately $0.7 million per year.
	     The overall expected long-term rate of return on assets was determined based upon
	weighted-average historical returns over an extended period of time for the asset classes in which
	the plans invest according to the Companys current investment policy.
	     The Company uses the RP-2000 mortality table to value its domestic pension liabilities.
|  |  |  |  |  |  |  |  |  | 
| Assumed Health Care Cost Trend Rates at December 31 |  | 2008 |  | 2007 | 
| 
	Health care cost trend rate assumed for next year
 |  |  | 10.0 | % |  |  | 9.0 | % | 
| 
	Rate to which the cost trend rate is assumed to
	decline (the ultimate rate)
 |  |  | 5.0 | % |  |  | 5.0 | % | 
| 
	Year that the rate reaches the ultimate trend rate
 |  |  | 2013 |  |  |  | 2013 |  | 
 
	     A one percentage point change in the assumed health-care cost trend rate would have an impact
	of not more than $0.1 million on net periodic benefit cost and $0.8 million on benefit obligations.
	Plan Assets
	     The asset allocation for pension plans at the end of 2008 and 2007, and the target allocation
	for 2009, by asset category are as follows:
	71
 
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Target |  |  | 
|  |  | Allocation |  | Plan Assets at December 31, | 
| 
	Asset Category
 |  | 2009 |  | 2008 |  | 2007 | 
| 
	Equity securities
 |  |  | 65 | % |  |  | 65 | % |  |  | 65 | % | 
| 
	Fixed income
 |  |  | 35 | % |  |  | 35 | % |  |  | 35 | % | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  | 100 | % |  |  | 100 | % |  |  | 100 | % | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
 
	     The Companys investment goal is to maximize the return on assets, over the long term, by
	investing in equities and fixed income investments while diversifying investments within each asset
	class to reduce the impact of losses in individual securities. Equity investments include a mix of
	U.S. large capitalization equities, U.S. small capitalization equities and non-U.S. equities.
	Fixed income investments include a mix of corporate bonds, treasury obligations and mortgage backed
	securities. The asset allocation policy is reviewed periodically and any variation from the target
	asset allocation mix greater than 2% is rebalanced on a monthly basis. The plans have no direct
	investments in the Companys common stock.
	Estimated Future Benefit Payments
	     The following benefit payments, which reflect expected future service, as appropriate, are
	expected to be paid:
|  |  |  |  |  |  |  |  |  | 
|  |  | Pension |  |  | Other |  | 
|  |  | Benefits |  |  | Benefits |  | 
|  |  | (in millions) |  | 
| 
	2009
 |  | $ | 6.5 |  |  | $ | 4.9 |  | 
| 
	2010
 |  |  | 7.0 |  |  |  | 1.3 |  | 
| 
	2011
 |  |  | 7.7 |  |  |  | 1.1 |  | 
| 
	2012
 |  |  | 8.5 |  |  |  | 1.1 |  | 
| 
	2013
 |  |  | 9.4 |  |  |  | 1.1 |  | 
| 
	Years 2014  2018
 |  |  | 62.2 |  |  |  | 5.5 |  | 
| 
	 
 |  |  |  |  |  |  | 
| 
	 
 |  | $ | 101.3 |  |  | $ | 15.0 |  | 
| 
	 
 |  |  |  |  |  |  | 
 
	Foreign Plans
	     The following table sets forth the changes in projected benefit obligations and plan assets of
	the Companys foreign defined benefit pension and other postretirement plans as of and for the
	years ended December 31, 2008 and 2007.
	72
 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Pension Benefits |  |  | Other Benefits |  | 
|  |  | 2008 |  |  | 2007 |  |  | 2008 |  |  | 2007 |  | 
|  |  | (in millions) |  | 
| 
	Change in Projected Benefit Obligations
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Projected benefit obligations at
	beginning of year
 |  | $ | 19.3 |  |  | $ | 18.2 |  |  | $ | 1.4 |  |  | $ | 1.5 |  | 
| 
	Service cost
 |  |  | 0.7 |  |  |  | 0.7 |  |  |  |  |  |  |  | 0.1 |  | 
| 
	Interest cost
 |  |  | 1.0 |  |  |  | 0.9 |  |  |  |  |  |  |  | 0.1 |  | 
| 
	Curtailments and settlements
 |  |  |  |  |  |  |  |  |  |  | (1.4 | ) |  |  |  |  | 
| 
	Actuarial gain
 |  |  | (2.8 | ) |  |  | (1.1 | ) |  |  |  |  |  |  | (0.3 | ) | 
| 
	Benefits paid
 |  |  | (1.2 | ) |  |  | (1.8 | ) |  |  |  |  |  |  |  |  | 
| 
	Other, primarily exchange
	rate adjustment
 |  |  | (2.3 | ) |  |  | 2.4 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Projected benefit obligations at end of year
 |  |  | 14.7 |  |  |  | 19.3 |  |  |  |  |  |  |  | 1.4 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Change in Plan Assets
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Fair value of plan assets
	at beginning of year
 |  |  | 12.4 |  |  |  | 10.6 |  |  |  |  |  |  |  |  |  | 
| 
	Actual return on plan assets
 |  |  | (1.9 | ) |  |  | 0.1 |  |  |  |  |  |  |  |  |  | 
| 
	Company contributions
 |  |  | 1.3 |  |  |  | 1.9 |  |  |  |  |  |  |  |  |  | 
| 
	Benefits paid
 |  |  | (1.2 | ) |  |  | (1.8 | ) |  |  |  |  |  |  |  |  | 
| 
	Other, primarily exchange rate adjustment
 |  |  | (2.0 | ) |  |  | 1.6 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Fair value of plan assets at end of year
 |  |  | 8.6 |  |  |  | 12.4 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Funded Status
 |  | $ | (6.1 | ) |  | $ | (6.9 | ) |  | $ |  |  |  | $ | (1.4 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Amounts Recognized in the
	Consolidated Balance Sheets
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Noncurrent assets
 |  | $ | 0.4 |  |  | $ | 0.8 |  |  | $ |  |  |  | $ |  |  | 
| 
	Current liabilities
 |  |  | (0.3 | ) |  |  | (0.3 | ) |  |  |  |  |  |  |  |  | 
| 
	Noncurrent liabilities
 |  |  | (6.2 | ) |  |  | (7.4 | ) |  |  |  |  |  |  | (1.4 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  | $ | (6.1 | ) |  | $ | (6.9 | ) |  | $ |  |  |  | $ | (1.4 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
 
	     Pre-tax charges (credits) recognized in accumulated other comprehensive income as of December
	31, 2008 and 2007 consist of:
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Pension Benefits |  |  | Other Benefits |  | 
|  |  | 2008 |  |  | 2007 |  |  | 2008 |  |  | 2007 |  | 
|  |  | (in millions) |  | 
| 
	Net actuarial loss (gain)
 |  | $ | 1.5 |  |  | $ | 2.4 |  |  | $ |  |  |  | $ | (0.6 | ) | 
| 
	Net transition asset
 |  |  | (0.2 | ) |  |  | (0.3 | ) |  |  |  |  |  |  |  |  | 
| 
	Prior service cost
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.9 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  | $ | 1.3 |  |  | $ | 2.1 |  |  | $ |  |  |  | $ | 0.3 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
 
	     The accumulated benefit obligations for all foreign defined benefit pension plans was $12.7
	million and $16.9 million at December 31, 2008 and 2007, respectively.
	73
 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Pension Benefits |  |  | Other Benefits |  | 
|  |  | 2008 |  |  | 2007 |  |  | 2006 |  |  | 2008 |  |  | 2007 |  |  | 2006 |  | 
|  |  | (in millions) |  | 
| 
	Net Periodic Benefit Cost
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Service cost
 |  | $ | 0.7 |  |  | $ | 0.7 |  |  | $ | 0.6 |  |  | $ |  |  |  | $ | 0.1 |  |  | $ | 0.1 |  | 
| 
	Interest cost
 |  |  | 1.0 |  |  |  | 0.9 |  |  |  | 0.8 |  |  |  |  |  |  |  | 0.1 |  |  |  | 0.1 |  | 
| 
	Expected return on plan assets
 |  |  | (0.8 | ) |  |  | (0.8 | ) |  |  | (0.7 | ) |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Recognized net actuarial loss
 |  |  | 0.1 |  |  |  | 0.1 |  |  |  | 0.3 |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Curtailment and settlement loss (gain)
 |  |  |  |  |  |  |  |  |  |  | 0.1 |  |  |  | (1.1 | ) |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Net periodic benefit cost
 |  |  | 1.0 |  |  |  | 0.9 |  |  | $ | 1.1 |  |  |  | (1.1 | ) |  |  | 0.2 |  |  | $ | 0.2 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Other Changes in Plan Assets and
	Benefit Obligations Recognized in
	Other Comprehensive Income
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Net (loss) gain
 |  |  | (0.1 | ) |  |  | (0.4 | ) |  |  |  |  |  |  | 0.6 |  |  |  | (0.4 | ) |  |  |  |  | 
| 
	Amortization of transition asset
 |  |  | (0.1 | ) |  |  | (0.1 | ) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Curtailment
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (0.9 | ) |  |  |  |  |  |  |  |  | 
| 
	Other, primarily exchange rate
	adjustment
 |  |  | (0.6 | ) |  |  | 0.4 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Total
	recognized in other comprehensive income
 |  |  | (0.8 | ) |  |  | (0.1 | ) |  |  |  |  |  |  | (0.3 | ) |  |  | (0.4 | ) |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Total Recognized in Net Periodic Benefit
	Cost and Other Comprehensive
	Income
 |  | $ | 0.2 |  |  | $ | 0.8 |  |  |  |  |  |  | $ | (1.4 | ) |  | $ | (0.2 | ) |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
 
	     The estimated net loss for the defined benefit pension plans that will be amortized from
	accumulated other comprehensive income into net periodic benefit cost over the next fiscal year is
	$0.1 million.
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Pension Benefits |  | Other Benefits | 
|  |  | 2008 |  | 2007 |  | 2006 |  | 2008 |  | 2007 |  | 2006 | 
| 
	Weighted-Average Assumptions Used to
	Determine Benefit Obligations at
	December 31
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Discount rate
 |  |  | 7.0 | % |  |  | 5.6 | % |  |  | 5.0 | % |  |  | 6.25 | % |  |  | 5.5 | % |  |  | 4.5 | % | 
| 
	Rate of compensation increase
 |  |  | 3.0 | % |  |  | 3.0 | % |  |  | 3.0 | % |  |  | 3.0 | % |  |  | 3.0 | % |  |  | 3.0 | % | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Weighted-Average Assumptions Used to
	Determine Net Periodic Benefit Cost for
	Years Ended December 31
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Discount rate
 |  |  | 5.6 | % |  |  | 5.0 | % |  |  | 4.7 | % |  |  | 5.5 | % |  |  | 4.5 | % |  |  | 4.0 | % | 
| 
	Expected long-term
	return on plan assets
 |  |  | 6.8 | % |  |  | 7.0 | % |  |  | 7.4 | % |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Rate of compensation increase
 |  |  | 3.0 | % |  |  | 3.0 | % |  |  | 3.0 | % |  |  | 3.0 | % |  |  | 3.0 | % |  |  | 3.0 | % | 
 
	74
 
	Assumed Health Care Cost Trend Rates
	     The assumed health care cost trend rate at December 31, 2008 and 2007 was 4%.
	Plan Assets
	     The asset allocation for the Canadian pension plan at the end of 2008 and 2007 and the target
	allocation for 2009 is 60% equity securities, 35% fixed income, and 5% other. The asset allocation
	for the Mexican pension plan at the end of 2008 and 2007 and the target allocation for 2009 is 100%
	fixed income. The European plans are generally unfunded.
	Estimated Future Benefit Payments
	     The following benefit payments, which reflect expected future service, as appropriate, are
	expected to be made:
|  |  |  |  |  |  |  |  |  | 
|  |  | Pension |  |  | Other |  | 
|  |  | Benefits |  |  | Benefits |  | 
|  |  | (in millions) |  | 
| 
	2009
 |  | $ | 1.0 |  |  | $ |  |  | 
| 
	2010
 |  |  | 0.8 |  |  |  |  |  | 
| 
	2011
 |  |  | 0.8 |  |  |  |  |  | 
| 
	2012
 |  |  | 0.9 |  |  |  |  |  | 
| 
	2013
 |  |  | 1.1 |  |  |  |  |  | 
| 
	Years 2014  2018
 |  |  | 6.5 |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  | 
| 
	 
 |  | $ | 11.1 |  |  | $ |  |  | 
| 
	 
 |  |  |  |  |  |  | 
 
	13. Accumulated Other Comprehensive Income (Loss)
	     Accumulated other comprehensive income (loss) consists of the following:
|  |  |  |  |  |  |  |  |  | 
|  |  | As of December 31, |  | 
|  |  | 2008 |  |  | 2007 |  | 
|  |  | (in millions) |  | 
| 
	Unrealized translation adjustments
 |  | $ | 37.1 |  |  | $ | 68.7 |  | 
| 
	Pension and other postretirement plans
 |  |  | (55.1 | ) |  |  | (19.5 | ) | 
| 
	Accumulated net gain on cash flow hedges
 |  |  | 0.6 |  |  |  | 0.7 |  | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Accumulated other comprehensive income
	(loss)
 |  | $ | (17.4 | ) |  | $ | 49.9 |  | 
| 
	 
 |  |  |  |  |  |  | 
 
	     The unrealized translation adjustments are net of deferred taxes of $1.0 million in 2008. The
	pension and other postretirement plans are net of deferred taxes of $33.2 million and $11.8
	million, in 2008 and 2007, respectively. The accumulated net gain on cash flow hedges is net of
	deferred taxes of $0.4 million and $0.5 million in 2008 and 2007, respectively.
	75
 
	14. Shareholders Equity
	     On March 3, 2008, pursuant to a $100 million share repurchase authorization approved by the
	Companys board of directors, the Company entered into an accelerated share repurchase (ASR)
	agreement with a financial institution to provide for the immediate retirement of $50 million of
	the Companys common stock. Under the ASR agreement, the Company purchased approximately 1.7
	million shares of its common stock from a financial institution at an initial price of $29.53 per
	share. The financial institution borrowed these shares from third parties. Total consideration
	paid to the financial institution at initial settlement to repurchase these shares, including
	commissions and other fees, was approximately $50.2 million and was recorded in shareholders
	equity as a reduction of common stock and additional paid-in capital.
	     The price adjustment period under the ASR terminated in August 2008. During the term of the
	ASR, the financial institution purchased shares of the Companys common stock in the open market to
	settle its obligation related to shares borrowed from third parties and sold to the Company. The
	Company was required to remit a final settlement adjustment of $11.9 million based on an average of
	the reported daily volume weighted average price of its common stock during the term of the ASR.
	The final settlement adjustment was remitted in cash and was recorded in shareholders equity as a
	reduction of additional paid-in capital.
	     Pursuant to the share repurchase authorization and in accordance with the terms of a plan to
	repurchase shares announced on September 8, 2008, the Company acquired 252,400 shares of its common
	stock in open-market transactions at an average price of about $28.00 per share, resulting in total
	repurchases of approximately $7.1 million, including commissions and fees, from October 1, 2008 to
	October 29, 2008. On October 29, 2008, in light of the volatility in the financial and credit
	markets, the board of directors terminated the share repurchase plan.
	15. Equity Compensation Plan
	     The Company has an equity compensation plan (the Plan) that initially provided for the
	delivery of up to 3.6 million shares pursuant to various market and performance-based incentive
	awards. As of December 31, 2008, there are 0.7 million shares available for future awards. The
	Companys policy is to issue new shares to satisfy share option exercises.
	     Under the terms of the Plan, performance share awards were granted to executives and other key
	employees during 2008, 2007 and 2006. Each grant will vest if the Company achieves specific
	financial objectives at the end of a three-year performance period. Additional shares may be
	awarded if objectives are exceeded, but some or all shares may be forfeited if objectives are not
	met. Performance shares earned at the end of a performance period, if any, will be paid in actual
	shares of Company common stock, less the number of shares equal in value to applicable withholding
	taxes if the employee chooses. During the performance period, a grantee receives dividend
	equivalents accrued in cash (if any), and shares are forfeited if a grantee terminates employment.
	     A summary of the performance share activity during the year ended December 31, 2008, is
	presented below. The number of performance share awards shown in the table below represents the
	maximum number that could be issued.
	76
 
|  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  | Weighted-Average |  | 
|  |  |  |  |  |  | Grant-Date |  | 
|  |  | Shares |  |  | Fair Value |  | 
| 
	Nonvested at January 1, 2008
 |  |  | 377,195 |  |  | $ | 32.57 |  | 
| 
	Granted
 |  |  | 357,644 |  |  |  | 30.66 |  | 
| 
	Vested
 |  |  | (175,115 | ) |  |  | 28.71 |  | 
| 
	Forfeited
 |  |  | (72,384 | ) |  |  | 31.19 |  | 
| 
	Achievement level adjustment
 |  |  | (1,246 | ) |  |  | 28.71 |  | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Nonvested at December 31, 2008
 |  |  | 486,094 |  |  | $ | 32.73 |  | 
| 
	 
 |  |  |  |  |  |  | 
 
	     The performance share awards granted had a fair value, which approximated market value, at the
	grant date of $5.5 million, $5.0 million and $4.3 million or $30.66, $36.69 and $28.71 per share in
	2008, 2007 and 2006, respectively. Compensation expense related to the performance shares is
	recorded over the applicable performance period and amounted to $3.1 million, $4.8 million and $5.0
	million in 2008, 2007 and 2006, respectively. The related income tax benefit was $1.2 million,
	$1.8 million and $1.9 million, respectively. The 2006 performance share awards vested as of
	December 31, 2008 and were paid in February 2009.
	     As of December 31, 2008, there was $2.3 million of unrecognized compensation cost related to
	nonvested performance share awards that is expected to be recognized over a period of two years.
	     Non-qualified and incentive stock options were granted in 2008, 2003 and 2002. No stock
	option has a term exceeding 10 years from the date of grant. All stock options were granted at not
	less than 100% of fair market value (as defined) on the date of grant. Compensation expense
	related to the stock options amounted to $0.3 million in 2008, with a related income tax benefit of
	$0.1 million. As of December 31, 2008, there was $1.0 million of unrecognized compensation cost
	related to nonvested stock options that is expected to be recognized over a period of two years.
	     The following table provides certain information with respect to stock options as of December
	31, 2008:
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | Weighted |  | 
|  |  |  |  |  |  |  |  |  |  |  |  |  |  | Average |  | 
| Range of |  | Stock Options |  |  | Stock Options |  |  | Weighted Average |  |  | Remaining |  | 
| Exercise Price |  | Outstanding |  |  | Exercisable |  |  | Exercise Price |  |  | Contractual Life |  | 
| 
	Under $20.00
 |  |  | 581,374 |  |  |  | 581,374 |  |  | $ | 5.01 |  |  | 2.35 years | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Over $20.00
 |  |  | 100,000 |  |  |  |  |  |  | $ | 34.55 |  |  | 9.28 years | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Total
 |  |  | 681,374 |  |  |  | 581,374 |  |  | $ | 9.35 |  |  | 3.59 years | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
 
	     The Company determines the fair value of stock options using the Black-Scholes option-pricing
	formula. Key inputs into this formula include expected term, expected volatility, expected
	dividend yield and the risk-free interest rate. Each assumption is discussed below. This fair
	value is amortized on a straight-line basis over the vesting period.
	     The expected term represents the period that the Companys stock options are expected to be
	outstanding, and is determined based on historical experience of similar awards, giving
	consideration to contractual terms of the awards, vesting schedules and expectations of future
	employee behavior. The fair value of stock options reflects a volatility factor calculated using
	historical market data for the Companys common stock. The time frame used was approximately three
	years prior to the grant date for
	77
 
	awards in 2008. The dividend assumption is based on the Companys current expectations about
	its dividend policy. The Company bases the risk-free interest rate on the yield to maturity at the
	time of the stock option grant on zero-coupon U.S. government bonds having a remaining life equal
	to the options expected life. When estimating forfeitures, the Company considers voluntary
	termination behavior as well as analysis of actual option forfeitures.
	     The following assumptions were used to estimate the fair value of the 2008 option awards:
|  |  |  |  |  | 
| 
	Average expected term
 |  | 6 years | 
| 
	Expected volatility
 |  |  | 33.0 | % | 
| 
	Risk-free interest rate
 |  |  | 2.8 | % | 
| 
	Expected dividend yield
 |  |  | 0.0 | % | 
 
	     A summary of option activity under the Plan as of December 31, 2008, and changes during the
	year then ended, is presented below:
|  |  |  |  |  |  |  |  |  | 
|  |  | Share |  |  | Weighted |  | 
|  |  | Options |  |  | Average |  | 
|  |  | Outstanding |  |  | Exercise Price |  | 
| 
	Balance at December 31, 2007
 |  |  | 668,820 |  |  | $ | 4.97 |  | 
| 
	Granted
 |  |  | 100,000 |  |  |  | 34.55 |  | 
| 
	Exercised
 |  |  | (87,446 | ) |  |  | 4.71 |  | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Balance at December 31, 2008
 |  |  | 681,374 |  |  | $ | 9.35 |  | 
| 
	 
 |  |  |  |  |  |  | 
 
	     As of December 31, 2008, the aggregate intrinsic value of the outstanding and exercisable
	shares was $9.6 million. The total intrinsic value of options exercised during the years ended
	December 31, 2008, 2007 and 2006, was $2.7 million, $8.3 million and $5.7 million, respectively.
	     All outstanding share options granted in 2003 and 2002 were fully vested by December 31, 2006
	and none of the share options granted in 2008 have vested. The total fair value of share options
	vested during the year ended December 31, 2006 was $0.5 million.
	     Cash received from option exercises under the Plan for the years ended December 31, 2008, 2007
	and 2006 was $0.4 million, $1.0 million and $0.7 million, respectively. The tax benefit realized
	for the tax deductions from option exercises totaled $0.7 million, $2.5 million and $1.3 million
	for the years ended December 31, 2008, 2007 and 2006, respectively.
	     During 2008, 133,103 shares of restricted stock were issued with restriction periods ranging
	from one to six years from the initial grant date. Compensation expense related to all restricted
	shares of $1.0 million in 2008 is based upon the market price of the underlying common stock as of
	the date of the grant and is amortized over the applicable restriction period using the
	straight-line method. All restricted stock awards were nonvested at the end of the year with a
	weighted-average grant date fair value of $32.57 per share. As of December 31, 2008, there was
	$3.4 million of unrecognized compensation cost related to restricted stock that is expected to be
	recognized over a weighted average period of 3.37 years.
	     Each non-employee director receives a one-time initial grant of phantom shares equal in value
	to $30,000 upon election to the board of directors. Each non-employee director also receives an
	annual grant of phantom shares equal in value to $75,000, beginning in the year following the
	directors election to the board of directors and continuing through the tenth year of service as a
	director. The Company will pay each non-employee director in cash the fair market value of certain
	of the directors phantom shares
	78
 
	granted, subject to applicable withholding taxes, upon termination of service as a member of the
	board of directors. The remaining phantom shares granted will be paid out in the form of one share
	of Company common stock for each phantom share, with the value of any fractional phantom shares
	paid in cash. Expense (income) recognized in the years ended December 31, 2008, 2007 and 2006
	related to these phantom share grants was $(0.1) million, $0.1 million and $0.6 million,
	respectively. Cash payments of $0.4 million were used to settle phantom shares during 2007. No
	cash was used to settle any phantom shares in 2006.
	16. Business Segment Information
	     The Company has three reportable segments. The Sealing Products segment manufactures sealing
	and PTFE products. The Engineered Products segment manufactures metal polymer and solid polymer
	bearings and filament wound products, air compressor systems and vacuum pumps, and reciprocating
	compressor components. The Engine Products and Services segment manufactures and services
	heavy-duty, medium-speed diesel, natural gas and dual fuel reciprocating engines. The Companys
	reportable segments are managed separately based on differences in their products and services and
	their end-customers. Segment profit is total segment revenue reduced by operating expenses and
	restructuring and other costs identifiable with the segment. Corporate expenses include general
	corporate administrative costs. Expenses not directly attributable to the segments, corporate
	expenses, net interest expense, asbestos-related expenses, gains/losses or impairments related to
	the sale of assets and income taxes are not included in the computation of segment profit. The
	accounting policies of the reportable segments are the same as those for the Company.
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Years Ended December 31, |  | 
|  |  | 2008 |  |  | 2007 |  |  | 2006 |  | 
|  |  | (in millions) |  | 
| 
	Sales
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Sealing Products
 |  | $ | 503.5 |  |  | $ | 457.3 |  |  | $ | 432.5 |  | 
| 
	Engineered Products
 |  |  | 524.1 |  |  |  | 445.5 |  |  |  | 391.7 |  | 
| 
	Engine Products and Services
 |  |  | 142.1 |  |  |  | 128.1 |  |  |  | 105.2 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  | 1,169.7 |  |  |  | 1,030.9 |  |  |  | 929.4 |  | 
| 
	Intersegment sales
 |  |  | (1.9 | ) |  |  | (0.9 | ) |  |  | (1.0 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Total sales
 |  | $ | 1,167.8 |  |  | $ | 1,030.0 |  |  | $ | 928.4 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Segment Profit
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Sealing Products
 |  | $ | 90.4 |  |  | $ | 78.0 |  |  | $ | 76.5 |  | 
| 
	Engineered Products
 |  |  | 68.1 |  |  |  | 69.4 |  |  |  | 61.5 |  | 
| 
	Engine Products and Services
 |  |  | 20.8 |  |  |  | 15.3 |  |  |  | 4.9 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Total segment profit
 |  |  | 179.3 |  |  |  | 162.7 |  |  |  | 142.9 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Corporate expenses
 |  |  | (34.5 | ) |  |  | (34.1 | ) |  |  | (31.6 | ) | 
| 
	Asbestos-related expenses
 |  |  | (52.1 | ) |  |  | (68.4 | ) |  |  | (359.4 | ) | 
| 
	Interest income (expense), net
 |  |  | (5.3 | ) |  |  | 0.2 |  |  |  | (3.2 | ) | 
| 
	Other expense, net
 |  |  | (6.7 | ) |  |  | (2.4 | ) |  |  | (2.9 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Income (loss) before income taxes
 |  | $ | 80.7 |  |  | $ | 58.0 |  |  | $ | (254.2 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
 
	     No customer accounted for 10% or more of net sales in 2008, 2007 or 2006.
	79
 
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Years Ended December 31, |  | 
|  |  | 2008 |  |  | 2007 |  |  | 2006 |  | 
|  |  | (in millions) |  | 
| 
	Capital Expenditures
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Sealing Products
 |  | $ | 24.8 |  |  | $ | 27.4 |  |  | $ | 22.3 |  | 
| 
	Engineered Products
 |  |  | 20.4 |  |  |  | 16.8 |  |  |  | 14.5 |  | 
| 
	Engine Products and Services
 |  |  | 3.7 |  |  |  | 2.2 |  |  |  | 4.4 |  | 
| 
	Corporate
 |  |  | 0.2 |  |  |  | 0.4 |  |  |  | 0.1 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Total capital expenditures
 |  | $ | 49.1 |  |  | $ | 46.8 |  |  | $ | 41.3 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Depreciation and Amortization Expense
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Sealing Products
 |  | $ | 15.9 |  |  | $ | 14.8 |  |  | $ | 13.5 |  | 
| 
	Engineered Products
 |  |  | 24.3 |  |  |  | 20.6 |  |  |  | 17.2 |  | 
| 
	Engine Products and Services
 |  |  | 3.9 |  |  |  | 4.0 |  |  |  | 3.7 |  | 
| 
	Corporate
 |  |  | 0.7 |  |  |  | 0.8 |  |  |  | 0.8 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Total depreciation and amortization
 |  | $ | 44.8 |  |  | $ | 40.2 |  |  | $ | 35.2 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Net Sales
	by Geographic Area
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	United States
 |  | $ | 610.6 |  |  | $ | 565.7 |  |  | $ | 543.0 |  | 
| 
	Europe
 |  |  | 329.7 |  |  |  | 277.8 |  |  |  | 222.8 |  | 
| 
	Other foreign
 |  |  | 227.5 |  |  |  | 186.5 |  |  |  | 162.6 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Total
 |  | $ | 1,167.8 |  |  | $ | 1,030.0 |  |  | $ | 928.4 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
 
	     Net sales are attributed to countries based on location of the customer.
|  |  |  |  |  |  |  |  |  | 
|  |  | As of December 31, |  | 
|  |  | 2008 |  |  | 2007 |  | 
|  |  | (in millions) |  | 
| 
	Assets
 |  |  |  |  |  |  |  |  | 
| 
	Sealing Products
 |  | $ | 291.4 |  |  | $ | 246.8 |  | 
| 
	Engineered Products
 |  |  | 484.9 |  |  |  | 464.3 |  | 
| 
	Engine Products and Services
 |  |  | 72.4 |  |  |  | 72.2 |  | 
| 
	Corporate
 |  |  | 503.8 |  |  |  | 687.0 |  | 
| 
	 
 |  |  |  |  |  |  | 
| 
	 
 |  | $ | 1,352.5 |  |  | $ | 1,470.3 |  | 
| 
	 
 |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  | 
| 
	Long-Lived Assets
 |  |  |  |  |  |  |  |  | 
| 
	United States
 |  | $ | 274.4 |  |  | $ | 231.6 |  | 
| 
	Germany
 |  |  | 71.9 |  |  |  | 74.5 |  | 
| 
	France
 |  |  | 69.2 |  |  |  | 71.2 |  | 
| 
	United Kingdom
 |  |  | 47.8 |  |  |  | 67.4 |  | 
| 
	Other foreign
 |  |  | 64.3 |  |  |  | 66.1 |  | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Total
 |  | $ | 527.6 |  |  | $ | 510.8 |  | 
| 
	 
 |  |  |  |  |  |  | 
 
	     Corporate assets include all of the Companys cash and cash equivalents, asbestos insurance
	receivables and noncurrent deferred income taxes. Long-lived assets consist of property, plant and
	equipment, goodwill and other intangible assets.
	80
 
	17. Commitments and Contingencies
	     
	General
	     Various claims, lawsuits and administrative proceedings, all arising in the ordinary course of
	business with respect to commercial, product liability, asbestos and environmental matters, are
	pending or threatened against the Company or its subsidiaries and seek monetary damages and/or
	other remedies. The Company believes that any liability that may finally be determined with
	respect to commercial and non-asbestos product liability claims should not have a material effect
	on the Companys consolidated financial condition or results of operations. From time to time, the
	Company and its subsidiaries are also involved as plaintiffs in legal proceedings involving
	contract, patent protection, environmental, insurance and other matters.
	     
	Environmental
	     The Companys facilities and operations are subject to federal, state and local environmental
	and occupational health and safety requirements of the U.S. and foreign countries. The Company
	takes a proactive approach in its efforts to comply with environmental, health and safety laws as
	they relate to its manufacturing operations and in proposing and implementing any remedial plans
	that may be necessary. The Company also regularly conducts comprehensive environmental, health and
	safety audits at its facilities to maintain compliance and improve operational efficiency.
	     Although the Company believes past operations were in substantial compliance with the then
	applicable regulations, the Company or one of its subsidiaries has been named as a potentially
	responsible party or is otherwise involved at 21 sites where the costs to it are expected to exceed
	$100,000. Investigations have been completed for 15 sites and are in progress at the other six
	sites. The majority of these sites relate to remediation projects at former operating facilities
	that were sold or closed and primarily deal with soil and groundwater contamination.
	     The Companys policy is to accrue environmental investigation and remediation costs when it is
	probable that a liability has been incurred and the amount can be reasonably estimated. The
	measurement of the liability is based on an evaluation of currently available facts with respect to
	each individual situation and takes into consideration factors such as existing technology,
	presently enacted laws and regulations and prior experience in remediation of contaminated sites.
	Liabilities are established for all sites based on the factors discussed above. As assessments and
	remediation progress at individual sites, these liabilities are reviewed periodically and adjusted
	to reflect additional technical data and legal information. As of December 31, 2008 and 2007,
	EnPro had accrued liabilities of $22.1 million and $27.7 million, respectively, for estimated
	future expenditures relating to environmental contingencies. The amounts recorded in the
	Consolidated Financial Statements have been recorded on an undiscounted basis.
	     The Company believes that its reserves for environmental contingencies are adequate based on
	currently available information. Actual costs to be incurred for identified situations in future
	periods may vary from estimates because of the inherent uncertainties in evaluating environmental
	exposures due to unknown conditions, changing government regulations and legal standards regarding
	liability. Subject to the imprecision in estimating future environmental costs, the Company
	believes that maintaining compliance with current environmental laws and government regulations
	will not require significant capital expenditures or have a material adverse effect on its
	financial condition, but could be material to its results of operations or cash flows in a given
	period.
	81
 
	     
	Colt Firearms and Central Moloney
	     The Company has contingent liabilities related to divested businesses for which certain of its
	subsidiaries retained liability or are obligated under indemnity agreements. These contingent
	liabilities include, but are not limited to, potential product liability and associated claims
	related to firearms manufactured prior to 1990 by Colt Firearms, a former operation of Coltec, and
	for electrical transformers manufactured prior to 1994 by Central Moloney, another former Coltec
	operation. No product liability claims are currently pending against the Company related to Colt
	Firearms or Central Moloney. The Company also has ongoing obligations, which are included in
	retained liabilities of previously owned businesses in the Consolidated Balance Sheets, with regard
	to workers compensation, retiree medical and other retiree benefit matters that relate to the
	Companys periods of ownership of these operations.
	     
	Crucible Materials Corporation
	     Crucible Materials Corporation (Crucible), which is engaged primarily in the manufacture and
	distribution of specialty metal products, was a wholly owned subsidiary of Coltec until 1985 when a
	majority of the outstanding shares were sold. Coltec divested its remaining minority interest in
	2004.
	     In conjunction with the closure of a Crucible plant in the early 1980s, Coltec was required to
	fund two trusts for retiree medical benefits for union employees at the plant. The first trust
	(the Benefits Trust) pays for these retiree medical benefits on an ongoing basis. Coltec has no
	ownership interest in the Benefits Trust, and thus the assets and liabilities of this trust are not
	included in the Companys Consolidated Balance Sheets. Under the terms of the Benefits Trust
	agreement, the trustees retained an actuary to assess the adequacy of the assets in the Benefits
	Trust in 1995, another actuarial report was completed in 2005, and a third report will be required
	in 2015. The actuarial reports in 1995 and 2005 determined that there were adequate assets to fund
	the payment of future benefits. If it is determined in 2015 that the trust assets are not adequate
	to fund the payment of future medical benefits, Coltec will be required to contribute additional
	amounts to the Benefits Trust. In the event there are ever excess assets in the Benefits Trust,
	those excess assets will not revert to Coltec.
	     Because of the possibility that Coltec could be required to make additional contributions to
	the Benefits Trust to cover potential shortfalls, Coltec was required to establish a second trust
	(the Back-Up Trust). The trust assets and a corresponding liability of the Back-Up Trust are
	reflected in the Companys Consolidated Balance Sheets in other non-current assets and in retained
	liabilities of previously owned businesses, respectively, and amounted to $22.4 million each at
	December 31, 2008. As noted above, based on the valuation completed in early 2005, the actuary
	determined that there were adequate assets in the Benefits Trust to fund the estimated payments by
	the trust until the next valuation date. Until such time as a payment is required or the remaining
	excess trust assets revert to the Company, the trust assets and liabilities will be kept equal to
	each other on the Companys Consolidated Balance Sheets.
	     The Company also has ongoing obligations, which are included in retained liabilities of
	previously owned businesses in the Consolidated Balance Sheets, with regard to workers
	compensation, retiree medical and other retiree benefit matters, in addition to those mentioned
	previously, that relate to the Companys period of ownership of this operation.
	82
 
	     
	Debt and Capital Lease Guarantees
	     As of December 31, 2008, the Company had contingent liabilities for potential payments on
	guarantees of certain debt and lease obligations totaling $6.2 million. These guarantees arose
	from the divestitures of Crucible and Central Moloney and expire at various dates through 2010.
	There is no liability for these guarantees reflected in the Companys Consolidated Balance Sheets.
	In the event that the other parties do not fulfill their obligations under the debt or lease
	agreements, the Company could be responsible for these obligations.
	     
	Other Contingent Liability Matters
	     The Company provides warranties on many of its products. The specific terms and conditions of
	these warranties vary depending on the product and the market in which the product is sold. The
	Company records a liability based upon estimates of the costs that may be incurred under its
	warranties after a review of historical warranty experience and information about specific warranty
	claims. Adjustments are made to the liability as claims data and historical experience warrant.
	     Changes in the carrying amount of the product warranty liability for the years ended December
	31, 2008 and 2007, are as follows:
|  |  |  |  |  |  |  |  |  | 
|  |  | 2008 |  |  | 2007 |  | 
|  |  | (in millions) |  | 
| 
	Balance at beginning of year
 |  | $ | 3.6 |  |  | $ | 4.0 |  | 
| 
	Charges to expense
 |  |  | 4.5 |  |  |  | 2.7 |  | 
| 
	Charges to the accrual
 |  |  | (4.0 | ) |  |  | (3.1 | ) | 
| 
	 
 |  |  |  |  |  |  | 
| 
	Balance at end of year
 |  | $ | 4.1 |  |  | $ | 3.6 |  | 
| 
	 
 |  |  |  |  |  |  | 
 
	     
	Asbestos
	     
	History
	. Certain of the Companys subsidiaries, primarily Garlock Sealing
	Technologies LLC (Garlock) and The Anchor Packing Company (Anchor), are among a large number of
	defendants in actions filed in various states by plaintiffs alleging injury or death as a result of
	exposure to asbestos fibers. Among the products at issue in these actions are industrial sealing
	products, including gaskets and packing products. The damages claimed vary from action to action,
	and in some cases plaintiffs seek both compensatory and punitive damages. To date, neither Garlock
	nor Anchor has been required to pay any punitive damage awards, although there can be no assurance
	that they will not be required to do so in the future. Liability for compensatory damages has
	historically been allocated among responsible defendants. Since the first asbestos-related
	lawsuits were filed against Garlock in 1975, Garlock and Anchor have processed more than 900,000
	asbestos claims to conclusion (including judgments, settlements and dismissals) and, together with
	their insurers, have paid almost $1.4 billion in settlements and judgments and over $400 million in
	fees and expenses.
	     
	Claims Mix
	. Of those claims resolved, approximately 3% have been claims of plaintiffs
	alleging the disease mesothelioma, approximately 7% have been claims of plaintiffs with lung or
	other cancers, and approximately 90% have been claims of plaintiffs alleging asbestosis, pleural
	plaques or other non-malignant impairment of the respiratory system. The mix of cases filed in
	2008 contains approximately 27% mesothelioma claims and 17% lung or other cancer claims. In the
	remaining 56% of the new cases, either the plaintiffs alleged non-malignant impairment or the
	disease or condition is not alleged and remains unknown to us. Of the 104,100 open cases at
	December 31, 2008, the Company is aware of approximately 4,600 (4.4%) that involve claimants
	alleging mesothelioma.
	83
 
	     
	New Filings
	. The number of new actions filed against the Companys subsidiaries in
	2008 (5,500) was about 5% higher than the number filed in 2007 (5,200) but was significantly lower
	than the number filed in 2006 (7,700). The number filed against our subsidiaries in each of the
	three years was much lower than the number filed in the peak filing year, 2003, when 44,700 new
	claims were filed. Factors in the decline include, but are not limited to, tort reform in some
	high profile states, especially Mississippi, Texas and Ohio; tort reform in Florida, Georgia, South
	Carolina, Kansas and Tennessee; actions taken and rulings by some judges and court administrators
	that have had the effect of limiting access to their courts for claimants without sufficient ties
	to the jurisdiction or claimants with no discernible disease; acceleration of claims into past
	years; and declining incidence of asbestos-related disease. The trend of declining new filings has
	been principally in non-malignant claims; however, the number of new filings of claims alleging
	mesothelioma, lung and other cancers has declined only modestly since 2005 and was essentially flat
	for the two-year period 2006 through 2007. While we believe that the number of new mesothelioma
	filings was actually higher for 2008 than for 2007, the exact mix of 2008 claims is not yet fully
	known.
	     
	Product Defenses
	. The asbestos in products formerly sold by Garlock and Anchor was
	encapsulated, which means the asbestos fibers were incorporated into the products during the
	manufacturing process and sealed in a binder. The products were also nonfriable, which means they
	could not be crumbled by hand pressure. The U.S. Occupational Safety and Health Administration,
	which began generally requiring warnings on asbestos-containing products in 1972, has never
	required that a warning be placed on products such as Garlocks gaskets. Even though no warning
	label was required, Garlock included one on all of its asbestos-containing products beginning in
	1978. Further, gaskets such as those previously manufactured and sold by Garlock are one of the
	few asbestos-containing products still permitted to be manufactured under regulations of the U.S.
	Environmental Protection Agency. Nevertheless, Garlock discontinued all manufacture and
	distribution of asbestos-containing products in the U.S. during 2000 and worldwide in mid-2001.
	From the mid-1980s until 2000, U.S. sales of asbestos-containing industrial sealing products were
	not a material part of Garlocks sales and were predominantly to sophisticated purchasers such as
	the U.S. Navy and large petrochemical facilities.
	     Garlocks product defenses have enabled it to be successful more often than not at trial.
	Garlock won defense verdicts in three of the six cases tried to verdict in 2008, and in seven of 12
	cases tried to verdict in the three-year period 2006 through 2008. In the successful jury trials,
	the juries determined that either Garlocks products were not defective, that Garlock was not
	negligent, or that the claimant was not exposed to Garlocks products.
	     
	Recent Trial Results
	. In 2008, Garlock began eleven trials involving thirteen
	plaintiffs. Garlock received three jury verdicts in its favor, one in an Ohio case and two in a
	Pennsylvania trial involving two plaintiffs. In a Kentucky lung cancer case, the jury awarded the
	plaintiff $1.52 million. Garlocks share of this verdict was approximately $682,000; Garlock will
	appeal. In a Pennsylvania lung cancer case the jury awarded the plaintiff $400,000. Garlocks
	share was $200,000, 50% of the total verdict. In an Illinois case the jury awarded $500,000
	against Garlock to a plaintiff with asbestosis. Garlock will appeal. Also in Pennsylvania, four
	lawsuits involving five plaintiffs settled during trial before the jury reached a verdict. A
	lawsuit in California also dismissed during trial. In South Carolina, Garlock obtained a dismissal
	in one case during trial because there was insufficient evidence of exposure to Garlock products.
	     In 2007, Garlock began nine trials involving twelve plaintiffs. A Massachusetts jury returned
	a defense verdict in favor of Garlock. In a Kentucky case, the jury awarded the plaintiff $145,000
	against Garlock. Garlock plans to appeal this verdict. Four lawsuits in Pennsylvania settled
	during trial before the juries had reached a verdict. Garlock also settled cases during trial in
	Louisiana, Maryland and Washington.
	84
 
	     In 2006, Garlock began ten trials involving eleven plaintiffs. Garlock received jury verdicts
	in its favor in Oakland, California; Easton, Pennsylvania; and Louisville, Kentucky. In
	Pennsylvania, three other lawsuits involving four plaintiffs settled during trial before the juries
	reached verdict. Garlock also settled cases in Massachusetts, California and Texas during trial.
	In a retrial of a Kentucky case, the jury awarded the plaintiff $900,000 against Garlock. The
	award was significantly less than the $1.75 million award against Garlock in the previous trial,
	which Garlock successfully appealed. Garlock has also appealed the new verdict. In addition,
	Garlock obtained dismissals in two cases in Philadelphia after the juries were selected but before
	the trials began because there was insufficient evidence of exposure to Garlock products.
	     
	Appeals
	. Garlock has historically enjoyed success in a majority of its appeals. The
	Company believes that Garlock will continue to be successful in the appellate process, although
	there can be no assurance of success in any particular pending or future appeal. In June 2007, the
	New York Court of Appeals, in a unanimous decision, overturned an $800,000 verdict that was entered
	against Garlock in 2004, granting a new trial. In March 2006, a three-judge panel of the Ohio
	Court of Appeals, in a unanimous decision, overturned a $6.4 million verdict that was entered
	against Garlock in 2003, granting a new trial. The case subsequently settled. On the other hand,
	the Maryland Court of Appeals denied Garlocks appeal from a 2005 verdict in a mesothelioma case in
	Baltimore, and Garlock paid that verdict, with post-judgment interest, in the fourth quarter of
	2006. In a separate Baltimore case in the fourth quarter of 2006, the Maryland Court of Special
	Appeals denied Garlocks appeal from another 2005 verdict. The subsequent appeal of that decision
	was also denied and Garlock paid that verdict in the second quarter of 2007. At December 31, 2008,
	four Garlock appeals were pending from adverse verdicts totaling $2.2 million, up from $1.4 million
	at December 31, 2007 and down from $6.8 million at December 31, 2006.
	     In some cases, appeals require the provision of security in the form of appeal bonds,
	potentially in amounts greater than the verdicts. The Company is required to provide cash
	collateral or letters of credit to secure the full amount of the bonds, which can restrict the use
	of a significant amount of the Companys cash for the periods of such appeals. At December 31,
	2008, the Company had approximately $1.7 million of appeal bonds secured by letters of credit
	rather than cash collateral. This amount securing appeal bonds compares to $1.1 million at
	December 31, 2007 and $1.3 million at December 31, 2006. In 2007 and 2006, the cash collateral
	relating to appeal bonds was recorded as restricted cash on the Companys Consolidated Balance
	Sheet.
	     
	Settlements
	. Garlock settles and disposes of actions on a regular basis. Garlocks
	historical settlement strategy was to settle only cases in advanced stages of litigation. In 1999
	and 2000, however, Garlock employed a more aggressive settlement strategy. The purpose of this
	strategy was to achieve a permanent reduction in the number of overall asbestos claims through the
	settlement of a large number of claims, including some early-stage claims and some claims not yet
	filed as lawsuits. Due to this short-term aggressive settlement strategy and a significant overall
	increase in claims filings, the settlement amounts paid in those years and several subsequent years
	were greater than the amounts paid in any year prior to 1999. In 2001, Garlock resumed its
	historical settlement strategy and focused on reducing settlement commitments to match insurance
	recoveries. As a result, Garlock reduced new settlement commitments from $180 million in 2000 to
	$94 million in 2001 and $86 million in 2002. New settlement commitments totaled $84 million in
	2006, $76 million in 2007 and $71 million in 2008. Approximately $15 million of the 2006 amount
	and approximately $5 million of the 2007 amount were committed in settlements to pay verdicts that
	had been rendered in the years 2003  2005.
	     Settlements are made without any admission of liability. Settlement amounts vary depending
	upon a number of factors, including the jurisdiction where the action was brought, the nature and
	extent of the disease alleged and the associated medical evidence, the age and occupation of the
	plaintiff, the
	85
 
	presence or absence of other possible causes of the plaintiffs alleged illness, alternative
	sources of payment available to the plaintiff, the availability of legal defenses, and whether the
	action is an individual one or part of a group.
	     Before any payment on a settled claim is made, the claimant is required to submit a medical
	report acceptable to Garlock substantiating the asbestos-related illness and meeting specific
	criteria of disability. In addition, sworn testimony or other evidence that the claimant worked
	with or around Garlock asbestos-containing products is required. The claimant is also required to
	sign a full and unconditional release of Garlock, its subsidiaries, parent, officers, directors,
	affiliates and related parties from any liability for asbestos-related injuries or claims.
	     
	Status of Anchor
	. Anchor is an inactive and insolvent indirect subsidiary of Coltec.
	There is no remaining insurance coverage available to Anchor. Anchor has no remaining assets and
	has not committed to settle any actions since 1998. As cases reach the trial stage, Anchor is
	typically dismissed without payment.
	     
	Insurance Coverage
	. At December 31, 2008, Garlock had available $307.4 million of
	insurance and trust coverage that the Company believes will be
	available to cover current and future asbestos
	claims and certain expense payments. The Company believes that
	Garlock may also recover some additional insurance from insolvent
	carriers over time. Garlock collected approximately $0.1 million
	and $1.0 million, respectively, from insolvent carriers in 2008 and 2007. There can be no
	assurance that Garlock will collect any additional insurance from
	insolvent carriers.
	     Of the $307.4 million of collectible insurance and trust assets, the Company considers $295.8
	million (96%) to be of high quality because (a) the insurance policies are written or guaranteed by
	U.S.-based carriers whose credit rating by S&P is investment grade (BBB) or better, and whose AM
	Best rating is excellent (A-) or better, or (b) in the form of cash or liquid investments held in
	insurance trusts resulting from commutation agreements. The Company considers $11.6 million (4%)
	to be of moderate quality because the insurance policies are written with (a) other solvent U.S.
	carriers who are unrated or below investment grade ($7.8 million) or (b) with various London market
	carriers ($3.8 million). Of the $307.4 million, $228.7 million is allocated to claims that have
	been paid by Garlock and submitted to its insurance companies for reimbursement and the remainder
	is allocated to pending and estimated future claims as described later in this section.
	     Arrangements with Garlocks insurance carriers limit the amount of insurance proceeds that
	Garlock is entitled to receive in any one year. Based on these arrangements, which include
	settlement agreements in place with most of the carriers involved, the Company anticipates that its
	remaining solvent insurance will be collected during the period 2009 through 2018 in approximately
	the following annual amounts: 2009 and 2010  $67 million per year; 2011  $40 million; 2012 and
	2013  $25 million per year; 2014 through 2016  $20 million per year; and 2017 and 2018  $12
	million per year. The Company collected $73 million of insurance in 2008.
	     During the fourth quarter of 2006, the Company reached an agreement with a significant group
	of related U.S. insurers. These insurers had withheld payments pending resolution of a dispute.
	The agreement provides for the payment of the full amount of the insurance policies ($194 million)
	in various annual payments to be made from 2007 through 2018. Under the agreement, Garlock
	received $20 million in 2008 and $22 million in 2007.
	86
 
	     In May 2006, the Company reached agreement with a U.S. insurer that resolved two lawsuits and
	an arbitration proceeding. Pursuant to the settlement, Garlock received $3 million in 2008, $3
	million in 2007 and $4 million in 2006 and is scheduled to receive another $11 million in the
	future.
	     In the second quarter of 2004, the Company reached agreement with Equitas, the London-based
	entity responsible for the pre-1993 Lloyds of London policies in the Companys insurance block,
	concerning settlement of its exposure to the Companys subsidiaries asbestos claims. As a result
	of the settlement, $88 million was placed in an independent trust. In the fourth quarter of 2004,
	the Company reached agreement with a group of London market carriers (other than Equitas) and one
	of its U.S. carriers that has some policies reinsured through the London market. As a result of
	the settlement, $55.5 million was placed in an independent trust. At December 31, 2008, the
	aggregate market value of the funds remaining in the two trusts was $20.6 million, which was
	included in the $307.4 million of insurance and trust coverage available to pay future
	asbestos-related claims and expenses.
	     Insurance coverage for asbestos claims is not available to cover exposures initially occurring
	on and after July 1, 1984. Although Garlock and Anchor continue to be named as defendants in new
	actions, only a few allege initial exposure after July 1, 1984. To date, no payments have been
	made with respect to these few claims, pursuant to a settlement or otherwise. Garlock and Anchor
	believe that they have substantial defenses to these claims and therefore automatically reject them
	for settlement. However, there can be no assurance that any or all of these defenses will be
	successful in the future.
	     
	The Companys Liability Estimate
	. Prior to mid-2004, the Company maintained that its
	subsidiaries liability for unasserted claims was not reasonably estimable. The Company estimated
	and recorded liabilities only for pending claims in advanced stages of processing, for which it
	believed it had a basis for making a reasonable estimate. The Company disclosed the significance
	of the total potential liability for unasserted claims in considerable detail. During 2004, the
	Company authorized counsel to retain Bates White to assist in estimating the Companys
	subsidiaries liability for pending and future asbestos claims.
	     Bates Whites first report, dated February 17, 2005, provided an estimate of the liability as
	of December 31, 2004 for the following ten years, which represented a time horizon within which
	Bates White believed such liability was both probable and estimable within a range of values.
	Bates White has updated its estimate every quarter since the end of 2004.
	     Each quarter until the fourth quarter of 2006, the Company adopted the Bates White estimate
	and adjusted the liability to equal the low end of the then-current range. Until the second
	quarter of 2006, the additional liability was recorded with a corresponding increase in the
	Companys insurance receivable, and thus did not affect net income. During the second quarter of
	2006, however, the Companys
	87
 
	insurance was fully allocated to past, present and future claims, and therefore subsequent
	changes to the Bates White estimate were recorded as charges to income.
	     The estimated range of potential liabilities provided by Bates White at December 31, 2008 was
	$431 million to $627 million. According to Bates White, increases in the range over time have been
	attributable primarily to (1) the propensity to sue Garlock, (2) an increase in settlement values
	of mesothelioma claims, (3) an increase in claims filings and values in some jurisdictions, most
	notably California, and (4) the delay in, and uncertain impact of, the funding and implementation
	of trusts formed under Section 524(g) of the United States Bankruptcy Code to pay asbestos claims
	against numerous defendants in Chapter 11 reorganization cases. Because the 524(g) trusts are
	estimated by some, including Bates White, to have billions of dollars available for the payment of
	asbestos claims, they could have a significant impact on the Companys future settlement payments
	and could therefore significantly affect its liability.
	     The Company has independently developed internal estimates for asbestos-related liabilities.
	It has used those estimates for a variety of purposes, including guidance for settlement
	negotiations and trial strategy, in its strategic planning, budgeting and cash flow planning
	processes, and in setting targets for annual and long-term incentive compensation. The Companys
	internal estimate has been within the Bates White range of equally likely estimates and has proven
	to be a more precise predictor of the actual amounts spent on settlements and verdicts than the low
	end of the Bates White range. As a result, while the low end of the Bates White range still
	provides a reasonable lower boundary of possible outcomes, Bates White and management believe that
	the Companys internal estimate for the next ten years represents the most likely point within the
	range. Accordingly, the Company adjusted the recorded liability from the low end of the Bates
	White estimate to its point estimate in the fourth quarter of 2006 and has adjusted the liability
	in each subsequent quarter consistent with its internal estimate.
	     The Company focuses on future cash flows to prepare its estimate. It makes assumptions about
	future asbestos spending based on (1) past trends, (2) publicly available epidemiological data, (3)
	current agreements with plaintiff firms and managements judgment about the current and future
	litigation environment, (4) the availability to claimants of other payment sources, both
	co-defendants and the 524(g) trusts, (5) the Companys remaining available insurance; (6) general
	developments in the asbestos litigation; and (7) the input and insight provided to the Company by
	Bates White. The Company adjusts its estimate when current cash flow results and long-term trends
	suggest that its targets cannot be met. As a result, the Company has a process that it believes
	produces the best estimate of the future liability for the ten-year time period within the Bates
	White range.
	     The Company currently estimates that the liability of its subsidiaries for the indemnity cost
	of resolving asbestos claims for the next ten years will be $458.7 million. The estimated
	liability of $458.7 million is before any tax benefit and is not discounted to present value, and
	it does not include fees and expenses, which are recorded as incurred. The recorded liability will
	continue to be impacted by actual claims and settlement experience and any change in the legal
	environment that could cause a significant increase or decrease in the long-term expectations of
	management and Bates White. The Company expects the recorded liability to fluctuate, perhaps
	significantly. Any significant change in the estimated liability could have a material effect on
	the Companys consolidated financial position and results of operations.
	     The Companys estimate is within the Bates White range, developed independently, and the
	Company believes that its estimate is the best estimate within the Bates White range of reasonable
	and probable estimates of Garlocks future obligation.
	     Bates White also indicated a broader range of potential estimates from $189 million to $711
	million. The Company cautions that points within that broader range remain possible outcomes.
	Also, while the Company agrees with Bates White that beyond two to four years for Garlocks
	economically-driven non-malignant claims and beyond ten years for Garlocks cancer claims and
	medically-driven non-malignant claims, there are reasonable scenarios in which the [asbestos]
	expenditure is
	de minimus
	, it cautions that the process of estimating future liabilities is highly
	uncertain. Adjusting the Companys liability to the best estimate within the range does not change
	that fact. In the words of the Bates White report, the reliability of estimates of future
	probable expenditures of Garlock for asbestos-related personal injury claims declines significantly
	for each year further into the future. Scenarios continue to exist that could result in a total
	future asbestos liability for Garlock in excess of $1 billion.
	     As previously mentioned, the liability estimate does not include legal fees and expenses,
	which add considerably to the costs each year. Over the last two years, these expenses have
	averaged
	88
 
	approximately $7 million per quarter. In addition to these legal fees and expenses, the
	Company expects to continue to record charges to income in future quarters for:
|  |  |  | Increases or decreases, if any, in the Companys estimate of Garlocks potential
	liability, plus | 
|  | 
|  |  |  | Increases, if any, that result from additional quarters added to maintain the
	ten-year estimation period (increases of this type have averaged approximately $6  7
	million per quarter for the last two years), plus | 
|  | 
|  |  |  | Amounts, if any, of solvent insurance lost or commuted, offset by insolvent
	recoveries and earnings from insurance settlement trusts. | 
 
	     In 2008, the Company recorded a pre-tax charge of $52.1 million to reflect net cash outlays of
	$26.2 million for legal fees and expenses paid during the year and a $25.9 million non-cash charge.
	The non-cash charge included $23.8 million, primarily to add an estimate of the liability for 2018
	to maintain a ten-year estimate and $2.1 million to reduce the remaining insurance estimated to be
	available from remaining policies with various London market carriers.
	     In 2007, the Company recorded a pre-tax charge to income of $68.4 million to reflect net cash
	outlays of $25.8 million for legal fees and expenses incurred during the year, and a $42.6 million
	non-cash charge. The non-cash charge included $23.2 million related to the addition of periods to
	maintain a ten-year liability estimate and $19.4 million to adjust the liability based on revisions
	to managements estimate in the fourth quarter of 2007. The Company made this adjustment based on
	its review of negotiations and payment trends and its belief that it is more likely that, in the
	future, a higher percentage of settlement commitments made in any year will also be paid in that
	same year.
	     
	Quantitative Claims and Insurance Information
	. The Companys liability as of December
	31, 2008 was $465.5 million (the Companys estimate of the liability described above of $458.7
	million plus $6.8 million of accrued legal and other fees already incurred but not yet paid). The
	liability included $85.3 million classified as a current liability and $380.2 million classified as
	a noncurrent liability. The recorded amounts do not include legal fees and expenses to be incurred
	in the future.
	     As of December 31, 2008, the Company had remaining insurance and trust coverage of $307.4
	million which is reflected on its balance sheet as a receivable ($67.9 million classified in
	current assets and $239.5 classified in non-current assets), which it believes will be available
	for the payment of asbestos-related claims. Included in the receivable is $228.7 million in
	insured claims and expenses that our subsidiaries have paid out in excess of amounts recovered from
	insurance. These amounts are recoverable under the terms of the Companys insurance policies and
	have been billed to the insurance carriers. The remaining $78.7 million will be available for
	pending and future claims.
	     The table below quantitatively depicts the number of pending cases, asbestos-related cash
	flows, the amount that the Company expects Garlock to recover from insurance related to this
	liability, and an analysis of the liability.
	89
 
|  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | As of and for the |  | 
|  |  | Year Ended |  | 
|  |  | December 31, |  | 
|  |  | 2008 |  |  | 2007 |  |  | 2006 |  | 
| 
	Pending Cases (1)
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	New actions filed during period
 |  |  | 5,500 |  |  |  | 5,200 |  |  |  | 7,700 |  | 
| 
	Open actions at period-end
 |  |  | 104,100 |  |  |  | 105,700 |  |  |  | 106,500 |  | 
| 
	Cash Flow (dollars in millions)
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Payments (2)
 |  | $ | (109.7 | ) |  | $ | (115.1 | ) |  | $ | (125.7 | ) | 
| 
	Insurance recoveries (3)
 |  |  | 72.7 |  |  |  | 90.2 |  |  |  | 87.7 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Net cash flow
 |  | $ | (37.0 | ) |  | $ | (24.9 | ) |  | $ | (38.0 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Solvent Insurance and Trust Assets (dollars in millions)
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Insurance receivable for previously paid claims (4)
 |  | $ | 228.7 |  |  | $ | 252.0 |  |  | $ | 251.2 |  | 
| 
	Insurance available for pending and future claims
 |  |  | 78.7 |  |  |  | 129.5 |  |  |  | 216.9 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Remaining solvent insurance and trust assets
 |  | $ | 307.4 |  |  | $ | 381.5 |  |  | $ | 468.1 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Liability Analysis (dollars in millions)
 |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Liability for pending and future claims (5)(6)
 |  | $ | 465.5 |  |  | $ | 524.4 |  |  | $ | 567.9 |  | 
| 
	Insurance available for pending and future claims
 |  |  | 78.7 |  |  |  | 129.5 |  |  |  | 216.9 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Liability in excess of insurance coverage (6)
 |  |  | 386.8 |  |  |  | 394.9 |  |  |  | 351.0 |  | 
| 
	Insurance receivable for previously paid claims
 |  |  | 228.7 |  |  |  | 252.0 |  |  |  | 251.2 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
| 
	Liability in excess of anticipated insurance collections (6)
 |  | $ | 158.1 |  |  | $ | 142.9 |  |  | $ | 99.8 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  | 
 
|  |  |  | 
| (1) |  | Includes actions actually filed with a court of competent jurisdiction. Each action in which
	both Garlock and one or more other of our subsidiaries is named as a defendant is shown as a
	single action. Multiple actions filed on behalf of the same plaintiff in multiple
	jurisdictions are also counted as one action. Claims not filed as actions in court but that
	are submitted and paid as part of previous settlements (approximately 800 in 2008, 900 in 2007
	and 700 in 2006) are not included. | 
|  | 
| (2) |  | Includes all payments for judgments, settlements, fees and expenses made in the period. | 
|  | 
| (3) |  | Includes all recoveries from insurance received in the period. | 
|  | 
| (4) |  | Includes previous payments for which Garlock is entitled to receive corresponding insurance
	recoveries but has not received payment, in large part due to annual limits imposed under
	insurance arrangements. | 
|  | 
| (5) |  | The liability represents managements best estimate of the future payments for the following
	ten-year period. Amounts shown include $6.8 million, $5.4 million and $6.9 million at
	December 31, 2008, 2007 and 2006, respectively, of accrued fees and expenses for services
	previously rendered but unpaid. | 
|  | 
| (6) |  | Does not include fees and expenses to be incurred in the future, which are recorded as a
	charge to income when incurred. | 
	90
 
	     
	Other Commitments
	     The Company has several operating leases primarily for real estate, equipment and vehicles.
	Operating lease arrangements are generally utilized to secure the use of assets if the terms and
	conditions of the lease or the nature of the asset makes the lease arrangement more favorable than
	a purchase. Future minimum lease payments by year and in the aggregate, under noncancelable
	operating leases with initial or remaining noncancelable lease terms in excess of one year,
	consisted of the following at December 31, 2008:
|  |  |  |  |  | 
|  |  | (in millions) |  | 
| 
	 
 |  |  |  | 
| 
	2009
 |  | $ | 13.0 |  | 
| 
	2010
 |  |  | 10.7 |  | 
| 
	2011
 |  |  | 9.5 |  | 
| 
	2012
 |  |  | 7.9 |  | 
| 
	2013
 |  |  | 6.6 |  | 
| 
	Thereafter
 |  |  | 9.6 |  | 
| 
	 
 |  |  |  | 
| 
	Total minimum payments
 |  | $ | 57.3 |  | 
| 
	 
 |  |  |  | 
 
	     Net rent expense was $15.5 million, $12.0 million and $10.8 million for the years ended
	December 31, 2008, 2007 and 2006, respectively.
	18. Subsequent Event
	     In February the Company purchased PTM (UK) Limited, a privately-owned manufacturer and
	distributor of sealing products with two locations in the United Kingdom. The acquisition was paid
	for in cash and will be included in the Companys Sealing Products segment.
	91
 
	19. Selected Quarterly Financial Data (Unaudited)
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | First Quarter |  |  | Second Quarter |  |  | Third Quarter |  |  | Fourth Quarter |  | 
| (in millions, except per share data) |  | 2008 |  |  | 2007 |  |  | 2008 |  |  | 2007 |  |  | 2008 |  |  | 2007 |  |  | 2008 |  |  | 2007 |  | 
| 
	Net sales
 |  | $ | 283.1 |  |  | $ | 247.3 |  |  | $ | 316.8 |  |  | $ | 254.4 |  |  | $ | 278.6 |  |  | $ | 252.7 |  |  | $ | 289.3 |  |  | $ | 275.6 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Gross profit
 |  | $ | 103.5 |  |  | $ | 88.5 |  |  | $ | 115.0 |  |  | $ | 91.4 |  |  | $ | 98.9 |  |  | $ | 89.5 |  |  | $ | 89.9 |  |  | $ | 90.6 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Income (loss) before extraordinary
	Item
 |  | $ | 13.2 |  |  | $ | 12.3 |  |  | $ | 21.1 |  |  | $ | 13.8 |  |  | $ | 13.1 |  |  | $ | 12.3 |  |  | $ | 6.1 |  |  | $ | (0.7 | ) | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Extraordinary item, net of taxes
 |  | $ |  |  |  | $ |  |  |  | $ |  |  |  | $ |  |  |  | $ |  |  |  | $ |  |  |  | $ |  |  |  | $ | 2.5 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Net income (loss)
 |  | $ | 13.2 |  |  | $ | 12.3 |  |  | $ | 21.1 |  |  | $ | 13.8 |  |  | $ | 13.1 |  |  | $ | 12.3 |  |  | $ | 6.1 |  |  | $ | 1.8 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Basic earnings (loss) per share:
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Income (loss) before
	extraordinary item
 |  | $ | 0.63 |  |  | $ | 0.58 |  |  | $ | 1.05 |  |  | $ | 0.65 |  |  | $ | 0.66 |  |  | $ | 0.58 |  |  | $ | 0.31 |  |  | $ | (0.04 | ) | 
| 
	Extraordinary item
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.12 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Net income (loss)
 |  | $ | 0.63 |  |  | $ | 0.58 |  |  | $ | 1.05 |  |  | $ | 0.65 |  |  | $ | 0.66 |  |  | $ | 0.58 |  |  | $ | 0.31 |  |  | $ | 0.08 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Diluted earnings (loss) per share:
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Income (loss) before
	extraordinary item
 |  | $ | 0.61 |  |  | $ | 0.56 |  |  | $ | 0.99 |  |  | $ | 0.61 |  |  | $ | 0.62 |  |  | $ | 0.54 |  |  | $ | 0.30 |  |  | $ | (0.04 | ) | 
| 
	Extraordinary item
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.12 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
| 
	Net income (loss)
 |  | $ | 0.61 |  |  | $ | 0.56 |  |  | $ | 0.99 |  |  | $ | 0.61 |  |  | $ | 0.62 |  |  | $ | 0.54 |  |  | $ | 0.30 |  |  | $ | 0.08 |  | 
| 
	 
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
 
	92
 
	SCHEDULE II
	Valuation and Qualifying Accounts
	For the Years Ended December 31, 2008, 2007 and 2006
	(In millions)
	Allowance
	for Doubtful Accounts
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
|  |  | Balance, |  |  |  |  |  |  |  |  |  |  | 
|  |  | Beginning |  | Charge |  | Write-off of |  |  |  |  |  | Balance, | 
|  |  | of Year |  | to Expense |  | Receivables |  | Other (1) |  | End of Year | 
| 
	2008
 |  | $ | 3.6 |  |  | $ | 1.8 |  |  | $ | (0.7 | ) |  | $ | 0.2 |  |  | $ | 4.9 |  | 
| 
	2007
 |  | $ | 2.8 |  |  | $ | 0.8 |  |  | $ | (0.6 | ) |  | $ | 0.6 |  |  | $ | 3.6 |  | 
| 
	2006
 |  | $ | 2.8 |  |  | $ | 1.2 |  |  | $ | (1.4 | ) |  | $ | 0.2 |  |  | $ | 2.8 |  | 
 
|  |  |  | 
| (1) |  | Consists primarily of acquisitions and the effect of changes in currency rates. | 
	93
 
	Exhibit 10.13
	MANAGEMENT CONTINUITY AGREEMENT
	     
	THIS AGREEMENT
	dated as of this 14
	th
	day of April 2008 between Stephen E. Macadam
	(the Executive) and EnPro Industries, Inc., a North Carolina corporation (the Company).
	     
	WHEREAS,
	the Company considers it essential to the best interests of its shareholders to
	foster the continuous employment of key management personnel in the event there is, or is
	threatened, a change in control of the Company; and
	     
	WHEREAS
	, the Company recognizes that the uncertainty and questions which may arise among key
	management in connection with the possibility of a change in control may result in the departure or
	distraction of key management personnel to the detriment of the Company and its shareholders; and
	     
	WHEREAS
	, the Company desires to provide certain protection to Executive in the event of a
	change in control of the Company as set forth in this Agreement in order to induce Executive to
	remain in the employ of the Company notwithstanding any risks and uncertainties created by the
	possibility of a change in control of the Company;
	WITNESSETH:
	     
	NOW, THEREFORE
	, in consideration of the foregoing and the mutual promises herein contained,
	the parties agree as follows:
	     1. 
	Term
	. The Term of this Agreement shall mean the period commencing on the date
	hereof and ending thirty-six (36) months after such date; provided, however, that commencing on the
	date one year after the date hereof, and on each annual anniversary of such date (such date and
	each annual anniversary thereof shall be hereinafter referred to as the Renewal Date), the Term
	shall be automatically extended so as to terminate thirty-six (36) months from such Renewal Date,
	unless at least sixty (60) days prior to the Renewal Date the Company shall give notice to the
	Executive that the Term shall not be so extended.
	     2. 
	Period of Employment
	. Executives Period of Employment shall commence on the
	date on which a Change in Control occurs during the Term and shall end on the date that is
	thirty-six (36) months after the date on which such Change in Control occurs (subject to the
	provisions of Section 20 below pursuant to which the Period of Employment may be deemed to have
	commenced prior to the date of a Change in Control in certain circumstances).
	     3. 
	Certain Definitions
	. For purposes of this Agreement:
	     Board shall mean the Board of Directors of the Company.
	     Cause shall mean Executives termination of employment with the Company due to (A)
	the willful and continued failure by Executive to substantially perform Executives duties
	with the Company, which failure causes material and demonstrable injury to the Company
	(other than any such failure resulting from Executives incapacity due to physical or mental
	illness), after a demand for substantial performance is delivered
 
	 
	to Executive by the Board which specifically identifies the manner in which the Board
	believes that Executive has not substantially performed Executives duties, and after
	Executive has been given a period (hereinafter known as the Cure Period) of at least
	thirty (30) days to correct Executives performance, or (B) the willful engaging by
	Executive in other gross misconduct materially and demonstrably injurious to the Company.
	For purposes hereof, no act, or failure to act, on Executives part shall be considered
	willful unless conclusively demonstrated to have been done, or omitted to be done, by
	Executive not in good faith and without reasonable belief that Executives action or
	omission was in the best interests of the Company. Notwithstanding the foregoing, Executive
	shall not be deemed to have been terminated for Cause unless and until there shall have been
	delivered to Executive a Notice of Termination which shall include a copy of a resolution
	duly adopted by the affirmative vote of not less than three-quarters of the entire
	membership of the Board at a meeting of the Board called and held for the purpose (after
	reasonable notice to Executive and an opportunity for Executive, together with Executives
	counsel, to be heard before the Board), finding that in the good faith opinion of the Board
	Executive was guilty of conduct set forth above in clause (A) (including the expiration of
	the Cure Period without the correction of Executives performance) or clause (B) above and
	specifying the particulars thereof in detail.
	     Change in Control shall mean:
	     (i) The acquisition by any individual, entity or group (within the meaning of Section
	13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the Exchange
	Act)), of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the
	Exchange Act) of 20% or more of either (A) the then outstanding shares of common stock of
	the Company (the Outstanding Company Common Stock) or (B) the combined voting power of the
	then outstanding voting securities of the Company entitled to vote generally in the election
	of directors (the Outstanding Company Voting Securities); provided, however, that the
	following acquisitions shall not constitute a Change in Control: (A) any acquisition
	directly from the Company (other than by exercise of a conversion privilege), (B) any
	acquisition by the Company or any of its subsidiaries, (C) any acquisition by any employee
	benefit plan (or related trust) sponsored or maintained by the Company or any of its
	subsidiaries or (D) any acquisition by any company with respect to which, following such
	acquisition, more than 70% of, respectively, the then outstanding shares of common stock of
	such company and the combined voting power of the then outstanding voting securities of such
	company entitled to vote generally in the election of directors is then beneficially owned,
	directly or indirectly, by all or substantially all of the individuals and entities who were
	the beneficial owners, respectively, of the Outstanding Company Common Stock and Outstanding
	Company Voting Securities immediately prior to such acquisition in substantially the same
	proportions as their ownership, solely in their capacity as shareholders of the Company,
	immediately prior to such acquisition, of the Outstanding Company Common Stock and
	Outstanding Company Voting Securities, as the case may be; or (ii) individuals who, as of
	the Distribution Date (as such term is defined in the Distribution Agreement among Goodrich
	Corporation, EnPro Industries, Inc. and Coltec Industries Inc.), constitute the Board (the
	Incumbent Board) cease for any reason to constitute at least a majority of the Board;
	provided, however, that any individual becoming a director subsequent to the Distribution
	Date whose election, or nomination for election by the Companys shareholders, was approved
	by a vote of at least a majority of the directors then comprising the Incumbent Board shall
	be considered as though such
	2
 
	 
	individual were a member of the Incumbent Board, but excluding, for this purpose, any
	such individual whose initial assumption of office occurs as a result of either an actual or
	threatened election contest; or (iii) consummation of a reorganization, merger or
	consolidation, in each case, with respect to which all or substantially all of the
	individuals and entities who were the beneficial owners, respectively, of the Outstanding
	Company Common Stock and Outstanding Company Voting Securities immediately prior to such
	reorganization, merger or consolidation, do not, following such reorganization, merger or
	consolidation, beneficially own, directly or indirectly, solely in their capacity as
	shareholders of the Company, more than 70% of, respectively, the then outstanding shares of
	common stock and the combined voting power of the then outstanding voting securities
	entitled to vote generally in the election of directors, as the case may be, of the company
	resulting from such reorganization, merger or consolidation in substantially the same
	proportions as their ownership, immediately prior to such reorganization, merger or
	consolidation of the Outstanding Company Common Stock and Outstanding Company Voting
	Securities, as the case may be; or (iv) consummation of (A) a complete liquidation or
	dissolution of the Company or (B) a sale or other disposition of all or substantially all of
	the assets of the Company, other than to a company, with respect to which following such
	sale or other disposition, more than 70% of, respectively, the then outstanding shares of
	common stock of such company and the combined voting power of the then outstanding voting
	securities of such company entitled to vote generally in the election of directors is then
	beneficially owned, directly or indirectly, by all or substantially all of the individuals
	and entities, solely in their capacity as shareholders of the Company, who were the
	beneficial owners, respectively, of the Outstanding Company Common Stock and Outstanding
	Company Voting Securities immediately prior to such sale or other disposition in
	substantially the same proportion as their ownership, immediately prior to such sale or
	other disposition, of the Outstanding Company Common Stock and Outstanding Company Voting
	Securities, as the case may be.
	     Date of Termination is as defined in Section 8 below.
	     Good Reason shall mean:
	     (i) without Executives express written consent, (A) the assignment to Executive of any
	new duties or responsibilities substantially inconsistent in character with Executives
	duties and responsibilities within the Company immediately prior to a Change in Control, (B)
	any substantial adverse change in Executives duties and responsibilities as in effect
	immediately prior to a Change in Control, including, but not limited to, a reduction in
	duties or responsibilities which occurs because the Company is no longer an independent
	publicly-held entity, (C) any removal of Executive from or any failure to re-elect Executive
	to any director position of the Company, (D) a change in the annual or long term incentive
	plan in which Executive currently participates such that Executives opportunity to earn
	incentive compensation is impaired, (E) a material reduction in the aggregate value of
	Company perquisites made available to Executive, (F) an elimination or material impairment
	of Executives ability to participate in retirement plans comparable to those in which
	Executive currently participates, (G) any substantial increase in Executives obligation to
	travel on the Companys business over Executives present business travel obligations, or
	(H) an elimination or material impairment of Executives ability to receive stock options
	with values comparable to those Executive was granted within the one year period preceding
	the commencement of the Period of Employment; (ii) the failure of the Company to comply
	with any other of its obligations
	3
 
	 
	under Section 4 herein; (iii) the relocation of the offices of the Company at which
	Executive was employed immediately prior to the Change in Control to a location which is
	more than fifty (50) miles from such prior location, or the failure of the Company to (A)
	pay or reimburse Executive, in accordance with the Companys relocation policy for its
	employees in existence immediately prior to a Change in Control, for all reasonable costs
	and expenses; plus gross ups referred to in such policy incurred by Executive relating to
	a change of Executives principal residence in connection with any relocation of the
	Companys offices to which Executive consents, and (B) indemnify Executive against any loss
	(defined as the difference between the actual sale price of such residence and the higher of
	(1) Executives aggregate investment in such residence or (2) the fair market value of such
	residence as determined by the relocation management organization used by the Company
	immediately prior to the Change in Control (or other real estate appraiser designated by
	Executive and reasonably satisfactory to the Company)) realized in the sale of Executives
	principal residence in connection with any such change of residence; (iv) the failure of
	the Company to obtain the assumption of and the agreement to perform this Agreement by any
	successor as contemplated in Section 11 hereof; or (v) any purported termination of
	Executives employment during the Period of Employment which is not effected pursuant to a
	Notice of Termination satisfying the requirements of Section 7 hereof.
	     Incapacity Discharge means Executives termination of employment with the Company if,
	as a result of Executives incapacity due to physical or mental illness, Executive shall
	have been absent from Executives duties with the Company on a full-time basis for
	one-hundred twenty (120) consecutive business days, and within thirty (30) days after a
	written Notice of Termination is given, Executive shall not have returned to the full-time
	performance of Executives duties.
	     Mandatory Retirement Date shall mean the compulsory retirement date, if any,
	established by the Company for those executives of the Company who, by reason of their
	positions and the size of their nonforfeitable annual retirement benefits under the
	Companys pension, profit-sharing, and deferred compensation plans, are exempt from, the
	provisions of the Age Discrimination in Employment Act, 29 U.S.C. Sections 621, et seq.,
	which date shall not in any event be earlier for any executive than the last day of the
	month in which such Executive reaches age 65.
	     Notice of Termination is as defined in Section 7 below.
	     Payment Period shall mean thirty-six (36) months, provided that the Payment Period
	shall not exceed the number of whole calendar months between the Executives Date of
	Termination and Mandatory Retirement Date (if applicable).
	     4. 
	Compensation During Period of Employment
	. For so long during Executives Period of
	Employment as Executive is an employee of the Company, the Company shall be obligated to compensate
	Executive as follows:
	     (a) Executive shall continue to receive Executives full base salary at the rate in
	effect immediately prior to the Change in Control. Executives base salary shall be
	increased annually, with each such increase due on the anniversary date of Executives most
	recent previous increase. Each such increase shall be no less than an amount which
	4
 
	 
	at least equals on a percentage basis the mean of the annualized percentage increases
	in base salary for all elected officers of the Company during the two full calendar years
	immediately preceding the Change in Control.
	     (b) Executive shall continue to participate in all benefit and compensation plans
	(including but not limited to the Equity Compensation Plan, Long-Term Incentive Program,
	Performance Share Deferred Compensation Plan, Annual Performance Plan, Executive Life
	Insurance Program, Deferred Compensation Plan, 401(K) plan, savings plan, flexible benefits
	plan, life insurance plan, health and accident plan or disability plan) in which Executive
	was participating immediately prior to the Change in Control, or in plans providing
	substantially similar benefits, in either case upon terms and conditions and at levels at
	least as favorable as those provided to Executive under the plans in which Executive was
	participating immediately prior to the Change in Control;
	     (c) Executive shall continue to receive all fringe benefits, perquisites, and similar
	arrangements which Executive was entitled to receive immediately prior to the Change in
	Control; and
	     (d) Executive shall continue to receive annually the number of paid vacation days and
	holidays Executive was entitled to receive immediately prior to the Change in Control.
	     5. 
	Compensation Upon Termination of Employment
	. The following provisions set forth
	the benefits that may become payable to Executive upon termination of employment with the Company
	during the Period of Employment in accordance with, and subject to, the provisions of Section 6
	below:
	     (a) By not later than the fifth business day following the Date of Termination, the
	Company shall pay Executive in a lump sum an amount equal to the sum of the following:
	     (i) any base salary that is earned but unpaid as of the Date of Termination;
	     (ii) a pro rata portion of the target incentive amount under the Annual
	Performance Plan for the calendar year in which the Date of Termination occurs
	(based on the number of calendar days in such calendar year completed through the
	Date of Termination); and
	     (iii) a pro rata portion of the calculated market value of the phantom
	Performance Shares, if any, awarded to Executive under the Companys Long-Term
	Incentive Program (the LTIP) for each Plan Cycle under the LTIP that has not been
	completed as of the Date of Termination, determined as follows:
	     (A) The performance for each such Plan Cycle under the applicable LTIP
	award agreement shall be determined based on (x) for any completed calendar
	year of the Plan Cycle as of the Date of Termination, actual performance for
	the calendar year, (y) for the calendar year in which the Date of
	Termination occurs if at least one calendar quarter has been completed
	during such calendar year, the greater of target
	5
 
	 
	performance for the calendar year or actual performance for the
	completed calendar quarter(s) for the calendar year annualized for the year,
	and (z) for any other calendar years of the Plan Cycle, target performance
	for the calendar year.
	     (B) The number of phantom Performance Shares for each such Plan Cycle
	shall be adjusted in accordance with the formula set forth in the applicable
	LTIP award agreement based on the performance for the Plan Cycle determined
	under paragraph (A) above.
	     (C) The pro rata portion of the calculated market value of the
	number of phantom Performance Shares adjusted in accordance with paragraph
	(B) above shall be based on the number of calendar days in the Plan Cycle
	completed through the Date of Termination.
	Section 5(c) below sets for the method for determining the target incentive amount under
	the Annual Performance Plan and the calculated market value of phantom Performance Shares
	under the LTIP. Any amounts payable under Sections 5(a)(ii) or (iii) above shall be offset
	dollar-for-dollar by any pro rata payments otherwise provided for under the Annual
	Performance Plan or the LTIP.
	     (b) In lieu of any salary payments that Executive would have received if he had
	continued in the employment of the Company during the Payment Period, the Company shall pay
	to Executive in a lump sum, by not later than the fifth business day following the Date of
	Termination, an amount equal to one-twelfth of Executives annualized base salary in effect
	immediately prior to the Date of Termination, multiplied by the number of months in the
	Payment Period.
	     (c) By not later than the fifth day following the Date of Termination, the Company
	shall pay Executive in a lump sum an amount equal to the sum of:
	     (i) under the Annual Performance Plan (and in lieu of any further awards under
	the Annual Performance Plan that Executive would have received if he had continued
	in the employment of the Company during the Payment Period), the number of months in
	the Payment Period multiplied by the greatest of one-twelfth of: (A) the amount most
	recently paid to Executive for a full calendar year; (B) Executives target
	incentive amount for the calendar year in which his Date of Termination occurs; or
	(C) Executives target incentive amount in effect prior to the Change in Control
	for the calendar year in which the Change in Control occurs; plus, if applicable,
	     (ii) under the LTIP (and in lieu of any further grants under the LTIP that
	Executive would have received if he had continued in the employment of the Company
	during the Payment Period), twenty-four (24) multiplied by the greatest of: (A) with
	respect to the most recently completed Plan Cycle as of the Date of Termination,
	one-twelfth of the calculated market value of the Performance Shares actually
	awarded Executive (including the value of any Performance Shares Executive may have
	elected to defer under the Performance Share Deferred Compensation Program); (B)
	with respect to the most recently
	6
 
	 
	commenced Plan Cycle under the LTIP (if Executive is a participant in such Plan
	Cycle) prior to Executives Date of Termination, one-twelfth of the calculated
	market value of the phantom Performance Shares, if any, awarded to Executive; or
	(C) with respect to the most recently commenced Plan Cycle prior to the date of the
	occurrence of the Change in Control, one-twelfth of the calculated market value of
	the phantom Performance Shares, if any, awarded to Executive.
	     For purposes of this Section 5, Executives target incentive amount under the
	Annual Performance Plan for a given calendar year (i.e., the calendar year in which
	the Date of Termination occurs or the Change in Control occurs, as applicable) is
	determined by multiplying (i) Executives annualized total gross base salary for the
	calendar year by (ii) the incentive target percentage which is applicable to
	Executives incentive category under the Annual Performance Plan for the calendar
	year. For purposes of this Section 5, the calculated market value of each
	Performance Share actually awarded upon completion of a Plan Cycle, Performance
	Share deferred under the Performance Share Deferred Compensation Program or phantom
	Performance Share granted under the LTIP shall be the mean of the high and low
	prices of the Companys common stock on the relevant date as reported on the New
	York Stock Exchange Composite Transactions listing (or similar report), or, if no
	sale was made on such date, then on the next preceding day on which a sale was made
	multiplied by the number of shares involved in the calculation. The relevant date
	for Section 5(a)(iii) and clauses 5(c)(ii)(B) and 5(c)(ii)(C) is the date upon which
	the Compensation Committee (Committee) of the Board of Directors awarded the
	phantom Performance Shares in question; for clause 5(c)(ii)(A) the relevant date is
	the date on which the Committee made a determination of attainment of financial
	objectives and awarded Performance Shares (including any Performance Shares
	Executive may have elected to defer under the Performance Share Deferred
	Compensation Program).
	     Any payments received pursuant to Sections 5(c)(i) or (ii) above shall be in
	addition to, and not in lieu of, any payments required to be made to Executive as
	the result of the happening of an event that would constitute a change in control
	pursuant to the provisions of the Annual Performance Plan or LTIP, as applicable.
	     (d) By not later than the fifth day following the Date of Termination, the Company
	shall pay Executive in a lump sum an amount equal to the sum of:
	     (i) If Executive is under age 55, or over the age of 55 but not eligible to
	retire, at the Date of Termination the present value of all health and welfare
	benefits the Executive would have been entitled to had the Executive continued as an
	employee of the Company during the Payment Period and been entitled to or
	participated in the same health and welfare benefits during the Payment Period as
	immediately prior to the Date of Termination plus an amount in cash equal to the
	amount necessary to cause the amount of the aggregate after-tax lump sum payment the
	Executive receives pursuant to this provision to be equal to the aggregate after-tax
	value of the benefits which Executive would have received if Executive continued to
	receive such benefits as an employee; or
	7
 
	 
	     (ii) If Executive is age 55 or over and eligible to retire on the Date of
	Termination, the present value of the health and welfare benefits to which Executive
	would have been entitled under the Companys general retirement policies if
	Executive retired on the Date of Termination with the Company paying that percentage
	of the premium cost of the plans which it would have paid under the terms of the
	plans in effect immediately prior to the Change of Control with respect to
	individuals who retire at age 65, regardless of Executives actual age on the
	Termination Date, provided such lump sum value would be at least equal to the lump
	sum value of the benefits which would have been payable if Executive had been
	eligible to retire and had retired immediately prior to the Change in Control.
	     (e) By not later than the fifth day following the Date of Termination, the Company
	shall pay Executive in a lump sum an amount equal to the sum of the present value of the
	fringe benefit programs, perquisites (if any), and similar arrangements the Executive would
	have been entitled to receive had the Executive continued in employment with the Company for
	the Payment Period and been entitled to or participated in the same such benefits during the
	Payment Period as immediately prior to the Date of Termination. In addition and
	notwithstanding any provision of the Companys 2002 Equity Compensation Plan (or any
	comparable equity award plan of the Company) or any applicable award agreement thereunder to
	the contrary, Executive may exercise any of Executives stock options that are vested as of
	Executives Date of Termination at any time during the Payment Period (but not exceeding the
	original expiration date of the options).
	     (f) The Company shall, in addition to the benefits to which Executive is entitled under
	the retirement plans or programs sponsored by the Company or its affiliates in which
	Executive participates (including without limitation any Supplemental Executive Retirement
	Plan in which Executive participates, if applicable), pay Executive in a lump sum in cash by
	no later than the fifth day following the Date of Termination an amount equal to the
	actuarial equivalent of the retirement pension to which Executive would have been entitled
	under the terms of such retirement plans or programs had Executive accumulated additional
	years of continuous service under such plans equal in length to Executives Payment Period.
	The length of the Payment Period will be added to total years of continuous service for
	determining vesting, the amount of benefit accrual, to the age which Executive will be
	considered to be for the purposes of determining eligibility for normal or early retirement
	calculations and the age used for determining the amount of any actuarial reduction. For the
	purposes of calculating the additional benefit accrual under this paragraph, the amount of
	compensation Executive will be deemed to have received during each month of Executives
	Payment Period shall be equal to the sum of Executives annual base salary prorated on a
	monthly basis as provided for under Section 4(a) immediately prior to the Date of
	Termination (including salary increases), plus under the Companys Annual Performance Plan
	the greatest of one-twelfth of:
	     (i) the amount most recently paid to Executive for a full calendar year,
	     (ii) Executives target incentive amount for the calendar year in which
	Executives Date of Termination occurs, or
	8
 
	 
	     (iii) Executives target incentive amount in effect prior to the Change in
	Control for the calendar year in which the Change in Control occurs. Attached as
	Exhibit 1 is an illustration, not intending to be exhaustive, of examples of how
	inclusion of the Payment Period may affect the calculation of Executives retirement
	benefit.
	     (g) In no event shall any amount payable to Executive described in this Section 5 be
	considered compensation or earnings under any pension, savings or other retirement plan of
	the Company.
	     6. 
	Termination
	.
	     (a)
	Termination Without Compensation.
	If Executives employment is terminated for any
	of the following reasons, Executive shall not be entitled by virtue of this Agreement to any
	of the benefits provided in the foregoing Section 5:
	     (i) If, prior to the commencement of the Period of Employment, Executives
	employment with the Company is terminated at any time for any reason, including
	without limitation due to (A) Executives death, (B) an Incapacity Discharge, (C) a
	termination initiated by the Company with or without Cause or (D) resignation,
	retirement or other termination initiated by Executive with or without Good Reason,
	subject, however, to the provisions of Section 20 below.
	     (ii) If Executives employment with the Company is terminated during the
	Period of Employment with Cause.
	     (iii) If Executive resigns, retires or otherwise voluntarily terminates
	employment with the Company during the Period of Employment without Good Reason.
	     (b)
	Termination with Compensation.
	If Executives employment is terminated for any of
	the following reasons, Executive shall be entitled by virtue of this Agreement to the
	benefits provided in the foregoing Section 5 as follows:
	     (i) If, during the Period of Employment, the Company discharges Executive
	other than for Cause, Executive shall receive all of the benefits and payments
	provided in Section 5.
	     (ii) Executive may terminate his employment with the Company at any time
	during the Period of Employment for Good Reason (Good Reason Termination) and
	shall receive all of the benefits and payments provided in Section 5.
	     (iii) If, during the Period of Employment, Executive either (A) retires from
	employment with the Company or (B) if the Company discharges Executive due to an
	Incapacity Discharge, in either case while Executive has cause to terminate his
	employment as a Good Reason Termination (whether or not Executive has provided
	Notice of Termination to the Company pursuant to
	9
 
	 
	Section 7), Executive shall receive all of the benefits and payments provided
	in Section 5.
	     (iv) If Executive dies while employed by the Company during the Period of
	Employment while having cause to terminate his employment as a Good Reason
	Termination (whether or not Executive has provided Notice of Termination to the
	Company pursuant to Section 7), Executives beneficiary or beneficiaries named on
	Exhibit 2 to this Agreement (or Executives estate if he has not named a
	beneficiary) shall be entitled to receive those payments provided under Sections
	5(a), 5(b) and 5(c) of this Agreement in addition to any benefits that such
	beneficiaries would be entitled under any other plan, program or policy of the
	Company as a result of Executives employment with the Company.
	     (v) Executive may become eligible for the benefits and payments under Section
	5 for termination of employment prior to a Change in Control in accordance with, and
	subject to, the provisions of Section 20 below.
	     7. 
	Notice of Termination.
	Any termination of Executives employment by the Company or
	any termination by Executive as a Good Reason Termination shall be communicated by written notice
	to the other party hereto. For purposes of this Agreement, such notice shall be referred to as a
	Notice of Termination. Such notice shall, to the extent applicable, set forth the specific reason
	for termination, and shall set forth in reasonable detail the facts and circumstances claimed to
	provide a basis for termination of Executives employment under the provision so indicated.
	     8. 
	Date of Termination.
	Date of Termination shall mean:
	     (a) If Executive terminates Executives employment as a Good Reason Termination, the
	date specified in the Notice of Termination, but in no event more than sixty (60) days after
	Notice of Termination is given.
	     (b) If Executives employment is terminated with Cause, the date on which a Notice of
	Termination is given, except that the Date of Termination shall not be any date prior to the
	date on which the Cure Period expires without the correction of Executives performance (if
	applicable).
	     (c) If Executives employment pursuant to this Agreement is terminated following
	absence due to physical incapacity as an Incapacity Discharge, then the Date of Termination
	shall be thirty (30) days after Notice of Termination is given (provided that Executive
	shall not have returned to the performance of Executives duties on a full-time basis during
	such thirty (30) day period).
	     (d) A termination of employment by either the Company or by Executive shall not affect
	any rights Executive or Executives surviving spouse or beneficiaries may have pursuant to
	any other agreement or plan of the Company providing benefits to Executive, except as
	provided in such agreement or plan.
	10
 
	 
	     9. 
	Certain Additional Payments
	.
	     (a) Anything in this Agreement to the contrary notwithstanding, in the event it shall
	be determined that any payment or distribution by the Company to Executive or for
	Executives benefit (whether paid or payable or distributed or distributable pursuant to the
	terms of this Agreement or otherwise, but determined without regard to any additional
	payments required under this Section 9) (a Payment) would be subject to the excise tax
	imposed by Section 4999 (or any successor provisions) of the Internal Revenue Code of 1986,
	as amended (the Code), or any interest or penalty is incurred by Executive with respect to
	such excise tax (such excise tax, together with any such interest and penalties, is
	hereinafter collectively referred to as the Excise Tax), then Executive shall be entitled
	to receive an additional payment (a Gross-Up Payment) in an amount such that after payment
	by Executive of all taxes (including any interest or penalties imposed with respect to such
	taxes), including, without limitation, any income taxes (and any interest and penalties
	imposed with respect thereto) and Excise Tax imposed on the Gross-Up Payment, Executive
	retains an amount of the Gross-Up Payment equal to the Excise Tax imposed upon the Payments.
	     (b) Subject to the provisions of Section 9(c), all determinations required to be made
	under this Section 9, including whether and when such a Gross-Up Payment is required and the
	amount of such Gross-Up Payment and the assumptions to be utilized in arriving at such
	determination, shall be made by Ernst & Young (or their successors) (the Accounting Firm)
	which shall provide detailed supporting calculations both to the Company and to Executive
	within fifteen (15) business days of the receipt of notice from Executive that there has
	been a Payment, or such earlier time as is requested by the Company. In the event that the
	Accounting Firm is serving as accountant or auditor for the individual, entity or group
	effecting the Change in Control, Executive shall appoint another nationally recognized
	accounting firm to make the determinations required hereunder (which accounting firm shall
	then be referred to as the Accounting Firm hereunder). All fees and expenses of the
	Accounting Firm shall be borne solely by the Company. Any Gross-Up Payment as determined
	pursuant to this Section 9, shall be paid by the Company to Executive within five (5) days
	of the receipt of the Accounting Firms determination. If the Accounting Firm determines
	that no Excise Tax is payable by Executive, it shall furnish Executive with a written
	opinion that failure to report the Excise Tax on Executives applicable federal income tax
	return would not result in the imposition of a negligence or similar penalty. Any
	determination by the Accounting Firm shall be binding upon the Company and Executive. As a
	result of the uncertainty of the application of Section 4999 of the Code at the time of the
	initial determination by the Accounting Firm hereunder, it is possible that Gross-Up
	Payments which will not have been made by the Company should have been made
	(Underpayment). In the event that the Company exhausts its remedies pursuant to Section
	9(c) and Executive thereafter is required to make a payment of any Excise Tax, the
	Accounting Firm shall determine the amount of the Underpayment that has occurred and any
	such Underpayment shall be promptly paid by the Company to Executive or for Executives
	benefit.
	     (c) Executive shall notify the Company in writing of any claim by the Internal Revenue
	Service that, if successful, would require the payment by the Company of the Gross-Up
	Payment. Such notification shall be given as soon as practicable but no later than ten (10)
	business days after Executive or his representative is informed in writing of
	11
 
	 
	such claim and shall apprise the Company of the nature of such claim and the date on
	which such claim is requested to be paid. Executive shall not pay such claim prior to the
	expiration of the thirty (30) day period following the date on which Executive gives such
	notice to the Company (or such shorter period ending on the date that any payment of taxes
	with respect to such claim is due). If the Company notifies Executive in writing prior to
	the expiration of such period that it desires to contest such claim, Executive shall:
	     (i) give the Company any information reasonably requested by the Company
	relating to such claim,
	     (ii) take such action in connection with contesting such claim as the Company
	shall reasonably request in writing from time to time, including, without
	limitation, accepting legal representation with respect to such claim by an attorney
	reasonably selected by the Company,
	     (iii) cooperate with the Company in good faith in order effectively to contest
	such claim, and
	     (iv) permit the Company to participate in any proceedings relating to such
	claim; however, that the Company shall bear and pay directly all costs and expenses
	(including additional interest and penalties) incurred in connection with such
	contest and shall indemnify and hold Executive harmless, on an after-tax basis, for
	any Excise Tax or income tax (including interest and penalties with respect thereto)
	imposed as a result of such representation and payment of costs and expenses.
	Without limitation on the foregoing provisions of this Section 9(c), the Company
	shall control all proceedings taken in connection with such contest and, at its sole
	option, may pursue or forego any and all administrative appeals, proceedings,
	hearings and conferences with the taxing authority in respect of any such claim and
	may, at its sole option, either direct Executive to pay the tax claimed and sue for
	a refund or contest the claim in any permissible manner, and Executive agree to
	prosecute such contest to a determination before any administrative tribunal, in a
	court of initial jurisdiction and in one or more appellate courts, as the Company
	shall determine; provided, however, that if the Company directs Executive to pay
	such claim and sue for a refund, the Company shall advance the amount of such
	payment to Executive, on an interest-free basis and shall indemnify and hold
	Executive harmless, on an after-tax basis, from any Excise Tax or income tax
	(including interest or penalties with respect thereto) imposed with respect to such
	advance or with respect to any imputed income with respect to such advance; and
	further provided that any extension of the statute of limitations relating to
	payment of taxes for Executives taxable year with respect to which such contested
	amount is claimed to be due is limited solely to such contested amount. Furthermore,
	the Companys control of the contest shall be limited to issues with respect to
	which a Gross-Up Payment would be payable hereunder and Executive shall be entitled
	to settle or contest, as the case may be, any other issue raised by the Internal
	Revenue Service or any other taxing authority.
	     (d) If, after the receipt by Executive of an amount advanced by the Company pursuant to
	Section 9(c), Executive become entitled to receive any refund with respect to
	12
 
	 
	such claim, Executive shall (subject to the Companys complying with the requirements
	of Section 9(c)) promptly pay to the Company the amount of such refund (together with any
	interest paid or credited thereon after taxes applicable thereto). If, after the receipt by
	Executive of an amount advanced by the Company pursuant to Section 9(c), a determination is
	made that Executive shall not be entitled to any refund with respect to such claim and the
	Company does not notify Executive in writing of its intent to contest such denial of refund
	prior to the expiration of thirty (30) days after such determination, then such advance
	shall be forgiven and shall not be required to be repaid and the amount of such advance
	shall offset, to the extent thereof, the amount of Gross-Up Payment required to be paid.
	     (e) Notwithstanding the provisions of this Section 9 to the contrary, in no event shall
	any payments made to Executive under this Section 9 be made later than the end of the
	calendar year following the calendar year in which Executive remits the Excise Tax.
	10.
	No Obligation to Mitigate Damages, No Effect on Other Contractual Rights.
	Executive
	shall not be required to refund the amount of any payment or employee benefit provided for or
	otherwise mitigate damages under this Agreement by seeking or accepting other employment or
	otherwise, nor shall the amount of any payment required to be made under this Agreement be reduced
	by any compensation earned by Executive as the result of any employment by another employer after
	the date of termination of Executives employment with the Company, or otherwise. Upon receipt of
	written notice from Executive that Executive has been reemployed by another company or entity on a
	full-time basis, benefits, fringe benefits and perquisites otherwise receivable by Executive
	pursuant to Sections 5(d) or 5(e) related to life, health, disability and accident insurance plans
	and programs and other similar benefits, company cars, financial planning, country club
	memberships, and the like (but not incentive compensation, LTIP, pension plans or other similar
	plans and programs) shall be reduced to the extent comparable benefits are made available to
	Executive at his new employment and any such benefits actually received by Executive shall be
	reported to the Company by Executive.
	     The provisions of the Agreement, and any payment or benefit provided for hereunder shall not
	reduce any amount otherwise payable, or in any way diminish Executives existing rights, or rights
	which would occur solely as a result of the passage of time, under any other agreement, contract,
	plan or arrangement with the Company.
	     11. 
	Successors and Binding Agreement.
	     (a) The Company shall require any successor (whether direct or indirect, by purchase,
	merger, consolidation or otherwise) to all or substantially all of the business or assets of
	the Company, by agreement in form and substance satisfactory to Executive, to assume and
	agree to perform this Agreement.
	     (b) This Agreement shall be binding upon the Company and any successor of or to the
	Company, including, without limitation, any person acquiring directly or indirectly all or
	substantially all of the assets of the Company whether by merger, consolidation, sale or
	otherwise (and such successor shall thereafter be deemed the Company for the purposes of
	this Agreement), but shall not otherwise be assignable by the Company.
	13
 
	 
	     (c) This Agreement shall inure to the benefit of and be enforceable by Executive and
	Executives personal or legal representatives, executors, administrators, successors, heirs,
	distributees, devisees and legatees. If Executive should die while any amounts would still
	be payable to Executive pursuant to Sections 5 and 6 hereunder if Executive had continued to
	live, all such amounts, unless otherwise provided herein, shall be paid in accordance with
	the terms of this Agreement to Executives devisee, legatee, or other designee or, if there
	be no such designee, to Executives estate.
	     12. 
	Notices
	. For the purposes of this Agreement, notices and all other communications
	provided for in the Agreement shall be in writing and shall be deemed to have been duly given when
	delivered or mailed by United States registered mail, return receipt requested, postage prepaid,
	addressed to the respective addresses set forth on the first page of this Agreement, provided that
	all notices to the Company shall be directed to the attention of the Chief Executive Officer of the
	Company with a copy to the Secretary of the Company, or to such other address as either party may
	have furnished to the other in writing, except that notices of change of address shall be effective
	only upon receipt.
	     13. 
	Governing Law.
	The validity, interpretation, construction and performance of this
	Agreement shall be governed by the laws of the State of North Carolina, without giving effect to
	the principles of conflict of laws of such State.
	     14. 
	Miscellaneous.
	No provisions of this Agreement may be modified, waived or
	discharged, and this Agreement may not be terminated before the end of the Term, unless such
	waiver, modification, discharge or termination is agreed to in a writing signed by Executive and
	the Company. No waiver by either party hereto at any time of any breach by the other party hereto
	or compliance with, any condition or provision of this Agreement to be performed by such other
	party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at
	any prior or subsequent time. No agreements or representations, oral or otherwise, express or
	implied, with respect to the subject matter hereof, have been made by either party which is not set
	forth expressly in this Agreement.
	     15. 
	Validity.
	The invalidity or unenforceability of any provisions of this Agreement
	shall not affect the validity or enforceability of any other provision of this Agreement, which
	shall remain in full force and effect.
	     16. 
	Counterparts.
	This Agreement may be executed in one or more counterparts, each of
	which shall be deemed to be an original, but all of which together will constitute one and the same
	agreement.
	     17. 
	Withholding of Taxes.
	The Company may withhold from any amounts payable under
	this Agreement all federal, state, city or other taxes as shall be required pursuant to any law or
	government regulation or ruling.
	     18. 
	Nonassignability.
	This Agreement is personal in nature and neither of the parties
	hereto shall, without the consent of the other, assign or transfer this Agreement or any rights or
	obligations hereunder, except as provided in Section 11 above. Without limiting the foregoing,
	Executives right to receive payments hereunder shall not be assignable or transferable, whether by
	pledge, creation of a security interest or otherwise, other than by a transfer by Executives will
	14
 
	 
	or by the laws of descent and distribution and in the event of any attempted assignment or
	transfer contrary to this Section 18 the Company shall have no liability to pay any amounts so
	attempted to be assigned or transferred.
	     19. 
	Legal Fees and Expenses.
	If a Change in Control shall have occurred, thereafter
	the Company shall pay and be solely responsible for any and all attorneys and related fees and
	expenses incurred by Executive to successfully (in whole or in part and whether by modification of
	the Companys position, agreement, compromise, settlement, or administrative or judicial
	determination) enforce this Agreement or any provision hereof or as a result of the Company or any
	Shareholder of the Company contesting the validity or enforceability of this Agreement or any
	provision hereof. To secure the foregoing obligation, the Company shall, within 90 days after being
	requested by Executive to do so, enter into a contract with an insurance company, open a letter of
	credit or establish an escrow in a form satisfactory to Executive. Notwithstanding the provisions
	of this Section 19 to the contrary, in no event shall any payments made to Executive under this
	Section 19 be made for expenses incurred by Executive following the end of the second calendar year
	following the calendar year in which Executives Date of Termination occurs, provided that the
	period during which reimbursement for such expenses may be made may extend to the end of the third
	calendar year in which Executives Date of Termination occurs.
	     20. 
	Employment Rights
	. Nothing expressed or implied in this Agreement shall create
	any right or duty on Executives part or on the part of the Company to have Executive remain in the
	employment of the Company prior to the commencement of the Period of Employment; provided, however,
	that any termination or purported termination of Executives employment by the Company without
	Cause, or termination of Executives employment by Executive under circumstances that would
	constitute Good Reason had a Change in Control occurred, in either case following the commencement
	of any discussion with a third party, or the announcement by a third party of the commencement of,
	or the intention to commence a tender offer, or other intention to acquire all or a portion of the
	equity securities of the Company that ultimately results in a Change in Control shall be deemed to
	be a termination of Executives employment after a Change in Control for purposes of (i) this
	Agreement and both the Period of Employment and the Payment Period shall be deemed to have begun on
	the day prior to such termination and (ii) the Companys Equity Compensation Plan as if the Change
	in Control had occurred on the day prior to such termination (resulting in the full vesting and
	extended exercisability of the Executives outstanding stock options under, and in accordance with,
	the provisions of the Equity Compensation Plan).
	     21. 
	Right of Setoff.
	There shall be no right of setoff or counterclaim against, or
	delay in, any payment by the Company to Executive or Executives designated beneficiary or
	beneficiaries provided for in this Agreement in respect of any claim against Executive or any debt
	or obligation owed by Executive, whether arising hereunder or otherwise.
	     22. 
	Rights to Other Benefits.
	The existence of the Agreement and Executives rights
	hereunder shall be in addition to, and not in lieu of, Executives rights under any other of the
	Companys compensation and benefit plans and programs, and under any other contract or agreement
	between Executive and the Company.
	     23. 
	Prior Agreements.
	This Agreement supersedes and replaces any and all prior
	agreements and understandings between the Company and the Executive with respect to the
	15
 
	 
	subject matter hereof. Any such prior agreements and understandings are no longer in force or
	effect.
	     24. 
	Compliance with Section 409A of the Internal Revenue Code
	.
	Any payments under
	this Agreement that are deemed to be deferred compensation subject to the requirements of Section
	409A (Section 409A) of the Internal Revenue Code of 1986, as amended, are intended to comply with
	the requirements of Section 409A. To this end and notwithstanding any other provision of this
	Agreement to the contrary, if at the time of Executives termination of employment with the
	Company, (i) the Companys securities are publicly traded on an established securities market; (ii)
	Executive is a specified employee (as defined in Section 409A); and (iii) the deferral of the
	commencement of any payments or benefits otherwise payable pursuant to this Agreement as a result
	of such termination of employment is necessary in order to prevent any accelerated or additional
	tax under Section 409A, then the Company will defer the commencement of such payments (without any
	reduction in amount ultimately paid or provided to Executive) that are not paid within the
	short-term deferral rule under Section 409A (and any regulations thereunder) or within the
	involuntary separation exemption of Treasury Regulation § 1.409A-1(b)(9)(iii). Such deferral
	shall last until the date that is six (6) months following Executives termination of employment
	with the Company (or the earliest date as is permitted under Section 409A). Any amounts the
	payment of which are so deferred shall be paid in a lump sum payment within ten (10) days after the
	end of such deferral period. If Executive dies during the deferral period prior to the payment of
	any deferred amount, then the unpaid deferred amount shall be paid to the personal representative
	of Executives estate within sixty (60) days after the date of Executives death. For purposes of
	Section 409A, the right to a series of installment payments under this Agreement shall be treated
	as a right to a series of separate payments.
	     IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Effective Date.
|  |  |  |  |  | 
|  | ENPRO INDUSTRIES, INC. 
 |  | 
|  | By: | /s/ Richard L. Magee |  | 
|  |  | Name: | Richard L. Magee |  | 
|  |  | Title: | Senior Vice President and General
	Counsel |  | 
|  | 
|  |  |  | 
|  | /s/ Stephen E. Macadam |  | 
|  | Stephen E. Macadam |  | 
|  |  |  | 
|  | 
	16
 
	 
	EXHIBIT 1
	     A. If as of Executives Date of Termination Executives years of continuous service under the
	applicable retirement plans for purposes of determining eligibility for normal or early retirement
	plus the length of Executives Payment Period is at least 5, then
	     1. If as of Executives Date of Termination Executives age plus the length of
	Executives Payment Period is at least 65, Executives retirement benefit under Section 5(f)
	will be calculated as a normal retirement benefit to which Executive would have been
	entitled under the terms of the retirement plan in which Executive participates had
	Executive accumulated benefit service under the retirement plan that included the Payment
	Period; and
	     2. If as of Executives Date of Termination Executives age plus the length of
	Executives Payment Period is at least 55 but less than 65, Executives retirement benefit
	under Section 5(f) will be calculated as an early retirement benefit to which Executive
	would have been entitled under the terms of the retirement plan in which Executive
	participates had Executive accumulated benefit service under the retirement plan that
	included the Payment Period. The actuarial reduction used shall be the actuarial reduction
	factor for early retirement, calculated to Executives actual age plus the length of
	Executives Payment Period, at Executives Date of Termination.
	     B. If as of Executives Date of Termination the sum of Executives years of continuous service
	under the applicable retirement plans for purposes of determining eligibility for normal or early
	retirement plus the length of Executives Payment Period is less than 5, or Executives age plus
	the length of Executives Payment Period is less than 55, Executives retirement benefit under
	Section 5(f) will be calculated as a deferred vested pension to which Executive would have been
	entitled under the terms of the retirement plans in which Executive participates had Executive
	accumulated benefit service under the retirement plan that included the Payment Period. The
	actuarial reduction used shall be the actuarial reduction factor for a deferred vested pension,
	calculated to Executives actual age at Executives Date of Termination plus the length of
	Executives Payment Period.
	     C. For purposes of Section 5(f), actuarial equivalent shall be determined using the same
	methods and assumptions as those utilized under the Companys retirement plans and programs
	immediately prior to the Change in Control.
 
	 
	EXHIBIT 2
	BENEFICIARY DESIGNATION
	     I hereby designate the following person(s) as a beneficiary for the purposes of Section
	6(b)(iv) to the extent of the percentage interest listed next to their name:
|  |  |  | 
| NAME |  | PERCENTAGE INTEREST | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	TOTAL (CANNOT EXCEED 100%)
 |  |  | 
| 
	 
 |  |  | 
 
 
	Exhibit 10.19
	MANAGEMENT CONTINUITY AGREEMENT
	     
	THIS AGREEMENT
	dated as of this 11
	th
	day of February 2009 between Orville G.
	Lunking (the Executive) and EnPro Industries, Inc., a North Carolina corporation (the Company).
	     
	WHEREAS,
	the Company considers it essential to the best interests of its shareholders to
	foster the continuous employment of key management personnel in the event there is, or is
	threatened, a change in control of the Company; and
	     
	WHEREAS
	, the Company recognizes that the uncertainty and questions which may arise among key
	management in connection with the possibility of a change in control may result in the departure or
	distraction of key management personnel to the detriment of the Company and its shareholders; and
	     
	WHEREAS
	, the Company desires to provide certain protection to Executive in the event of a
	change in control of the Company as set forth in this Agreement in order to induce Executive to
	remain in the employ of the Company notwithstanding any risks and uncertainties created by the
	possibility of a change in control of the Company;
	WITNESSETH:
	     
	NOW, THEREFORE
	, in consideration of the foregoing and the mutual promises herein contained,
	the parties agree as follows:
	     1. 
	Term
	. The Term of this Agreement shall mean the period commencing on the date
	hereof and ending eighteen (18) months after such date; provided, however, that commencing on the
	date one year after the date hereof, and on each annual anniversary of such date (such date and
	each annual anniversary thereof shall be hereinafter referred to as the Renewal Date), the Term
	shall be automatically extended so as to terminate eighteen (18) months from such Renewal Date,
	unless at least sixty (60) days prior to the Renewal Date the Company shall give notice to the
	Executive that the Term shall not be so extended.
	     2. 
	Period of Employment
	. Executives Period of Employment shall commence on the
	date on which a Change in Control occurs during the Term and shall end on the date that is eighteen
	(18) months after the date on which such Change in Control occurs (subject to the provisions of
	Section 20 below pursuant to which the Period of Employment may be deemed to have commenced prior
	to the date of a Change in Control in certain circumstances).
	     3. 
	Certain Definitions
	. For purposes of this Agreement:
	     Board shall mean the Board of Directors of the Company.
	     Cause shall mean Executives termination of employment with the Company due to (A)
	the willful and continued failure by Executive to substantially perform Executives duties
	with the Company, which failure causes material and demonstrable injury to the Company
	(other than any such failure resulting from Executives incapacity due to physical or mental
	illness), after a demand for substantial performance is delivered
 
	 
	to Executive by the Board which specifically identifies the manner in which the Board
	believes that Executive has not substantially performed Executives duties, and after
	Executive has been given a period (hereinafter known as the Cure Period) of at least
	thirty (30) days to correct Executives performance, or (B) the willful engaging by
	Executive in other gross misconduct materially and demonstrably injurious to the Company.
	For purposes hereof, no act, or failure to act, on Executives part shall be considered
	willful unless conclusively demonstrated to have been done, or omitted to be done, by
	Executive not in good faith and without reasonable belief that Executives action or
	omission was in the best interests of the Company. Notwithstanding the foregoing, Executive
	shall not be deemed to have been terminated for Cause unless and until there shall have been
	delivered to Executive a Notice of Termination which shall include a copy of a resolution
	duly adopted by the affirmative vote of not less than three-quarters of the entire
	membership of the Board at a meeting of the Board called and held for the purpose (after
	reasonable notice to Executive and an opportunity for Executive, together with Executives
	counsel, to be heard before the Board), finding that in the good faith opinion of the Board
	Executive was guilty of conduct set forth above in clause (A) (including the expiration of
	the Cure Period without the correction of Executives performance) or clause (B) above and
	specifying the particulars thereof in detail.
	     Change in Control shall mean:
	     (i) The acquisition by any individual, entity or group (within the meaning of Section
	13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the Exchange
	Act)), of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the
	Exchange Act) of 20% or more of either (A) the then outstanding shares of common stock of
	the Company (the Outstanding Company Common Stock) or (B) the combined voting power of the
	then outstanding voting securities of the Company entitled to vote generally in the election
	of directors (the Outstanding Company Voting Securities); provided, however, that the
	following acquisitions shall not constitute a Change in Control: (A) any acquisition
	directly from the Company (other than by exercise of a conversion privilege), (B) any
	acquisition by the Company or any of its subsidiaries, (C) any acquisition by any employee
	benefit plan (or related trust) sponsored or maintained by the Company or any of its
	subsidiaries or (D) any acquisition by any company with respect to which, following such
	acquisition, more than 70% of, respectively, the then outstanding shares of common stock of
	such company and the combined voting power of the then outstanding voting securities of such
	company entitled to vote generally in the election of directors is then beneficially owned,
	directly or indirectly, by all or substantially all of the individuals and entities who were
	the beneficial owners, respectively, of the Outstanding Company Common Stock and Outstanding
	Company Voting Securities immediately prior to such acquisition in substantially the same
	proportions as their ownership, solely in their capacity as shareholders of the Company,
	immediately prior to such acquisition, of the Outstanding Company Common Stock and
	Outstanding Company Voting Securities, as the case may be; or (ii) individuals who, as of
	the Distribution Date (as such term is defined in the Distribution Agreement among Goodrich
	Corporation, EnPro Industries, Inc. and Coltec Industries Inc.), constitute the Board (the
	Incumbent Board) cease for any reason to constitute at least a majority of the Board;
	provided, however, that any individual becoming a director subsequent to the Distribution
	Date whose election, or nomination for election by the Companys shareholders, was approved
	by a vote of at least a majority of the directors then comprising the Incumbent Board shall
	be considered as though such
	2
 
	 
	individual were a member of the Incumbent Board, but excluding, for this purpose, any
	such individual whose initial assumption of office occurs as a result of either an actual or
	threatened election contest; or (iii) consummation of a reorganization, merger or
	consolidation, in each case, with respect to which all or substantially all of the
	individuals and entities who were the beneficial owners, respectively, of the Outstanding
	Company Common Stock and Outstanding Company Voting Securities immediately prior to such
	reorganization, merger or consolidation, do not, following such reorganization, merger or
	consolidation, beneficially own, directly or indirectly, solely in their capacity as
	shareholders of the Company, more than 70% of, respectively, the then outstanding shares of
	common stock and the combined voting power of the then outstanding voting securities
	entitled to vote generally in the election of directors, as the case may be, of the company
	resulting from such reorganization, merger or consolidation in substantially the same
	proportions as their ownership, immediately prior to such reorganization, merger or
	consolidation of the Outstanding Company Common Stock and Outstanding Company Voting
	Securities, as the case may be; or (iv) consummation of (A) a complete liquidation or
	dissolution of the Company or (B) a sale or other disposition of all or substantially all of
	the assets of the Company, other than to a company, with respect to which following such
	sale or other disposition, more than 70% of, respectively, the then outstanding shares of
	common stock of such company and the combined voting power of the then outstanding voting
	securities of such company entitled to vote generally in the election of directors is then
	beneficially owned, directly or indirectly, by all or substantially all of the individuals
	and entities, solely in their capacity as shareholders of the Company, who were the
	beneficial owners, respectively, of the Outstanding Company Common Stock and Outstanding
	Company Voting Securities immediately prior to such sale or other disposition in
	substantially the same proportion as their ownership, immediately prior to such sale or
	other disposition, of the Outstanding Company Common Stock and Outstanding Company Voting
	Securities, as the case may be.
	     Date of Termination is as defined in Section 8 below.
	     Good Reason shall mean:
	     (i) without Executives express written consent, (A) the assignment to Executive of any
	new duties or responsibilities substantially inconsistent in character with Executives
	duties and responsibilities within the Company immediately prior to a Change in Control, (B)
	any substantial adverse change in Executives duties and responsibilities as in effect
	immediately prior to a Change in Control, including, but not limited to, a reduction in
	duties or responsibilities which occurs because the Company is no longer an independent
	publicly-held entity, (C) any removal of Executive from or any failure to re-elect Executive
	to any director position of the Company, (D) a change in the annual or long term incentive
	plan in which Executive currently participates such that Executives opportunity to earn
	incentive compensation is impaired, (E) a material reduction in the aggregate value of
	Company perquisites made available to Executive, (F) an elimination or material impairment
	of Executives ability to participate in retirement plans comparable to those in which
	Executive currently participates, (G) any substantial increase in Executives obligation to
	travel on the Companys business over Executives present business travel obligations, or
	(H) an elimination or material impairment of Executives ability to receive stock options
	with values comparable to those Executive was granted within the one year period preceding
	the commencement of the Period of Employment; (ii) the failure of the Company to comply
	with any other of its obligations
	3
 
	 
	under Section 4 herein; (iii) the relocation of the offices of the Company at which
	Executive was employed immediately prior to the Change in Control to a location which is
	more than fifty (50) miles from such prior location, or the failure of the Company to (A)
	pay or reimburse Executive, in accordance with the Companys relocation policy for its
	employees in existence immediately prior to a Change in Control, for all reasonable costs
	and expenses; plus gross ups referred to in such policy incurred by Executive relating to
	a change of Executives principal residence in connection with any relocation of the
	Companys offices to which Executive consents, and (B) indemnify Executive against any loss
	(defined as the difference between the actual sale price of such residence and the higher of
	(1) Executives aggregate investment in such residence or (2) the fair market value of such
	residence as determined by the relocation management organization used by the Company
	immediately prior to the Change in Control (or other real estate appraiser designated by
	Executive and reasonably satisfactory to the Company)) realized in the sale of Executives
	principal residence in connection with any such change of residence; (iv) the failure of
	the Company to obtain the assumption of and the agreement to perform this Agreement by any
	successor as contemplated in Section 11 hereof; or (v) any purported termination of
	Executives employment during the Period of Employment which is not effected pursuant to a
	Notice of Termination satisfying the requirements of Section 7 hereof.
	     Incapacity Discharge means Executives termination of employment with the Company if,
	as a result of Executives incapacity due to physical or mental illness, Executive shall
	have been absent from Executives duties with the Company on a full-time basis for
	one-hundred twenty (120) consecutive business days, and within thirty (30) days after a
	written Notice of Termination is given, Executive shall not have returned to the full-time
	performance of Executives duties.
	     Mandatory Retirement Date shall mean the compulsory retirement date, if any,
	established by the Company for those executives of the Company who, by reason of their
	positions and the size of their nonforfeitable annual retirement benefits under the
	Companys pension, profit-sharing, and deferred compensation plans, are exempt from, the
	provisions of the Age Discrimination in Employment Act, 29 U.S.C. Sections 621, et seq.,
	which date shall not in any event be earlier for any executive than the last day of the
	month in which such Executive reaches age 65.
	     Notice of Termination is as defined in Section 7 below.
	     Payment Period shall mean eighteen (18) months, provided that the Payment Period
	shall not exceed the number of whole calendar months between the Executives Date of
	Termination and Mandatory Retirement Date (if applicable).
	     4. 
	Compensation During Period of Employment
	. For so long during Executives Period of
	Employment as Executive is an employee of the Company, the Company shall be obligated to compensate
	Executive as follows:
	     (a) Executive shall continue to receive Executives full base salary at the rate in
	effect immediately prior to the Change in Control. Executives base salary shall be
	increased annually, with each such increase due on the anniversary date of Executives most
	recent previous increase. Each such increase shall be no less than an amount which
	4
 
	 
	at least equals on a percentage basis the mean of the annualized percentage increases
	in base salary for all elected officers of the Company during the two full calendar years
	immediately preceding the Change in Control.
	     (b) Executive shall continue to participate in all benefit and compensation plans
	(including but not limited to the Equity Compensation Plan, Long-Term Incentive Program,
	Performance Share Deferred Compensation Plan, Annual Performance Plan, Executive Life
	Insurance Program, Deferred Compensation Plan, 401(K) plan, savings plan, flexible benefits
	plan, life insurance plan, health and accident plan or disability plan) in which Executive
	was participating immediately prior to the Change in Control, or in plans providing
	substantially similar benefits, in either case upon terms and conditions and at levels at
	least as favorable as those provided to Executive under the plans in which Executive was
	participating immediately prior to the Change in Control;
	     (c) Executive shall continue to receive all fringe benefits, perquisites, and similar
	arrangements which Executive was entitled to receive immediately prior to the Change in
	Control; and
	     (d) Executive shall continue to receive annually the number of paid vacation days and
	holidays Executive was entitled to receive immediately prior to the Change in Control.
	     5. 
	Compensation Upon Termination of Employment
	. The following provisions set forth
	the benefits that may become payable to Executive upon termination of employment with the Company
	during the Period of Employment in accordance with, and subject to, the provisions of Section 6
	below:
	     (a) By not later than the fifth business day following the Date of Termination, the
	Company shall pay Executive in a lump sum an amount equal to the sum of the following:
	     (i) any base salary that is earned but unpaid as of the Date of Termination;
	     (ii) a pro rata portion of the target incentive amount under the Annual
	Performance Plan for the calendar year in which the Date of Termination occurs
	(based on the number of calendar days in such calendar year completed through the
	Date of Termination); and
	     (iii) a pro rata portion of the calculated market value of the phantom
	Performance Shares, if any, awarded to Executive under the Companys Long-Term
	Incentive Program (the LTIP) for each Plan Cycle under the LTIP that has not been
	completed as of the Date of Termination, determined as follows:
	     (A) The performance for each such Plan Cycle under the applicable LTIP
	award agreement shall be determined based on (x) for any completed calendar
	year of the Plan Cycle as of the Date of Termination, actual performance for
	the calendar year, (y) for the calendar year in which the Date of
	Termination occurs if at least one calendar quarter has been completed
	during such calendar year, the greater of target
	5
 
	 
	performance for the calendar year or actual performance for the
	completed calendar quarter(s) for the calendar year annualized for the year,
	and (z) for any other calendar years of the Plan Cycle, target performance
	for the calendar year.
	     (B) The number of phantom Performance Shares for each such Plan Cycle
	shall be adjusted in accordance with the formula set forth in the applicable
	LTIP award agreement based on the performance for the Plan Cycle determined
	under paragraph (A) above.
	     (C) The pro rata portion of the calculated market value of the
	number of phantom Performance Shares adjusted in accordance with paragraph
	(B) above shall be based on the number of calendar days in the Plan Cycle
	completed through the Date of Termination.
	Section 5(c) below sets for the method for determining the target incentive amount under
	the Annual Performance Plan and the calculated market value of phantom Performance Shares
	under the LTIP. Any amounts payable under Sections 5(a)(ii) or (iii) above shall be offset
	dollar-for-dollar by any pro rata payments otherwise provided for under the Annual
	Performance Plan or the LTIP.
	     (b) In lieu of any salary payments that Executive would have received if he had
	continued in the employment of the Company during the Payment Period, the Company shall pay
	to Executive in a lump sum, by not later than the fifth business day following the Date of
	Termination, an amount equal to one-twelfth of Executives annualized base salary in effect
	immediately prior to the Date of Termination, multiplied by the number of months in the
	Payment Period.
	     (c) By not later than the fifth day following the Date of Termination, the Company
	shall pay Executive in a lump sum an amount equal to the sum of:
	     (i) under the Annual Performance Plan (and in lieu of any further awards under
	the Annual Performance Plan that Executive would have received if he had continued
	in the employment of the Company during the Payment Period), the number of months in
	the Payment Period multiplied by the greatest of one-twelfth of: (A) the amount most
	recently paid to Executive for a full calendar year; (B) Executives target
	incentive amount for the calendar year in which his Date of Termination occurs; or
	(C) Executives target incentive amount in effect prior to the Change in Control
	for the calendar year in which the Change in Control occurs; plus, if applicable,
	     (ii) under the LTIP (and in lieu of any further grants under the LTIP that
	Executive would have received if he had continued in the employment of the Company
	during the Payment Period), twelve (12) multiplied by the greatest of: (A) with
	respect to the most recently completed Plan Cycle as of the Date of Termination,
	one-twelfth of the calculated market value of the Performance Shares actually
	awarded Executive (including the value of any Performance Shares Executive may have
	elected to defer under the Performance Share Deferred Compensation Program); (B)
	with respect to the most recently
	6
 
	 
	commenced Plan Cycle under the LTIP (if Executive is a participant in such Plan
	Cycle) prior to Executives Date of Termination, one-twelfth of the calculated
	market value of the phantom Performance Shares, if any, awarded to Executive; or
	(C) with respect to the most recently commenced Plan Cycle prior to the date of the
	occurrence of the Change in Control, one-twelfth of the calculated market value of
	the phantom Performance Shares, if any, awarded to Executive.
	     For purposes of this Section 5, Executives target incentive amount under the
	Annual Performance Plan for a given calendar year (i.e., the calendar year in which
	the Date of Termination occurs or the Change in Control occurs, as applicable) is
	determined by multiplying (i) Executives annualized total gross base salary for the
	calendar year by (ii) the incentive target percentage which is applicable to
	Executives incentive category under the Annual Performance Plan for the calendar
	year. For purposes of this Section 5, the calculated market value of each
	Performance Share actually awarded upon completion of a Plan Cycle, Performance
	Share deferred under the Performance Share Deferred Compensation Program or phantom
	Performance Share granted under the LTIP shall be the mean of the high and low
	prices of the Companys common stock on the relevant date as reported on the New
	York Stock Exchange Composite Transactions listing (or similar report), or, if no
	sale was made on such date, then on the next preceding day on which a sale was made
	multiplied by the number of shares involved in the calculation. The relevant date
	for Section 5(a)(iii) and clauses 5(c)(ii)(B) and 5(c)(ii)(C) is the date upon which
	the Compensation Committee (Committee) of the Board of Directors awarded the
	phantom Performance Shares in question; for clause 5(c)(ii)(A) the relevant date is
	the date on which the Committee made a determination of attainment of financial
	objectives and awarded Performance Shares (including any Performance Shares
	Executive may have elected to defer under the Performance Share Deferred
	Compensation Program).
	     Any payments received pursuant to Sections 5(c)(i) or (ii) above shall be in
	addition to, and not in lieu of, any payments required to be made to Executive as
	the result of the happening of an event that would constitute a change in control
	pursuant to the provisions of the Annual Performance Plan or LTIP, as applicable.
	     (d) By not later than the fifth day following the Date of Termination, the Company
	shall pay Executive in a lump sum an amount equal to the sum of:
	     (i) If Executive is under age 55, or over the age of 55 but not eligible to
	retire, at the Date of Termination the present value of all health and welfare
	benefits the Executive would have been entitled to had the Executive continued as an
	employee of the Company during the Payment Period and been entitled to or
	participated in the same health and welfare benefits during the Payment Period as
	immediately prior to the Date of Termination plus an amount in cash equal to the
	amount necessary to cause the amount of the aggregate after-tax lump sum payment the
	Executive receives pursuant to this provision to be equal to the aggregate after-tax
	value of the benefits which Executive would have received if Executive continued to
	receive such benefits as an employee; or
	7
 
	 
	     (ii) If Executive is age 55 or over and eligible to retire on the Date of
	Termination, the present value of the health and welfare benefits to which Executive
	would have been entitled under the Companys general retirement policies if
	Executive retired on the Date of Termination with the Company paying that percentage
	of the premium cost of the plans which it would have paid under the terms of the
	plans in effect immediately prior to the Change of Control with respect to
	individuals who retire at age 65, regardless of Executives actual age on the
	Termination Date, provided such lump sum value would be at least equal to the lump
	sum value of the benefits which would have been payable if Executive had been
	eligible to retire and had retired immediately prior to the Change in Control.
	     (e) By not later than the fifth day following the Date of Termination, the Company
	shall pay Executive in a lump sum an amount equal to the sum of the present value of the
	fringe benefit programs, perquisites (if any), and similar arrangements the Executive would
	have been entitled to receive had the Executive continued in employment with the Company for
	the Payment Period and been entitled to or participated in the same such benefits during the
	Payment Period as immediately prior to the Date of Termination. In addition and
	notwithstanding any provision of the Companys 2002 Equity Compensation Plan (or any
	comparable equity award plan of the Company) or any applicable award agreement thereunder to
	the contrary, Executive may exercise any of Executives stock options that are vested as of
	Executives Date of Termination at any time during the Payment Period (but not exceeding the
	original expiration date of the options).
	     (f) The Company shall, in addition to the benefits to which Executive is entitled under
	the retirement plans or programs sponsored by the Company or its affiliates in which
	Executive participates (including without limitation any Supplemental Executive Retirement
	Plan in which Executive participates, if applicable), pay Executive in a lump sum in cash by
	no later than the fifth day following the Date of Termination an amount equal to the
	actuarial equivalent of the retirement pension to which Executive would have been entitled
	under the terms of such retirement plans or programs had Executive accumulated additional
	years of continuous service under such plans equal in length to Executives Payment Period.
	The length of the Payment Period will be added to total years of continuous service for
	determining vesting, the amount of benefit accrual, to the age which Executive will be
	considered to be for the purposes of determining eligibility for normal or early retirement
	calculations and the age used for determining the amount of any actuarial reduction. For the
	purposes of calculating the additional benefit accrual under this paragraph, the amount of
	compensation Executive will be deemed to have received during each month of Executives
	Payment Period shall be equal to the sum of Executives annual base salary prorated on a
	monthly basis as provided for under Section 4(a) immediately prior to the Date of
	Termination (including salary increases), plus under the Companys Annual Performance Plan
	the greatest of one-twelfth of:
	     (i) the amount most recently paid to Executive for a full calendar year,
	     (ii) Executives target incentive amount for the calendar year in which
	Executives Date of Termination occurs, or
	8
 
	 
	     (iii) Executives target incentive amount in effect prior to the Change in
	Control for the calendar year in which the Change in Control occurs. Attached as
	Exhibit 1 is an illustration, not intending to be exhaustive, of examples of how
	inclusion of the Payment Period may affect the calculation of Executives retirement
	benefit.
	     (g) In no event shall any amount payable to Executive described in this Section 5 be
	considered compensation or earnings under any pension, savings or other retirement plan of
	the Company.
	     6. 
	Termination
	.
	     (a)
	Termination Without Compensation.
	If Executives employment is terminated for any
	of the following reasons, Executive shall not be entitled by virtue of this Agreement to any
	of the benefits provided in the foregoing Section 5:
	     (i) If, prior to the commencement of the Period of Employment, Executives
	employment with the Company is terminated at any time for any reason, including
	without limitation due to (A) Executives death, (B) an Incapacity Discharge, (C) a
	termination initiated by the Company with or without Cause or (D) resignation,
	retirement or other termination initiated by Executive with or without Good Reason,
	subject, however, to the provisions of Section 20 below.
	     (ii) If Executives employment with the Company is terminated during the
	Period of Employment with Cause.
	     (iii) If Executive resigns, retires or otherwise voluntarily terminates
	employment with the Company during the Period of Employment without Good Reason.
	     (b)
	Termination with Compensation.
	If Executives employment is terminated for any of
	the following reasons, Executive shall be entitled by virtue of this Agreement to the
	benefits provided in the foregoing Section 5 as follows:
	     (i) If, during the Period of Employment, the Company discharges Executive
	other than for Cause, Executive shall receive all of the benefits and payments
	provided in Section 5.
	     (ii) Executive may terminate his employment with the Company at any time
	during the Period of Employment for Good Reason (Good Reason Termination) and
	shall receive all of the benefits and payments provided in Section 5.
	     (iii) If, during the Period of Employment, Executive either (A) retires from
	employment with the Company or (B) if the Company discharges Executive due to an
	Incapacity Discharge, in either case while Executive has cause to terminate his
	employment as a Good Reason Termination (whether or not Executive has provided
	Notice of Termination to the Company pursuant to
	9
 
	 
	Section 7), Executive shall receive all of the benefits and payments provided
	in Section 5.
	     (iv) If Executive dies while employed by the Company during the Period of
	Employment while having cause to terminate his employment as a Good Reason
	Termination (whether or not Executive has provided Notice of Termination to the
	Company pursuant to Section 7), Executives beneficiary or beneficiaries named on
	Exhibit 2 to this Agreement (or Executives estate if he has not named a
	beneficiary) shall be entitled to receive those payments provided under Sections
	5(a), 5(b) and 5(c) of this Agreement in addition to any benefits that such
	beneficiaries would be entitled under any other plan, program or policy of the
	Company as a result of Executives employment with the Company.
	     (v) Executive may become eligible for the benefits and payments under Section
	5 for termination of employment prior to a Change in Control in accordance with, and
	subject to, the provisions of Section 20 below.
	     7. 
	Notice of Termination.
	Any termination of Executives employment by the Company or
	any termination by Executive as a Good Reason Termination shall be communicated by written notice
	to the other party hereto. For purposes of this Agreement, such notice shall be referred to as a
	Notice of Termination. Such notice shall, to the extent applicable, set forth the specific reason
	for termination, and shall set forth in reasonable detail the facts and circumstances claimed to
	provide a basis for termination of Executives employment under the provision so indicated.
	     8. 
	Date of Termination.
	Date of Termination shall mean:
	     (a) If Executive terminates Executives employment as a Good Reason Termination, the
	date specified in the Notice of Termination, but in no event more than sixty (60) days after
	Notice of Termination is given.
	     (b) If Executives employment is terminated with Cause, the date on which a Notice of
	Termination is given, except that the Date of Termination shall not be any date prior to the
	date on which the Cure Period expires without the correction of Executives performance (if
	applicable).
	     (c) If Executives employment pursuant to this Agreement is terminated following
	absence due to physical incapacity as an Incapacity Discharge, then the Date of Termination
	shall be thirty (30) days after Notice of Termination is given (provided that Executive
	shall not have returned to the performance of Executives duties on a full-time basis during
	such thirty (30) day period).
	     (d) A termination of employment by either the Company or by Executive shall not affect
	any rights Executive or Executives surviving spouse or beneficiaries may have pursuant to
	any other agreement or plan of the Company providing benefits to Executive, except as
	provided in such agreement or plan.
	10
 
	 
	     9. 
	Certain Additional Payments
	.
	     (a) Anything in this Agreement to the contrary notwithstanding, in the event it shall
	be determined that any payment or distribution by the Company to Executive or for
	Executives benefit (whether paid or payable or distributed or distributable pursuant to the
	terms of this Agreement or otherwise, but determined without regard to any additional
	payments required under this Section 9) (a Payment) would be subject to the excise tax
	imposed by Section 4999 (or any successor provisions) of the Internal Revenue Code of 1986,
	as amended (the Code), or any interest or penalty is incurred by Executive with respect to
	such excise tax (such excise tax, together with any such interest and penalties, is
	hereinafter collectively referred to as the Excise Tax), then Executive shall be entitled
	to receive an additional payment (a Gross-Up Payment) in an amount such that after payment
	by Executive of all taxes (including any interest or penalties imposed with respect to such
	taxes), including, without limitation, any income taxes (and any interest and penalties
	imposed with respect thereto) and Excise Tax imposed on the Gross-Up Payment, Executive
	retains an amount of the Gross-Up Payment equal to the Excise Tax imposed upon the Payments.
	     (b) Subject to the provisions of Section 9(c), all determinations required to be made
	under this Section 9, including whether and when such a Gross-Up Payment is required and the
	amount of such Gross-Up Payment and the assumptions to be utilized in arriving at such
	determination, shall be made by Ernst & Young (or their successors) (the Accounting Firm)
	which shall provide detailed supporting calculations both to the Company and to Executive
	within fifteen (15) business days of the receipt of notice from Executive that there has
	been a Payment, or such earlier time as is requested by the Company. In the event that the
	Accounting Firm is serving as accountant or auditor for the individual, entity or group
	effecting the Change in Control, Executive shall appoint another nationally recognized
	accounting firm to make the determinations required hereunder (which accounting firm shall
	then be referred to as the Accounting Firm hereunder). All fees and expenses of the
	Accounting Firm shall be borne solely by the Company. Any Gross-Up Payment as determined
	pursuant to this Section 9, shall be paid by the Company to Executive within five (5) days
	of the receipt of the Accounting Firms determination. If the Accounting Firm determines
	that no Excise Tax is payable by Executive, it shall furnish Executive with a written
	opinion that failure to report the Excise Tax on Executives applicable federal income tax
	return would not result in the imposition of a negligence or similar penalty. Any
	determination by the Accounting Firm shall be binding upon the Company and Executive. As a
	result of the uncertainty of the application of Section 4999 of the Code at the time of the
	initial determination by the Accounting Firm hereunder, it is possible that Gross-Up
	Payments which will not have been made by the Company should have been made
	(Underpayment). In the event that the Company exhausts its remedies pursuant to Section
	9(c) and Executive thereafter is required to make a payment of any Excise Tax, the
	Accounting Firm shall determine the amount of the Underpayment that has occurred and any
	such Underpayment shall be promptly paid by the Company to Executive or for Executives
	benefit.
	     (c) Executive shall notify the Company in writing of any claim by the Internal Revenue
	Service that, if successful, would require the payment by the Company of the Gross-Up
	Payment. Such notification shall be given as soon as practicable but no later than ten (10)
	business days after Executive or his representative is informed in writing of
	11
 
	 
	such claim and shall apprise the Company of the nature of such claim and the date on
	which such claim is requested to be paid. Executive shall not pay such claim prior to the
	expiration of the thirty (30) day period following the date on which Executive gives such
	notice to the Company (or such shorter period ending on the date that any payment of taxes
	with respect to such claim is due). If the Company notifies Executive in writing prior to
	the expiration of such period that it desires to contest such claim, Executive shall:
	     (i) give the Company any information reasonably requested by the Company
	relating to such claim,
	     (ii) take such action in connection with contesting such claim as the Company
	shall reasonably request in writing from time to time, including, without
	limitation, accepting legal representation with respect to such claim by an attorney
	reasonably selected by the Company,
	     (iii) cooperate with the Company in good faith in order effectively to contest
	such claim, and
	     (iv) permit the Company to participate in any proceedings relating to such
	claim; however, that the Company shall bear and pay directly all costs and expenses
	(including additional interest and penalties) incurred in connection with such
	contest and shall indemnify and hold Executive harmless, on an after-tax basis, for
	any Excise Tax or income tax (including interest and penalties with respect thereto)
	imposed as a result of such representation and payment of costs and expenses.
	Without limitation on the foregoing provisions of this Section 9(c), the Company
	shall control all proceedings taken in connection with such contest and, at its sole
	option, may pursue or forego any and all administrative appeals, proceedings,
	hearings and conferences with the taxing authority in respect of any such claim and
	may, at its sole option, either direct Executive to pay the tax claimed and sue for
	a refund or contest the claim in any permissible manner, and Executive agree to
	prosecute such contest to a determination before any administrative tribunal, in a
	court of initial jurisdiction and in one or more appellate courts, as the Company
	shall determine; provided, however, that if the Company directs Executive to pay
	such claim and sue for a refund, the Company shall advance the amount of such
	payment to Executive, on an interest-free basis and shall indemnify and hold
	Executive harmless, on an after-tax basis, from any Excise Tax or income tax
	(including interest or penalties with respect thereto) imposed with respect to such
	advance or with respect to any imputed income with respect to such advance; and
	further provided that any extension of the statute of limitations relating to
	payment of taxes for Executives taxable year with respect to which such contested
	amount is claimed to be due is limited solely to such contested amount. Furthermore,
	the Companys control of the contest shall be limited to issues with respect to
	which a Gross-Up Payment would be payable hereunder and Executive shall be entitled
	to settle or contest, as the case may be, any other issue raised by the Internal
	Revenue Service or any other taxing authority.
	     (d) If, after the receipt by Executive of an amount advanced by the Company pursuant to
	Section 9(c), Executive become entitled to receive any refund with respect to
	12
 
	 
	such claim, Executive shall (subject to the Companys complying with the requirements
	of Section 9(c)) promptly pay to the Company the amount of such refund (together with any
	interest paid or credited thereon after taxes applicable thereto). If, after the receipt by
	Executive of an amount advanced by the Company pursuant to Section 9(c), a determination is
	made that Executive shall not be entitled to any refund with respect to such claim and the
	Company does not notify Executive in writing of its intent to contest such denial of refund
	prior to the expiration of thirty (30) days after such determination, then such advance
	shall be forgiven and shall not be required to be repaid and the amount of such advance
	shall offset, to the extent thereof, the amount of Gross-Up Payment required to be paid.
	     (e) Notwithstanding the provisions of this Section 9 to the contrary, in no event shall
	any payments made to Executive under this Section 9 be made later than the end of the
	calendar year following the calendar year in which Executive remits the Excise Tax.
	10.
	No Obligation to Mitigate Damages, No Effect on Other Contractual Rights.
	Executive
	shall not be required to refund the amount of any payment or employee benefit provided for or
	otherwise mitigate damages under this Agreement by seeking or accepting other employment or
	otherwise, nor shall the amount of any payment required to be made under this Agreement be reduced
	by any compensation earned by Executive as the result of any employment by another employer after
	the date of termination of Executives employment with the Company, or otherwise. Upon receipt of
	written notice from Executive that Executive has been reemployed by another company or entity on a
	full-time basis, benefits, fringe benefits and perquisites otherwise receivable by Executive
	pursuant to Sections 5(d) or 5(e) related to life, health, disability and accident insurance plans
	and programs and other similar benefits, company cars, financial planning, country club
	memberships, and the like (but not incentive compensation, LTIP, pension plans or other similar
	plans and programs) shall be reduced to the extent comparable benefits are made available to
	Executive at his new employment and any such benefits actually received by Executive shall be
	reported to the Company by Executive.
	     The provisions of the Agreement, and any payment or benefit provided for hereunder shall not
	reduce any amount otherwise payable, or in any way diminish Executives existing rights, or rights
	which would occur solely as a result of the passage of time, under any other agreement, contract,
	plan or arrangement with the Company.
	     11. 
	Successors and Binding Agreement.
	     (a) The Company shall require any successor (whether direct or indirect, by purchase,
	merger, consolidation or otherwise) to all or substantially all of the business or assets of
	the Company, by agreement in form and substance satisfactory to Executive, to assume and
	agree to perform this Agreement.
	     (b) This Agreement shall be binding upon the Company and any successor of or to the
	Company, including, without limitation, any person acquiring directly or indirectly all or
	substantially all of the assets of the Company whether by merger, consolidation, sale or
	otherwise (and such successor shall thereafter be deemed the Company for the purposes of
	this Agreement), but shall not otherwise be assignable by the Company.
	13
 
	 
	     (c) This Agreement shall inure to the benefit of and be enforceable by Executive and
	Executives personal or legal representatives, executors, administrators, successors, heirs,
	distributees, devisees and legatees. If Executive should die while any amounts would still
	be payable to Executive pursuant to Sections 5 and 6 hereunder if Executive had continued to
	live, all such amounts, unless otherwise provided herein, shall be paid in accordance with
	the terms of this Agreement to Executives devisee, legatee, or other designee or, if there
	be no such designee, to Executives estate.
	     12. 
	Notices
	. For the purposes of this Agreement, notices and all other communications
	provided for in the Agreement shall be in writing and shall be deemed to have been duly given when
	delivered or mailed by United States registered mail, return receipt requested, postage prepaid,
	addressed to the respective addresses set forth on the first page of this Agreement, provided that
	all notices to the Company shall be directed to the attention of the Chief Executive Officer of the
	Company with a copy to the Secretary of the Company, or to such other address as either party may
	have furnished to the other in writing, except that notices of change of address shall be effective
	only upon receipt.
	     13. 
	Governing Law.
	The validity, interpretation, construction and performance of this
	Agreement shall be governed by the laws of the State of North Carolina, without giving effect to
	the principles of conflict of laws of such State.
	     14. 
	Miscellaneous.
	No provisions of this Agreement may be modified, waived or
	discharged, and this Agreement may not be terminated before the end of the Term, unless such
	waiver, modification, discharge or termination is agreed to in a writing signed by Executive and
	the Company. No waiver by either party hereto at any time of any breach by the other party hereto
	or compliance with, any condition or provision of this Agreement to be performed by such other
	party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at
	any prior or subsequent time. No agreements or representations, oral or otherwise, express or
	implied, with respect to the subject matter hereof, have been made by either party which is not set
	forth expressly in this Agreement.
	     15. 
	Validity.
	The invalidity or unenforceability of any provisions of this Agreement
	shall not affect the validity or enforceability of any other provision of this Agreement, which
	shall remain in full force and effect.
	     16. 
	Counterparts.
	This Agreement may be executed in one or more counterparts, each of
	which shall be deemed to be an original, but all of which together will constitute one and the same
	agreement.
	     17. 
	Withholding of Taxes.
	The Company may withhold from any amounts payable under
	this Agreement all federal, state, city or other taxes as shall be required pursuant to any law or
	government regulation or ruling.
	     18. 
	Nonassignability.
	This Agreement is personal in nature and neither of the parties
	hereto shall, without the consent of the other, assign or transfer this Agreement or any rights or
	obligations hereunder, except as provided in Section 11 above. Without limiting the foregoing,
	Executives right to receive payments hereunder shall not be assignable or transferable, whether by
	pledge, creation of a security interest or otherwise, other than by a transfer by Executives will
	14
 
	 
	or by the laws of descent and distribution and in the event of any attempted assignment or
	transfer contrary to this Section 18 the Company shall have no liability to pay any amounts so
	attempted to be assigned or transferred.
	     19. 
	Legal Fees and Expenses.
	If a Change in Control shall have occurred, thereafter
	the Company shall pay and be solely responsible for any and all attorneys and related fees and
	expenses incurred by Executive to successfully (in whole or in part and whether by modification of
	the Companys position, agreement, compromise, settlement, or administrative or judicial
	determination) enforce this Agreement or any provision hereof or as a result of the Company or any
	Shareholder of the Company contesting the validity or enforceability of this Agreement or any
	provision hereof. To secure the foregoing obligation, the Company shall, within 90 days after being
	requested by Executive to do so, enter into a contract with an insurance company, open a letter of
	credit or establish an escrow in a form satisfactory to Executive. Notwithstanding the provisions
	of this Section 19 to the contrary, in no event shall any payments made to Executive under this
	Section 19 be made for expenses incurred by Executive following the end of the second calendar year
	following the calendar year in which Executives Date of Termination occurs, provided that the
	period during which reimbursement for such expenses may be made may extend to the end of the third
	calendar year in which Executives Date of Termination occurs.
	     20. 
	Employment Rights
	. Nothing expressed or implied in this Agreement shall create
	any right or duty on Executives part or on the part of the Company to have Executive remain in the
	employment of the Company prior to the commencement of the Period of Employment; provided, however,
	that any termination or purported termination of Executives employment by the Company without
	Cause, or termination of Executives employment by Executive under circumstances that would
	constitute Good Reason had a Change in Control occurred, in either case following the commencement
	of any discussion with a third party, or the announcement by a third party of the commencement of,
	or the intention to commence a tender offer, or other intention to acquire all or a portion of the
	equity securities of the Company that ultimately results in a Change in Control shall be deemed to
	be a termination of Executives employment after a Change in Control for purposes of (i) this
	Agreement and both the Period of Employment and the Payment Period shall be deemed to have begun on
	the day prior to such termination and (ii) the Companys Equity Compensation Plan as if the Change
	in Control had occurred on the day prior to such termination (resulting in the full vesting and
	extended exercisability of the Executives outstanding stock options under, and in accordance with,
	the provisions of the Equity Compensation Plan).
	     21. 
	Right of Setoff.
	There shall be no right of setoff or counterclaim against, or
	delay in, any payment by the Company to Executive or Executives designated beneficiary or
	beneficiaries provided for in this Agreement in respect of any claim against Executive or any debt
	or obligation owed by Executive, whether arising hereunder or otherwise.
	     22. 
	Rights to Other Benefits.
	The existence of the Agreement and Executives rights
	hereunder shall be in addition to, and not in lieu of, Executives rights under any other of the
	Companys compensation and benefit plans and programs, and under any other contract or agreement
	between Executive and the Company.
	     23. 
	Prior Agreements.
	This Agreement supersedes and replaces any and all prior
	agreements and understandings between the Company and the Executive with respect to the
	15
 
	 
	subject matter hereof. Any such prior agreements and understandings are no longer in force or
	effect.
	     24. 
	Compliance with Section 409A of the Internal Revenue Code
	.
	Any payments under
	this Agreement that are deemed to be deferred compensation subject to the requirements of Section
	409A (Section 409A) of the Internal Revenue Code of 1986, as amended, are intended to comply with
	the requirements of Section 409A. To this end and notwithstanding any other provision of this
	Agreement to the contrary, if at the time of Executives termination of employment with the
	Company, (i) the Companys securities are publicly traded on an established securities market; (ii)
	Executive is a specified employee (as defined in Section 409A); and (iii) the deferral of the
	commencement of any payments or benefits otherwise payable pursuant to this Agreement as a result
	of such termination of employment is necessary in order to prevent any accelerated or additional
	tax under Section 409A, then the Company will defer the commencement of such payments (without any
	reduction in amount ultimately paid or provided to Executive) that are not paid within the
	short-term deferral rule under Section 409A (and any regulations thereunder) or within the
	involuntary separation exemption of Treasury Regulation § 1.409A-1(b)(9)(iii). Such deferral
	shall last until the date that is six (6) months following Executives termination of employment
	with the Company (or the earliest date as is permitted under Section 409A). Any amounts the
	payment of which are so deferred shall be paid in a lump sum payment within ten (10) days after the
	end of such deferral period. If Executive dies during the deferral period prior to the payment of
	any deferred amount, then the unpaid deferred amount shall be paid to the personal representative
	of Executives estate within sixty (60) days after the date of Executives death. For purposes of
	Section 409A, the right to a series of installment payments under this Agreement shall be treated
	as a right to a series of separate payments.
	     IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Effective Date.
|  |  |  |  |  | 
|  | ENPRO INDUSTRIES, INC. 
 |  | 
|  | By: | /s/ Stephen E. Macadam |  | 
|  |  | Name: | Stephen E. Macadam |  | 
|  |  | Title: | President and Chief Executive Officer |  | 
|  | 
|  |  |  | 
|  |  | /s/ Orville G. Lunking |  | 
|  |  | Orville G. Lunking |  | 
|  |  |  | 
|  | 
	16
 
	 
	EXHIBIT 1
	     A. If as of Executives Date of Termination Executives years of continuous service under the
	applicable retirement plans for purposes of determining eligibility for normal or early retirement
	plus the length of Executives Payment Period is at least 5, then
	     1. If as of Executives Date of Termination Executives age plus the length of
	Executives Payment Period is at least 65, Executives retirement benefit under Section 5(f)
	will be calculated as a normal retirement benefit to which Executive would have been
	entitled under the terms of the retirement plan in which Executive participates had
	Executive accumulated benefit service under the retirement plan that included the Payment
	Period; and
	     2. If as of Executives Date of Termination Executives age plus the length of
	Executives Payment Period is at least 55 but less than 65, Executives retirement benefit
	under Section 5(f) will be calculated as an early retirement benefit to which Executive
	would have been entitled under the terms of the retirement plan in which Executive
	participates had Executive accumulated benefit service under the retirement plan that
	included the Payment Period. The actuarial reduction used shall be the actuarial reduction
	factor for early retirement, calculated to Executives actual age plus the length of
	Executives Payment Period, at Executives Date of Termination.
	     B. If as of Executives Date of Termination the sum of Executives years of continuous service
	under the applicable retirement plans for purposes of determining eligibility for normal or early
	retirement plus the length of Executives Payment Period is less than 5, or Executives age plus
	the length of Executives Payment Period is less than 55, Executives retirement benefit under
	Section 5(f) will be calculated as a deferred vested pension to which Executive would have been
	entitled under the terms of the retirement plans in which Executive participates had Executive
	accumulated benefit service under the retirement plan that included the Payment Period. The
	actuarial reduction used shall be the actuarial reduction factor for a deferred vested pension,
	calculated to Executives actual age at Executives Date of Termination plus the length of
	Executives Payment Period.
	     C. For purposes of Section 5(f), actuarial equivalent shall be determined using the same
	methods and assumptions as those utilized under the Companys retirement plans and programs
	immediately prior to the Change in Control.
 
	 
	EXHIBIT 2
	BENEFICIARY DESIGNATION
	     I hereby designate the following person(s) as a beneficiary for the purposes of Section
	6(b)(iv) to the extent of the percentage interest listed next to their name:
|  |  |  | 
| NAME |  | PERCENTAGE INTEREST | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	 
 |  |  | 
| 
	TOTAL (CANNOT EXCEED 100%)
 |  |  | 
| 
	 
 |  |  |